WO2018190383A1 - Dispersion liquid containing dispersant for pigments or powders - Google Patents
Dispersion liquid containing dispersant for pigments or powders Download PDFInfo
- Publication number
- WO2018190383A1 WO2018190383A1 PCT/JP2018/015275 JP2018015275W WO2018190383A1 WO 2018190383 A1 WO2018190383 A1 WO 2018190383A1 JP 2018015275 W JP2018015275 W JP 2018015275W WO 2018190383 A1 WO2018190383 A1 WO 2018190383A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- acid
- extract
- membered ring
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 **C(C(O)=O)NC(C(*#C)NC(C(*)NC(C(*)NC(*)=O)=O)=O)=O Chemical compound **C(C(O)=O)NC(C(*#C)NC(C(*)NC(C(*)NC(*)=O)=O)=O)=O 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
Definitions
- the present invention relates to a dispersion containing a pigment or a powder dispersant, and in particular, to a dispersion containing a pigment or powder dispersant made of a lipid peptide type compound and the pigment or powder dispersant.
- the water-based composition has a high refreshing feeling when applied to the skin, etc., and has a sticky feeling after use compared to the oil-based composition.
- New products have been put on the market and proposed.
- a solid aqueous composition conventionally, a solid oil-in-water makeup cosmetic (Patent Document 1) containing water, fatty acid soap, oil and powder, alkyl and / or alkenyl oligoglycoside, oily substance, and nonionic property
- Patent Document 2 containing an emulsifier has been proposed.
- liquid aqueous compositions there have been many proposals of water-based cosmetics containing water as the main ingredient and various additives such as moisturizers, and emulsion-type compositions containing oily ingredients and aqueous ingredients with emulsifiers. Has been.
- aqueous cosmetics for example, many products containing various pigments and powders for coloring the skin have been proposed, but when these aqueous cosmetics are left standing for a long period of time, the pigments and powders are separated. ⁇ Sedimentation and in some cases hard cake. Therefore, proposals to stabilize dispersions by blending various resins, thickeners, dispersants, and other additives have been studied, and the separation and sedimentation of pigments and powders, as well as the aggregation and solidification of them, are being investigated. Technical proposals that can be controlled are required.
- the present invention has been made on the basis of the above circumstances, and the problem to be solved is a dispersion and a dispersing agent capable of preventing separation and settling of pigments and the like over time in a dispersion containing pigment or powder. Is to provide.
- the present inventors have found that a dispersion using a lipid peptide type compound comprising a low-molecular-weight lipid peptide or a pharmaceutically usable salt thereof as a dispersant for pigments or powders
- the inventors have found that a dispersion in which separation and sedimentation with time in the blended pigments and the like are suppressed can be obtained, and the present invention has been completed.
- the present invention provides the first aspect as follows: A surfactant, water and, A pigment or powder dispersant comprising a lipid peptide type compound comprising at least one of the compounds represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof: 1,2-alkanediol or 1,3-alkanediol; At least one fatty acid, Including at least one selected from the group consisting of pigments and powders, Concerning the dispersion.
- R 1 represents an aliphatic group having 9 to 23 carbon atoms
- R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms
- R 3 represents a — (CH 2 ) n—X group, n represents a number of 1 to 4, X represents an amino group, a guanidino group, a —CONH 2 group, or 1 to 3 nitrogen atoms.
- R 4 represents an aliphatic group having 9 to 23 carbon atoms
- R 5 to R 7 each independently represents a hydrogen atom, or a carbon atom number that can have a branched chain having 1 or 2 carbon atoms.
- R 5 to R 7 represents — (CH 2 ) n—X groups
- n is 1 to 4 X represents an amino group, a guanidino group, a —CONH 2 group, or a 5- or 6-membered ring having 1 to 3 nitrogen atoms, or a condensed heterocycle composed of a 5-membered ring and a 6-membered ring.
- R 8 represents an aliphatic group having 9 to 23 carbon atoms
- R 9 to R 12 each independently represents a hydrogen atom, or the number of carbon atoms that may have a branched chain having 1 or 2 carbon atoms.
- the dispersion according to the first aspect wherein at least one selected from the group consisting of the pigment and the powder is contained in a proportion of 25% by mass or less based on the total mass of the dispersion.
- the pigment or the dispersant for powder is included in a ratio of 0.01% by mass to 1% by mass based on the total mass of the dispersion, described in the first aspect or the second aspect.
- Dispersion As a 4th viewpoint, it is related with the dispersion liquid as described in any one of the 1st viewpoint thru
- the surfactant is one or more compounds selected from the group consisting of ethylene glycol alkyl ethers, phospholipids, polyglycerin fatty acid esters, and polyoxyethylene polyoxypropylene alkyl ethers.
- or 5th viewpoint It is related with the dispersion liquid as described in any one.
- the present invention relates to the dispersion according to any one of the first to sixth aspects, in which the fatty acid is stearic acid.
- it is related with the dispersion liquid as described in any one among the 1st viewpoint thru
- the present invention relates to a pigment or a powder dispersant composed of a lipid peptide compound composed of at least one of the compounds represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof.
- R 1 represents an aliphatic group having 9 to 23 carbon atoms
- R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms
- R 3 represents a — (CH 2 ) n—X group, n represents a number of 1 to 4,
- X represents an amino group, a guanidino group, a —CONH 2 group, or 1 to 3 nitrogen atoms.
- R 4 represents an aliphatic group having 9 to 23 carbon atoms
- R 5 to R 7 each independently represents a hydrogen atom, or a carbon atom number that can have a branched chain having 1 or 2 carbon atoms.
- R 5 to R 7 represents — (CH 2 ) n—X groups
- n is 1 to 4 X represents an amino group, a guanidino group, a —CONH 2 group, or a 5- or 6-membered ring having 1 to 3 nitrogen atoms, or a condensed heterocycle composed of a 5-membered ring and a 6-membered ring.
- R 8 represents an aliphatic group having 9 to 23 carbon atoms
- R 9 to R 12 each independently represents a hydrogen atom, or the number of carbon atoms that may have a branched chain having 1 or 2 carbon atoms.
- R 9 to R 12 represents — (CH 2 ) n—X groups
- n is 1 to 4 X represents an amino group, a guanidino group, a —CONH 2 group, or a 5- or 6-membered ring having 1 to 3 nitrogen atoms, or a condensed heterocycle composed of a 5-membered ring and a 6-membered ring. Represents a ring.
- the pigments and powders can be stably dispersed without being separated or settled from the dispersion over time. It can be set as the made dispersion liquid.
- a stably dispersed dispersion can be prepared even when 10% by mass or more of the pigment is blended or when a relatively large powder such as a gold foil is blended.
- the lipid peptide compound constituting the dispersant of the present invention is a very safe artificial low molecular weight compound composed only of lipid and peptide.
- various components contained as additives in the dispersion of the present invention are general-purpose additives as additives for foods, cosmetics, and pharmaceuticals. That is, the dispersion of the present invention has high biological safety, and is particularly useful in the above applications from the viewpoint of safety required for pharmaceuticals and cosmetics.
- the dispersion of the present invention is expected to be a dispersion with good refreshing feeling and elongation when applied to human skin or the like, and is a liquid base containing pigments and powders for pharmaceuticals and cosmetics. It can be expected to be used as a material and is very useful.
- FIG. 1 shows the formulation of 10% by mass of pigments prepared in Examples 1 to 3 and Comparative Example 1 (Example 1, Example 2 and Comparative Example 1) and 15% by mass of pigment (Example 3). It is a figure which shows an external appearance.
- FIG. 2 is a view showing the appearance of a dispersion liquid containing a pearl pigment prepared in Example 4, Example 5, and Comparative Example 2.
- FIG. 3 is a view showing the appearance of a dispersion liquid containing tricalcium phosphate prepared in Example 6 and Comparative Example 3.
- FIG. 4 is a view showing the appearance of a dispersion of gold foil blends prepared in Example 7, Example 8, and Comparative Example 4.
- FIG. 1 shows the formulation of 10% by mass of pigments prepared in Examples 1 to 3 and Comparative Example 1 (Example 1, Example 2 and Comparative Example 1) and 15% by mass of pigment (Example 3). It is a figure which shows an external appearance.
- FIG. 2 is a view showing the appearance of a dispersion liquid containing a pearl pigment prepared in Example
- FIG. 5 is a view showing an observation result (photograph) of a polarizing microscope of the O / W liquid foundation prepared in Example 9 and Comparative Example 5.
- FIG. 6 is a view showing the appearance of the O / W liquid foundation prepared in Example 9 and Comparative Example 5 after one month of preparation.
- the present invention relates to a pigment comprising a lipid peptide compound comprising a surfactant, water, and a compound represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof: Or a dispersion containing a dispersant for powder, 1,2-alkanediol or 1,3-alkanediol, fatty acid, at least one selected from the group consisting of pigments and powder, and optionally other additives. Regarding liquids.
- the present invention is also directed to a pigment or powder dispersant comprising the lipid peptide type compound.
- each component will be described.
- the lipid peptide type compound used as the pigment or powder dispersant of the present invention is a compound (lipid peptide) represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof (hydrophobic)
- a low molecular compound having a lipid part as a site and a peptide part as a hydrophilic site can be used.
- R 1 represents an aliphatic group having 9 to 23 carbon atoms, and preferably R 1 is a straight chain having 11 to 23 carbon atoms which may have 0 to 2 unsaturated bonds.
- An aliphatic group is desirable.
- Specific examples of the lipid moiety (acyl group) composed of a carbonyl group adjacent to R 1 include lauroyl group, dodecylcarbonyl group, myristoyl group, tetradecylcarbonyl group, palmitoyl group, margaroyl group, oleoyl group, and elideoyl group.
- Examples include lauroyl group, myristoyl group, palmitoyl group, margaroyl group, stearoyl group, oleoyl group, elidoyl group, and behenoyl group.
- R 2 contained in the peptide part represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms.
- the alkyl group having 1 to 4 carbon atoms that may have a branched chain having 1 or 2 carbon atoms is a branched chain having 1 to 4 carbon atoms in the main chain and 1 or 2 carbon atoms.
- Means an alkyl group which may have, and specific examples thereof include methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, i-butyl group, sec-butyl group or tert-butyl group Etc.
- R 2 is preferably a hydrogen atom or an alkyl group having 1 to 3 carbon atoms which may have a branched chain having 1 carbon atom, and more preferably a hydrogen atom.
- the alkyl group having 1 to 3 carbon atoms which can have a branched chain having 1 carbon atom is an alkyl group having 1 to 3 carbon atoms in the main chain and having a branched chain having 1 carbon atom.
- a methyl group an ethyl group, an n-propyl group, an i-propyl group, an i-butyl group, or a sec-butyl group, preferably a methyl group, an i-propyl group, An i-butyl group or a sec-butyl group.
- R 3 represents a — (CH 2 ) n—X group.
- n represents a number of 1 to 4
- X is an amino group, a guanidino group, a —CONH 2 group, or a 5-membered cyclic group having 1 to 3 nitrogen atoms.
- X is preferably an amino group, guanidino group, carbamoyl group (—CONH 2 group), pyrrole group, imidazole group, pyrazole group or indole group, and more Preferably it is an imidazole group.
- n is preferably 1 or 2, and more preferably 1.
- the — (CH 2 ) n- group is preferably an aminomethyl group, 2-aminoethyl group, 3-aminopropyl group, 4-aminobutyl group, carbamoylmethyl group, 2-carbamoylethyl group, 3-carbamoyl group.
- a lipid peptide particularly suitable as a lipid peptide type compound is a compound formed from the following lipid part and peptide part (amino acid assembly part).
- amino acids alanine (Ala), asparagine (Asn), glutamine (Gln), glycine (Gly), histidine (His), isorosine (Ile), leucine (Leu), lysine (Lys), tryptophan (Trp) ), Valine (Val).
- Lauroyl-Gly-His Lauroyl-Gly-Gln, Lauroyl-Gly-Asn, Lauroyl-Gly-Trp, Lauroyl-Gly-Lys, Lauroyl-Ala-His, Lauroyl-Ala-Gln, Lauroyl-Ala-Asn, Lauroyl -Ala-Trp, Lauroyl-Ala-Lys; Myristoyl-Gly-His, Myristoyl-Gly-Gln, Myristoyl-Gly-Asn, Myristoyl-Gly-Trp, Myristoyl-Gly-Lys, Myristoyl-Ala-His, Myristoyl-Ala -Gln, Myristoyl-Ala-Asn, Myristoyl-Ala-Trp, Myristoyl-Ala-Lys; Palmitoyl-Gly-His, Palmitoyl-Gly-Gln, Palmi
- lauroyl-Gly-His lauroyl-Ala-His-myristoyl-Gly-His, myristoyl-Ala-His; palmitoyl-Gly-His, palmitoyl-Ala-His; stearoyl-Gly-His, stearoyl-Ala -His.
- R 4 represents an aliphatic group having 9 to 23 carbon atoms, and preferred specific examples include the same groups as defined for R 1 above.
- R 5 to R 7 each independently represent a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, or — ( CH 2 ) nX group, and at least one of R 5 to R 7 represents a — (CH 2 ) nX group.
- n a number of 1 to 4
- X represents an amino group, a guanidino group, a —CONH 2 group, or a 5-membered cyclic group or a 6-membered cyclic group which may have 1 to 3 nitrogen atoms, or a 5-membered ring And a condensed heterocyclic group composed of a 6-membered ring.
- R 5 to R 7 include the same groups as defined for R 2 and R 3 above.
- a preferable lipid peptide is a compound formed from the following lipid part and peptide part (amino acid assembly part).
- lauroyl-Gly-Gly-His lauroyl-Gly-Gly-Gln, lauroyl-Gly-Gly-Asn, lauroyl-Gly-Gly-Trp, lauroyl-Gly-Gly-Lys, lauroyl-Gly-Ala-His, Lauroyl-Gly-Ala-Gln, Lauroyl-Gly-Ala-Asn, Lauroyl-Gly-Ala-Trp, Lauroyl-Gly-Ala-Lys, Lauroyl-Ala-Gly-His, Lauroyl-Ala-Gly-Gln, Lauroyl- Ala-Gly-Asn, Lauroyl-Ala-Gly-Trp, Lauroyl-Ala-Gly-Gly-His, Lauroyl-A
- lauroyl-Gly-Gly-His myristoyl-Gly-Gly-His, palmitoyl-Gly-Gly-His, palmitoyl-Gly-His-Gly, palmitoyl-His-Gly-Gly, stearoyl -Gly-Gly-His.
- R 8 represents an aliphatic group having 9 to 23 carbon atoms, and preferred specific examples include the same groups as defined for R 1 above.
- R 9 to R 12 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, or — ( CH 2 ) nX group, and at least one of R 9 to R 12 represents a — (CH 2 ) nX group.
- n a number of 1 to 4
- X represents an amino group, a guanidino group, a —CONH 2 group, or a 5-membered cyclic group or a 6-membered cyclic group which may have 1 to 3 nitrogen atoms, or a 5-membered ring And a condensed heterocyclic group composed of a 6-membered ring.
- R 9 to R 12 include the same groups as defined for R 2 and R 3 above.
- particularly preferred lipid peptides include lauroyl-Gly-Gly-Gly-His, myristoyl-Gly-Gly-Gly-His, palmitoyl. -Gly-Gly-Gly-His, Palmitoyl-Gly-Gly-His-Gly, Palmitoyl-Gly-His-Gly-Gly, Palmitoyl-His-Gly-Gly-Gly, Stearoyl-Gly-Gly-Gly-His, etc. Can be mentioned.
- the amount of the lipid peptide type compound that is a pigment or a dispersant for powder is, for example, 0.01% by mass to 1% by mass, or 0.01% by mass with respect to the total mass of the resulting dispersion. These are less than 1% by mass, preferably 0.05% by mass to 0.5% by mass, more preferably 0.05% by mass to 0.3% by mass, for example 0.05% by mass to 0.2% by mass.
- the lipid peptide type compound used in the present invention comprises at least one of the compounds represented by the above formulas (1) to (3) (lipid peptide) or a pharmaceutically usable salt thereof, These compounds can be used alone or in combination of two or more as a dispersant for powder.
- surfactant used in the dispersion of the present invention, a compound having a hydrophilic part and a hydrophobic part in the molecule, and the hydrophilic part having a betaine structure (hereinafter also referred to as a betaine compound), ethylene glycol alkyl ether, Polyglycerin fatty acid ester or polyoxyethylene polyoxypropylene alkyl ether can be preferably used.
- betaine compounds as described above include N-alkyl-N, N-dimethylamino acid betaines such as lauryldimethylaminoacetic acid betaine (lauryl betaine); fatty acid amide alkyl-N such as cocamidopropyl betaine and lauramidopropyl betaine.
- N-dimethylamino acid betaine N-dimethylamino acid betaine; imidazoline-type betaines such as sodium cocoamphoacetate and sodium lauroamphoacetate; alkylsulfobetaines such as laurylhydroxysulfobetaine and alkyldimethyltaurine; sulfate-type betaines such as alkyldimethylaminoethanol sulfate; alkyldimethylaminoethanol Known betaine compounds such as phosphate-type betaines such as phosphate esters can be used as amphoteric surfactants.
- betaine compounds include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, diphosphatidylglycerol (cardiolipin), phosphatidic acid and other glycerophospholipids; lysophosphatidylcholine (lysolecithin), lysophosphatidylethanolamine, Examples thereof include lysoglycerophospholipids such as serine, lysophosphatidylinositol, lysophosphatidylglycerol, and lysophosphatidic acid; sphingophospholipids such as sphingomyelin; and hydrogenated products thereof.
- phospholipids may be derived from animals and plants such as soybeans and egg yolks, or may be synthesized by a chemical or enzymatic method.
- betaine compounds preferably lauryldimethylaminoacetic acid betaine, lauric acid amidopropyl betaine, lauryl hydroxysulfobetaine, stearyl betaine, lysophosphatidylcholine (lysolecithin), lysophosphatidylethanolamine, lysophosphatidylserine, lysophosphatidylinositol, lyso Examples thereof include phosphatidylglycerol and lysophosphatidic acid, and more preferably lysophosphatidylcholine (lysolecithin).
- ethylene glycol alkyl ether examples include polyoxyethylene alkyl ether, polyoxyethylene lauryl ether, polyoxyethylene palmitoyl ether, polyoxyethylene stearyl ether and the like. Also, commercially available ethylene glycol alkyl ethers can be used. Examples of such products include Emulgen 102KG, Emargen 103, and Emulgen 104P in Kao's Emulgen (registered trademark) series and Emanon (registered trademark) series.
- Emulgen 103 More preferably, Kao's Emulgen 103, Emulgen 104P, Emulgen 105, Emulgen 106, Emulgen 108, Emulgen 109P, Emulgen 210P, Emulgen 306P, Emulgen 320P, Emulgen 404, Emulgen 408, Emulgen 409PV, Emulgen 420, Emulgen 705 , Emulgen 707, Emulgen 709, Emulgen 1108, Emulgen 2020G-HA, Emanon 1112, Emanon 4110.
- Emulgen 104P More preferably, Kao's Emulgen 104P, Emulgen 105, Emulgen 106, Emulgen 108, Emulgen 210P, Emulgen 306P, Emulgen 408, Emulgen 409PV, Emulgen 705, Emulgen 707, Emulgen 709, Emulgen 1108, Emulgen 2020G-HA, Emanon 1112, Emanon 4110.
- it can be appropriately selected from the NIKKOL (registered trademark) series of Nikko Chemicals.
- NIKKOL BT-5, NIKKOL BT-7, NIKKOL BT-9, NIKKOL BT-12, NIKKOL BL-2, NIKKOL BL-4.2, NIKKOL BL-9EX, etc. most preferably NIKOL BL-9EX 4.2.
- polyglycerin fatty acid ester examples include glyceryl stearate, glyceryl isostearate, glyceryl palmitate, glyceryl myristate, glyceryl oleate, glyceryl coconut oil fatty acid, mono-cotton oil fatty acid glycerin, glyceryl monosulcate, glyceryl sesquioleate, ⁇ , ⁇ '-Glycerin fatty acid partial esters such as glyceryl oleate, glyceryl monostearate, and malic monostearate; polyglyceryl stearate-2, 3, 4, 5, 6, 6, 8, 10 polyglyceryl distearate 6, same 10, polyglyceryl tristearate-2, polyglyceryl 10 decastearate, polyglyceryl-2 isostearate 3, 3, 4, 5, 6, 8, 8, 10 Liglyceryl-2 (diglyceryl diisostearate), 3, 10 (decaglyceryl diisostearate
- Polyoxyethylene polyoxypropylene alkyl ethers include Kao's Emulgen (registered trademark) LS-106, Emulgen LS-110, Emulgen LS-114, Emulgen MS-110, and Nikko Chemicals' NIKKOL (registered) Trademarks) PBC-31, NIKKOL PBC-33, NIKKOL PBC-34, NIKKOL PBC-41, NIKKOL PBC-44, NIKKOL PBN-4612, NIKKOL PBN-4620, NIKKOL PBN-4630. More preferred are Emulgen LS-106, Emulgen LS-110, Emulgen LS-114, and Emulgen MS-110. More preferred are Emulgen LS-106, Emulgen LS-110, and Emulgen MS-110.
- HLB Hydrophile-Lipophile Balance
- surfactants include sorbitan isostearate, steareth-8, behenez-10, laureth-4, laureth-5, ceteth-7, oleth-8, PEG-8 glyceryl isostearate, choles-10, isostearic acid Acid PEG-10BG, PEG-30 glyceryl triisostearate, PEG-30 glyceryl triisostearate, PEG-30 glyceryl trioleate, PEG-30 triisostearate PEG-30, hydrogenated castor oil lauric acid PEG-30, PCA PEG-30 isostearic acid hydrogenated castor oil, octyldedes-10, PEG-12 dilaurate, sorbes-40 tetraoleate, polyglyceryl-10 di
- the compounding amount of the surfactant is, for example, 0.01% by mass to 2% by mass, or, for example, 0.01% by mass to 1% by mass, preferably 0% with respect to the total mass of the resulting dispersion. 0.01 mass% to 0.5 mass%, more preferably 0.01 mass% to 0.3 mass%, for example 0.02 mass% to 0.2 mass%.
- the surfactant used in the present invention is at least one of the above-mentioned surfactant group, and these surfactants can be used alone or in combination of two or more.
- the 1,2-alkanediol or 1,3-alkanediol used in the dispersion of the present invention has a function of promoting the solubility of the lipid peptide type compound which is the pigment or powder dispersant.
- Specific examples of the 1,2-alkanediol include 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, and the like. Preferred are 1,2-pentanediol, 1,2-hexanediol, and 1,2-octanediol.
- 1,2-pentanediol or 1,2-hexanediol More preferred is 1,2-pentanediol or 1,2-hexanediol.
- Specific examples of the 1,3-alkanediol include 1,3-propanediol, 2-methyl-1,3-propanediol, 1,3-butanediol, 3-methyl-1,3-butanediol, , 3-pentanediol, 1,3-hexanediol, 2-ethyl-1,3-hexanediol, 2-ethyl-1,3-octanediol, 1,3-decanediol, and the like.
- 1,3-butanediol 1,3-pentanediol, 1,3-hexanediol, 2-ethyl-1,3-hexanediol, and 2-ethyl-1,3-octanediol. More preferred are 1,3-butanediol, 2-ethyl-1,3-hexanediol, and 2-ethyl-1,3-octanediol. These 1,2-alkanediols or 1,3-alkanediols can be used alone or in combination of two or more.
- the blending amount of 1,2-alkanediol or 1,3-alkanediol is, for example, 0.001% by mass to 15% by mass, preferably 0.001% by mass with respect to the total mass of the resulting dispersion.
- 005 mass% to 15 mass% more preferably 0.01 mass% to 15 mass%, for example 0.01 mass% to 12 mass%.
- the fatty acid used in the dispersion of the present invention is preferably at least one selected from the group consisting of saturated and unsaturated fatty acids having 10 to 20 carbon atoms and salts of these fatty acids.
- the fatty acid is capric acid.
- the amount of fatty acid used is, for example, 0.001% to 1% by weight, preferably 0.001% to 0.1% by weight, based on the total weight of the resulting dispersion. Preferably it is 0.005 mass% thru
- the fatty acid used in this invention is at least 1 sort (s) selected from the said fatty acid group, These fatty acids can be used individually or in combination of 2 or more types.
- the pigment or powder blended in the dispersion of the present invention is not particularly limited.
- pigments include inorganic white pigments such as titanium dioxide and zinc oxide; inorganic red pigments such as red iron oxide (Bengara) and iron titanate; inorganic brown pigments such as ⁇ -iron oxide; yellow iron oxide and loess Inorganic black pigments such as black iron oxide and low-order titanium oxide; inorganic purple pigments such as mango violet and cobalt violet; inorganic green pigments such as chromium oxide, chromium hydroxide and cobalt titanate; Inorganic blue pigments such as ultramarine and bitumen; Titanium oxide coated mica, titanium oxide coated bismuth oxychloride chloride, titanium oxide coated talc, colored titanium oxide coated mica, bismuth oxychloride, fish scale foil, etc .; talc, sericite, mica , Constitutions such as kaolin, calcium carbonate, magnesium carbonate, silicic anhydride, barium
- the powders include mica, talc, kaolin, sericite, montmorillonite, kaolinite, mica, muscovite, phlogopite, synthetic mica, sausage, mica, permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, silica Barium, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, zeolite, barium sulfate, calcined calcium sulfate, tricalcium phosphate, calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder, bentonite, Smectite, clay, mud, metal soap (eg zinc myristate, calcium palmitate, aluminum stearate), calcium carbonate, bengara, yellow iron oxide, black iron oxide, ultramarine, bitumen, carbon black, Titanium fluoride, fine and ultrafine titanium oxide, zinc oxide, fine and ultrafine zinc oxide
- Organic-inorganic composite powders are preferred.
- the pigment or powder can be, for example, 25% by mass or less, preferably 20% by mass or less, with respect to the total mass of the dispersion.
- the lower limit of the amount of pigment or powder is not particularly limited, but is, for example, about 0.001% by mass.
- the said pigment or powder used in this invention is at least 1 type of the above-mentioned pigment group and powder group, These pigments or powder can be used individually or in combination of 2 or more types.
- the dispersion of the present invention may further contain a polyhydric alcohol.
- the polyhydric alcohol is a polyhydric alcohol different from the 1,2-alkanediol or 1,3-alkanediol listed above, and specific examples thereof include glycerin, propylene glycol, and polyethylene glycol.
- polyethylene glycol having an average molecular weight of 1,000 to 4,000 can be preferably used.
- the blending amount thereof is, for example, 1% by mass to 60% by mass, preferably 10% by mass to 30% by mass with respect to the total mass of the obtained dispersion. it can.
- additives that can be generally used as cosmetic additives, quasi-drug additives, and pharmaceutical additives can be blended as necessary.
- an additive component such as a physiologically active substance and a functional substance blended in a skin preparation for cosmetics, quasi-drugs or medicines, for example, an oily base, a moisturizer, a touch improver, a surfactant other than the above, Polymer, thickening / gelling agent, solvent, antioxidant, reducing agent, oxidizing agent, preservative, antibacterial agent, bactericidal agent, chelating agent, pH adjusting agent, acid, alkali, inorganic salt, UV absorber, whitening Agents, vitamins and derivatives thereof, hair growth agents, blood circulation promoters, stimulants, hormones, anti-wrinkle agents, anti-aging agents, squeeze agents, cooling sensation agents, warming sensation agents, wound healing promoters, irritation relaxation agents , Analgesic agent, cell activator, plant / animal / microbe extract,
- oily bases examples include oleyl alcohol, jojoba alcohol, chimyl alcohol, ceralkyl alcohol, batyl alcohol, hexyl decanol, isostearyl alcohol, 2-octyldodecanol, dimer diol and other higher (polyhydric) alcohols; benzyl alcohol, etc.
- Aralkyl alcohols and derivatives thereof isostearic acid, behenic acid, undecylenic acid, 12-hydroxystearic acid, palmitooleic acid, oleic acid, linoleic acid, linolenic acid, erucic acid, docosahexaenoic acid, eicosapentaenoic acid, isohexadecanoic acid, Antiisohenicosanoic acid, long-chain branched fatty acid, dimer acid, hydrogenated dimer acid, etc .; liquid paraffin (mineral oil), heavy liquid isoparaffin, light liquid isoparaffin, ⁇ -olefin Ligomers, polyisobutene, hydrogenated polyisobutene, polybutene, squalane, olive-derived squalane, squalene, petrolatum, solid paraffin, and other hydrocarbons; candelilla wax, carnauba wax, rice wax, wood wax, beeswax,
- moisturizers / feel improvers include glycerin, trimethylolpropane, pentaerythritol, hexylene glycol, diglycerin, polyglycerin, diethylene glycol, dipropylene glycol, polypropylene glycol, ethylene glycol / propylene glycol copolymer and the like polyols and Polymers; glycol alkyl ethers such as diethylene glycol monoethyl ether (ethoxydiglycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, diethylene glycol dibutyl ether; (eicosane diacid / tetradecanedioic acid) polyglyceryl-10, tetradecane Water-soluble esters such as polyglyceryl-10; sorbitol, xylitol, erythritol, man Sugar alcohols such as tol and maltitol; glucose, fructose
- Peptides Silylated peptides; Lactic acid bacteria culture, yeast extract, eggshell membrane protein, bovine submandibular gland mucin, hypotaurine, sesameignan glycoside, glutathione, Albumin, whey; choline chloride, phosphorylcholine; placenta extract, aerostin, collagen, aloe extract, hamamelis water, loofah water, chamomile extract, licorice extract, comfrey extract, silk extract, Izayoi rose extract, yarrow extract, eucalyptus extract Ceramides, such as animal and plant extract components such as merirot extract, natural ceramide (types 1, 2, 3, 4, 5, 6), hydroxyceramide, pseudoceramide, glycosphingolipid, ceramide and sugar ceramide-containing extract It is mentioned as preferable.
- Ceramides such as animal and plant extract components such as merirot extract, natural ceramide (types 1, 2, 3, 4, 5, 6), hydroxyceramide
- the surfactant include an anionic surfactant, a nonionic surfactant, a cationic surfactant, an amphoteric surfactant, and a polymer surfactant.
- preferable surfactants include fatty acid salts such as potassium laurate and potassium myristate; alkyl sulfate esters such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and ammonium lauryl sulfate; Polyoxyethylene alkyl sulfates such as sodium laureth sulfate and triethanolamine laureth sulfate; cocoyl methyl taurine sodium, cocoyl methyl taurine potassium, lauroyl methyl taurine sodium, myristoyl methyl taurine sodium, lauroyl methyl alanine sodium, lauroyl sarcosine sodium, lauroyl sarcosine tri Acyl N-methyl amino acid salts such as ethanolamine and sodium methylalanine sodium, la
- Polyoxyethylene alkyl ethers with various polyoxyethylene addition numbers such as silethylene behenyl ethers), isosteares (polyoxyethylene isostearyl ether) s, octyldecesses (polyoxyethylene octyldodecyl ethers); Ether: Polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil monoisostearate, polyoxyethylene hydrogenated castor oil triisostearate, polyoxyethylene hydrogenated castor oil monopyroglutamic acid monoisostearic acid diester Castor oil and hardened castor oil derivatives such as polyoxyethylene hydrogenated castor oil maleic acid; polyoxyethylene phytosterol; polyoxyethylene cholesterol Polyoxyethylene cholestanol; polyoxyethylene lanolin; polyoxyethylene reduced lanolin; polyoxyethylene / polyoxypropylene cetyl ether, polyoxyethylene / polyoxypropylene 2-decyltetradecyl ether, polyoxy
- Polyglyceryl ethers polyoxyethylene alkylamines; tetrapolyoxyethylene / tetrapolyoxypropylene-ethylenediamine condensates; natural surfactants such as saponins and sophorolipids; polyoxyethylene fatty acid amides; Palm oil fatty acid monoethanolamide (cocamide MEA), palm oil fatty acid diethanolamide (cocamide DEA), lauric acid monoethanolamide (Lauramide MEA), lauric acid diethanolamide (lauramide DEA), lauric acid monoisopropanolamide (lauramide MIPA), palmitic acid monoethanolamide (partamide MEA), palmitic acid diethanolamide (partamide DEA), palm oil fatty acid methylethanolamide ( Fatty acid alkanolamides such as cocamidomethyl MEA); alkyldimethylamine oxides such as lauramine oxide, cocamamine oxide, stearamine oxide, and behenamine oxide; alkylethoxydimethylamine oxide; polyoxyethylene al
- Nonionic surfactants of silicone, etc .; cationic surfactants include alkyltrimethylammonium chlorides such as behentrimonium chloride, steartrimonium chloride, cetrimonium chloride, lauryltrimonium chloride; stearyltrimonium bromide, etc.
- Alkyltrimethylammonium bromides dialkyldimethylammonium chlorides such as distearyldimonium chloride and dicocodimonium chloride; fatty acid amidoamines and salts thereof such as stearamidepropyldimethylamine and stearamideethyldiethylamine; alkyl ethers such as stearoxypropyldimethylamine Amines and salts or quaternary salts thereof; ethyl sulfate long chain branched fatty acid (12-31) aminopropylethyldimethylammonium Fatty acid amide type quaternary ammonium salts such as lanolin fatty acid aminopropylethyldimethylammonium; polyoxyethylene alkylamines and salts or quaternary salts thereof; alkylamine salts; fatty acid amidoguanidinium salts; alkyl etheraminemonium salts; Benzalkonium salts; benzethonium salts
- Silicone-based cationic surfactants such as amino-modified silicone, cation-modified silicone, cation-modified and polyether-modified silicone, amino-modified and polyether-modified silicone
- amphoteric surfactant etc N-alkyl-N, N-dimethylamino acid betaines such as lauryl betaine (lauryldimethylaminoacetic acid betaine); fatty acid amide alkyl-N, N-dimethylamino acid betaines such as cocamidopropyl betaine and lauramidopropyl betaine; sodium cocoamphoacetate; Imidazoline-type betaines such as sodium lauroamphoacetate; alkylsulfobetaines such as alkyldimethyltaurine; sulfate-type betaines such as alkyldimethylaminoethanol sulfate; phosphate-type betaines such as alkyldimethylaminoethanol phosphate; phosphati
- Polymers, thickeners and gelling agents include guar gum, locust bean gum, queens seed, carrageenan, galactan, arabic gum, tara gum, tamarind, far selelain, karaya gum, troarooi, cara gum, tragacanth gum, pectin, pectic acid and sodium Salt such as salt, salt such as alginic acid and sodium salt, mannan; starch such as rice, corn, potato, wheat; xanthan gum, dextran, succinoglucan, curdlan, hyaluronic acid and its salt, xanthan gum, pullulan, gellan gum, chitin , Chitosan, agar, gypsophila extract, chondroitin sulfate, casein, collagen, gelatin, albumin; methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypro Cellulose, hydroxypropylmethylcellulose, carboxymethylcellulose and salts thereof such as
- Acrylic acid / methyl acrylate / methacrylamidopropyltrimethylammonium chloride copolymer such as polyquaternium-47, methacrylic acid choline ester polymer; cationized oligosaccharide, cationized dextran, guar hydroxypropyltri Cationic polysaccharides such as monium chloride; polyethyleneimine; cationic polymers; copolymers of 2-methacryloyloxyethyl phosphorylcholine such as polyquaternium-51 and copolymers of butyl methacrylate; acrylic resin emulsion, polyacrylic acid Polymer emulsions such as ethyl emulsion, polyacrylic alkyl ester emulsion, polyvinyl acetate resin emulsion, natural rubber latex, synthetic latex; nitrocellulose; Tans and various copolymers; Various silicones; Various silicone-based copolymers such as acrylic-silicone graft
- Solvents include lower alcohols such as ethanol, 2-propanol (isopropyl alcohol), butanol and isobutyl alcohol; glycols such as propylene glycol, diethylene glycol, dipropylene glycol and isopentyl diol; diethylene glycol monoethyl ether (ethoxydiglycol) , Glycol ethers such as ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, triethylene glycol monoethyl ether, diethylene glycol diethyl ether, diethylene glycol dibutyl ether, propylene glycol monoethyl ether, dipropylene glycol monoethyl ether; ethylene glycol monoethyl ether Acetate, diethylene glycol Glycol ether esters such as ethyl ether acetate and propylene glycol monoethyl ether acetate; glycol esters such as diethoxyethyl succinate and ethylene
- Antioxidants include tocopherol derivatives such as tocopherol (vitamin E) and tocopherol acetate; BHT, BHA; gallic acid derivatives such as propyl gallate; vitamin C (ascorbic acid) and / or derivatives thereof; erythorbic acid and derivatives thereof; Preferred are sulfites such as sodium sulfite; bisulfites such as sodium bisulfite; thiosulfates such as sodium thiosulfate; metabisulfites; thiotaurine, hypotaurine; thioglycerol, thiourea, thioglycolic acid, cysteine hydrochloride As mentioned.
- Preferred examples of the reducing agent include thioglycolic acid, cysteine, cysteamine and the like.
- Preferred examples of the oxidizing agent include hydrogen peroxide water, ammonium persulfate, sodium bromate, percarbonate, and the like.
- preservatives, antibacterial agents, and bactericides include hydroxybenzoic acid such as methylparaben, ethylparaben, propylparaben, and butylparaben, and salts or esters thereof; salicylic acid; sodium benzoate; phenoxyethanol; methylchloroisothiazolinone, methylisothiazo Isothiazolinone derivatives such as linone; imidazolinium urea; dehydroacetic acid and its salts; phenols; halogenated bisphenols such as triclosan, acid amides, quaternary ammonium salts; trichlorocarbanide, zinc pyrithione, benzalkonium chloride, chloride Benzethonium, sorbic acid, chlorhexidine, chlorhexidine gluconate, halocarban, hexachlorophene, hinokitiol; phenol, isopropylphenol, cresol, Mall
- chelating agents include edetate (ethylenediaminetetraacetate) such as EDTA, EDTA2Na, EDTA3Na, and EDTA4Na; hydroxyethylethylenediaminetriacetate such as HEDTA3Na; pentetate (diethylenetriaminepentaacetate); phytic acid; Phosphonic acid and its sodium salt; polyamino acids such as polyaspartic acid and polyglutamic acid; sodium polyphosphate, sodium metaphosphate, phosphoric acid; sodium citrate, citric acid, alanine, dihydroxyethylglycine, gluconic acid, Ascorbic acid, succinic acid and tartaric acid are preferred.
- edetate ethylenediaminetetraacetate
- HEDTA3Na EDTA3Na
- EDTA4Na hydroxyethylethylenediaminetriacetate
- pentetate diethylenetriaminepentaacetate
- phytic acid
- pH adjusters / acids / alkalis include ascorbic acid, citric acid, sodium citrate, lactic acid, sodium lactate, potassium lactate, glycolic acid, succinic acid, acetic acid, sodium acetate, malic acid, tartaric acid, fumaric acid, phosphoric acid, Hydrochloric acid, sulfuric acid, monoethanolamine, diethanolamine, triethanolamine, isopropanolamine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propane Preferred examples include diol, arginine, sodium hydroxide, potassium hydroxide, aqueous ammonia, guanidine carbonate, and ammonium carbonate.
- Inorganic salts include sodium chloride-containing salts such as salt, common salt, rock salt, sea salt, natural salt; potassium chloride, aluminum chloride, calcium chloride, magnesium chloride, bittern, zinc chloride, ammonium chloride; sodium sulfate, aluminum sulfate, Aluminum sulfate / potassium sulfate (alum), aluminum sulfate / ammonium sulfate, barium sulfate, calcium sulfate, potassium sulfate, magnesium sulfate, zinc sulfate, iron sulfate, copper sulfate; sodium phosphates such as 1Na, 2Na and 3Na phosphates, phosphoric acid Potassium, calcium phosphates and magnesium phosphates are preferred.
- sodium chloride-containing salts such as salt, common salt, rock salt, sea salt, natural salt
- potassium chloride aluminum chloride, calcium chloride, magnesium chloride, bittern, zinc chloride, ammonium chlor
- ultraviolet absorbers examples include paraaminobenzoic acid, paraaminobenzoic acid monoglycerin ester, N, N-dipropoxyparaaminobenzoic acid ethyl ester, N, N-diethoxyparaaminobenzoic acid ethyl ester, and N, N-dimethylparaaminobenzoic acid ethyl ester.
- Benzoic acid ultraviolet absorbers such as esters, N, N-dimethylparaaminobenzoic acid butyl ester, N, N-dimethylparaaminobenzoic acid methyl ester; Anthranilic acid ultraviolet absorbers such as homomenthyl-N-acetylanthranilate; Salicylic acid And salicylic acid systems such as sodium salt, amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate External line absorbent: octyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl c
- UV absorbers 3- (4′-methylbenzylidene) -d, l-camphor, 3-benzylidene-d, l-camphor; 2-phenyl-5-methylbenzoxazole; 2,2′-hydroxy- 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole; 2- (2′-hydroxy-5′-methylphenylbenzotriazole; dibenzalazine; dianisoylmethane; 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one; dibenzoylmethane derivatives such as 4-t-butylmethoxydibenzoylmethane; octyl triazone; urocanic acid such as urocanic acid and ethyl urocanate Derivatives; 2- (2′-hydroxy-5′-methylphenyl) benzotriazole Hydantoin derivatives such as 1- (3,4-dimethoxypheny
- whitening agents include hydroquinone glycosides such as arbutin and ⁇ -arbutin and their esters; ascorbic acid phosphates such as ascorbic acid, sodium ascorbic acid phosphate and magnesium ascorbic acid phosphate, ascorbic acid Ascorbic acid fatty acid esters such as tetraisopalmitic acid ester, ascorbic acid alkyl ethers such as ascorbic acid ethyl ether, ascorbic acid glucosides such as ascorbic acid-2-glucoside and fatty acid esters thereof, ascorbic acid sulfate ester, tocopheryl ascorbyl phosphate Ascorbic acid derivatives such as kojic acid, ellagic acid, tranexamic acid and its derivatives, ferulic acid and its derivatives, placenta extract, glutathione, oryzanol, butylreso Shinoru, oil-soluble Kamomiraekisu, oil-soluble licorice extract,
- Vitamins and their derivatives include vitamin A such as retinol, retinol acetate, retinol palmitate; thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, pyridoxine dipalmitate, Flavin adenine dinucleotide, cyanocobalamin, folic acid, nicotinic acid such as nicotinic acid amide / benzyl nicotinate, vitamin B group such as choline; vitamin C such as ascorbic acid and its sodium salt; vitamin D; ⁇ , Vitamin E such as ⁇ , ⁇ , and ⁇ -tocopherol; other vitamins such as pantothenic acid and biotin; ascorbic acid phosphates such as ascorbic acid phosphate sodium salt and ascorbic acid phosphate magnesium salt, Ascorbic acid fatty acid esters
- Plant extracts and tinctures such as assembly extract, red pepper tincture, ginger tincture, ginger extract, cantalis tincture; capsaicin, nonylic acid vanillylamide, gingeron, ictamol, tannic acid Borneol, cyclandrate, cinnarizine, trazoline, acetylcholine, verapamil, cephalanthin, ⁇ -oryzanol, vitamin E and derivatives such as tocopherol / nicotinic acid tocopherol, ⁇ -oryzanol, nicotinic acid, nicotinic acid amide, nicotinic acid benzyl ester, Inositol hexanicotinate, derivatives such as nicotine alcohol, allantoin, photosensitive element 301, photosensitive element 401, capronium chloride, pentadecanoic acid monoglyceride, flavonol Derivatives, stigmasterol or stigmasterol and its glycoside
- hormones include estradiol, estrone, ethinyl estradiol, cortisone, hydrocortisone, prednisone and the like.
- Other remedies such as anti-wrinkle agents, anti-aging agents, squeeze agents, cooling sensations, warming sensation agents, wound healing promoters, irritation relievers, analgesics, cell activators include retinols, retinoic acids, retinoin Acid tocopheryl; derivatives such as lactic acid, glycolic acid, gluconic acid, fruit acid, salicylic acid and glycosides / esterified products thereof, ⁇ - or such as hydroxycapric acid, long chain ⁇ -hydroxy fatty acid, long chain ⁇ -hydroxy fatty acid cholesteryl ⁇ -hydroxy acids and derivatives thereof; ⁇ -aminobutyric acid, ⁇ -amino- ⁇ -hydroxybutyric acid; carnitine; carnosine; creatine; ceramides, sphingosines; caffeine, xant
- Antioxidant / active oxygen scavengers include catechins; flavones such as quercetin; isoflavones; gallic acid and ester sugar derivatives; polyphenols such as tannin, sesamin, protoanthocyanidin, chlorogenic acid, apple polyphenol; rutin and glycosides, etc.
- Plant / animal / microbe extracts include iris extract, ashitaba extract, asunalo extract, asparagus extract, avocado extract, achacha extract, almond extract,retea extract, arnica extract, aloe extract, apricot extract, apricot kernel extract, ginkgo biloba extract , Chinchilla extract, fennel extract, ginseng extract, turmeric extract, oolong tea extract, walnut extract, ages extract, echinacea leaf extract, enme extract, gonon extract, duckweed extract, pollen extract, barley extract, ginseng extract, hypericum extract , Nettle extract, onionis extract, Dutch mustard extract, orange extract, dried sea water, seaweed extract, oyster leaf extract, oyster extract, hydrolyzed elastin, water Dehydrated wheat powder, hydrolyzed silk, cocoon extract, chamomile extract, oil-soluble chamomile extract, carrot extract, cormorant mugwort extract, oat extract, calcade extract, licorice extract, oil-soluble lic
- antipruritic agents examples include diphenhydramine hydrochloride, chlorpheniramine maleate, camphor, substance-P inhibitor, and the like.
- exfoliating / dissolving agent examples include salicylic acid, sulfur, resorcin, selenium sulfide, pyridoxine and the like.
- antiperspirants examples include chlorohydroxyaluminum, aluminum chloride, zinc oxide, zinc paraphenol sulfonate, and the like.
- Examples of the refreshing agent include menthol and methyl salicylate.
- astringents include citric acid, tartaric acid, lactic acid, aluminum sulfate / potassium, and tannic acid.
- Enzymes include superoxide dismutase, catalase, lysozyme chloride, lipase, papain, pancreatin, protease, and the like.
- Preferred nucleic acids include ribonucleic acid and its salts, deoxyribonucleic acid and its salts, and adenosine triphosphate disodium.
- Orange No. 201 Orange No. 203, Orange No. 204, Orange No. 205, Orange No. 206, Orange No. 207, Orange No. 401, Orange No. 402, Orange No. 403, Yellow No. 201, Yellow No. 202-1 Yellow 202-2, Yellow 203, Yellow 204, Yellow 205, Yellow 4, Yellow 401, Yellow 402, Yellow 403-1, Yellow 404, Yellow 405, Yellow 406, Yellow Legal pigments such as No. 407 and Yellow No.
- Anti-inflammatory / anti-inflammatory agents include glycyrrhizic acid and its derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, guaiazulene, allantoin, indomethacin, ketoprofen, ibuprofen, diclofenac, loxoprofen, celecoxib, infliximab, etanercept, zinc oxide, hydroacetic acid, zinc acetate, Preferred examples include prednisone, diphedramine hydrochloride, chlorpheniramine maleate; and plant extracts such as peach leaf extract and persimmon leaf extract.
- Anti-asthma, anti-chronic obstructive pulmonary disease, anti-allergy, immunomodulators include aminophylline, theophylline, steroids (fluticasone, beclomethasone, etc.), leukotriene antagonists, thromboxane inhibitors, intal, ⁇ 2-stimulant (Formoterol, salmeterol, albuterol, tulobuterol, clenbuterol, epinephrine, etc.), tiotropium, ipratropium, dextromethorphan, dimemorphan, bromhexine, tranilast, ketotifen, azelastine, cetirizine, chlorpheniramine, polyquitolsine, Preferred examples include cytokine regulators, interferons, omalizumab, and protein / antibody preparations.
- Preferred examples of the anti-infective and antifungal agents include oseltamivir, zanamivir, and itraconazole.
- cosmetic raw material standards cosmetic ingredient-specific combination ingredient standards, Japan Cosmetic Industry Association ingredient display name list, INCI dictionary (The International Cosmetic Ingredients and Handbooks), quasi-drug ingredients standards, Japanese pharmacopoeia, pharmaceutical additive standards Ingredients listed in the Food Addendum, etc., and the international patent classification IPC described in Japan and other foreign patent gazettes and patent publications (including publications and republications) belonging to the A61K7 and A61K8 classifications It is possible to contain known cosmetic ingredients, pharmaceutical ingredients, food ingredients, etc., in known combinations, blending ratios and blending amounts.
- the dispersion of the present invention is a pigment or powder dispersant comprising a lipid peptide compound comprising at least one of the compounds represented by the formulas (1) to (3) or a pharmaceutically usable salt thereof. And at least one selected from the group consisting of surfactants, water, 1,2-alkanediols or 1,3-alkanediols, fatty acids, pigments and powders, and optionally other additives such as polyhydric alcohols These are mixed and stirred with heating, and then stirred and cooled to about room temperature.
- the dispersion of the present invention is produced by the following process as an example. a) a step of blending the above-mentioned pigment or powder dispersant (lipid peptide compound), a surfactant, and water, and heating to prepare a solution (or dispersion); b) adding the solution (or dispersion) to water and heating at a temperature of room temperature to less than 100 ° C .; c) A step of cooling with stirring until the temperature is lower than the temperature in the heating step to obtain the dispersion of the present invention.
- At least one selected from the group consisting of 1,2-alkanediol or 1,3-alkanediol, fatty acid, and pigment and powder, and the other components are the solution (or dispersion) in step a). It may be added in the preparation step, or may be added in advance to the water to which the solution (or dispersion) is added in step b). Further, water is 60% by mass or more and 99.9% by mass or less based on the total mass of the dispersion liquid (including at least one selected from the group consisting of pigment and powder) of the present invention thus obtained. preferable.
- the heating temperature in the step a) and the step b) is preferably 50 ° C. to 90 ° C., more preferably 60 ° C. to 90 ° C., for example 80 ° C., and stirring is preferably performed while heating.
- the heating and stirring time in each step at this time varies depending on the pigment or powder dispersant (lipid peptide compound) used, the type of the surfactant and other components, and the blending amount thereof, but usually from 1 minute to 50 minutes. It can be dissolved and dispersed in about minutes.
- cooling is performed with stirring until the liquid temperature is lower than the temperature in step b) (step c).
- the cooling temperature is, for example, room temperature to 80 ° C., room temperature to 60 ° C., or room temperature to 40 ° C.
- the dispersion liquid of this invention can also be manufactured by adding another compounding component to this premix suitably.
- the following is mentioned as a manufacturing method of the dispersion liquid which passed through the premix.
- Step for preparing premix 1-1) Surfactant and water, pigment or powder dispersant (compound represented by the above formulas (1) to (3) or pharmaceutically usable thereof)
- a step of appropriately adding 1,2-alkanediol or 1,3-alkanediol, fatty acid and other additives to the heated mixed system, 1-3)
- the aqueous composition (premix) heated to a temperature of room temperature to less than 100 ° C.
- aqueous phase in an aqueous phase heated to a temperature of room temperature to less than 100 ° C.
- Process, 2-2) A cooling step in which the mixture obtained in the mixing step is stirred and cooled to obtain a dispersion.
- the aqueous phase in the above step 2-1) contains water, may further contain higher alcohols and pigments, and may contain 1,2-alkanediol or 1,3-alkanediol, fatty acids, and other additives. .
- a pigment and other additives may be mixed with the aqueous composition (premix) and then combined with the aqueous phase. Furthermore, in the mixing step, a dispersion (preparation) to which a drug is added can also be produced by adding a drug solution.
- the heating temperature of the mixed system (and aqueous composition) in the steps 1-1) and 1-2) is preferably 50 ° C. to 90 ° C., more preferably 60 ° C. to 90 ° C., for example 70 ° C., or 80 ° C. It is.
- This step is preferably carried out with stirring.
- the heating (stirring) time in each step at this time varies depending on the types of pigments, powder dispersants (lipid peptide compounds), surfactants and other components contained in the aqueous composition, and the blending amount thereof. Usually, about 5 to 50 minutes. By this step, the aqueous composition is uniformly dissolved.
- the cooling temperature in the step 1-3) is, for example, room temperature to 80 ° C., room temperature to 60 ° C., or room temperature to 40 ° C. In this step, it is more preferable to cool with stirring, and then stop stirring and leave still. In addition, it is preferable that water is 30 mass% or more and less than 80 mass% with respect to the total mass of the aqueous composition (premix) obtained by the 1) process.
- the heating temperature of the aqueous phase and the aqueous composition (premix) is preferably 50 ° C. to 90 ° C., more preferably 60 ° C. to 90 ° C., such as 70 ° C., or 80 ° C., or 90 ° C. It is.
- the aqueous phase is preferably heated with stirring because it contains other components, and it is usually preferred to carry out heating (stirring) for about 1 to 50 minutes until the contained components are uniformly dissolved and dispersed.
- the heating temperature of the aqueous phase may be the same as the heating temperature of the aqueous composition (premix).
- the mixture obtained in the previous step is stirred and cooled to obtain a dispersion.
- stirring may be performed until the cooling temperature reaches room temperature to 80 ° C., room temperature to 60 ° C., for example, about 60 ° C., and then stirring may be stopped and allowed to stand and cool.
- the blending amount of water is preferably 60% by mass or more and 99.9% by mass or less with respect to the total mass of the dispersion.
- the obtained solid was dissolved in 120 g of tetrahydrofuran and 60 g of acetonitrile, heated to 60 ° C., stirred for 1 hour, cooled, and filtered.
- the solid obtained here was washed with 120 g of water, dried under reduced pressure after filtration, and 26.9 g (yield 65) of white crystals of N-palmitoyl-Gly-His free form (hereinafter also simply referred to as “Pal-GH”). %).
- Example 1 Preparation of liquid foundation containing 10% by mass of pigment
- a liquid foundation containing 10% by mass of pigment was prepared.
- a Laboran screw tube No. 7, As One Co., Ltd.
- 5.0 g of pigment and 33.0 g of pure water were stirred at 80 ° C. for 2 minutes and heated to 80 ° C. with 1,2-hexane.
- 1.0 g of diol was added and stirred for 2 minutes.
- 1.0 g of the composition [1] heated to 80 ° C. was added and stirred for 2 minutes, then 10.0 g of glycerin heated to 80 ° C. was added and stirred for 3 minutes, and the temperature reached room temperature.
- Composition [1] has the composition shown in Table 1 and is mixed with Pal-GH, polyoxyethylene lauryl ether, and purified water, heated and stirred at 70 ° C., and 1,2-hexanediol and stearic acid were added thereto. The mixture was further stirred at 70 ° C. and then allowed to cool to room temperature. Also in the following examples, the composition [1] obtained by the same procedure was used. All stirring in the above manufacturing process was performed at 400 rpm.
- Example 2 Preparation of 10% by mass pigment white water powder foundation
- a white powder foundation containing 10% by mass of the pigment shown in Table 1 was produced in the same procedure as in Example 1 except that 0.5 g of the composition [1] and 33.5 g of pure water were used.
- Example 3 Preparation of a white powder foundation containing 15% by mass of pigment
- a white powder foundation containing 15% by mass of the pigment shown in Table 1 was produced in the same procedure as in Example 2 except that 7.5 g of the pigment and 31 g of pure water were used.
- Comparative Example 1 A foundation of a comparative example in which 10% by mass of the pigment shown in Table 1 was blended was prepared in the same procedure as in Example 1 except that the composition [1] was not blended and the pure water was changed to 34.0 g.
- FIG. 1 shows the foundations (appearance) of Examples 1 to 3 and Comparative Example 1.
- Examples 1 to 3 in which the composition [1] containing Pal-GH was blended, the pigment was scattered and the dispersion stability of the pigment was confirmed. Further, by adjusting the blending amount of the composition [1] containing Pal-GH, a liquid foundation type with high viscosity (Example 1) and a white powder foundation type with low viscosity (Example 2 and Example) Example 3) could be prepared.
- Comparative Example 1 in which the composition [1] containing Pal-GH was not blended as shown in FIG. 1, the pigment and other components were separated, resulting in precipitation of the pigment.
- Example 4 Preparation of dispersion liquid containing 2% by mass of pearl pigment
- Table 2 a dispersion containing 2% by mass of pearl pigment was prepared.
- 1.0 g of pearl pigment and 33.5 g of pure water were stirred at 80 ° C. for 2 minutes, and then heated to 80 ° C.
- 5.0 g of butylene glycol (1,3-butanediol) was added and mixed with stirring for 2 minutes.
- 0.5 g of composition [1] heated to 80 ° C. was added and mixed with stirring for 2 minutes, then 10.0 g of glycerin heated to 80 ° C. was added and mixed for 3 minutes, and the temperature reached room temperature.
- the solution was stirred and cooled to obtain a dispersion. All stirring in the above manufacturing process was performed at 400 rpm.
- Example 5 Preparation of 0.5% by mass of pearl pigment dispersion
- a dispersion liquid containing 0.5% by mass of a pearl pigment was prepared.
- 0.25 g of pearl pigment and 49.25 g of pure water were stirred at 80 ° C. for 2 minutes and heated to 80 ° C.
- the mixture was stirred and cooled to room temperature as it was to obtain a dispersion. All stirring in the above manufacturing process was performed at 400 rpm.
- FIG. 2 shows pearl pigment-containing dispersions (appearance) of Examples 4 and 5 and Comparative Example 2.
- Comparative Example 2 in which the composition [1] containing Pal-GH was not blended, the pearl pigment and other components were separated, resulting in precipitation of the pearl pigment.
- Example 4 and Example 5 in which the composition [1] was blended, the dispersibility of the pearl pigment was improved.
- Example 6 Preparation of tricalcium phosphate dispersion
- Table 3 a dispersion containing 0.5% by mass of tricalcium phosphate was prepared.
- a composition obtained by stirring 0.25 g of tricalcium phosphate and 49.25 g of pure water at 80 ° C. for 2 minutes in a Laborun screw tube bottle (No. 7, As One Co., Ltd.) and heating it to 80 ° C. [1] After adding 0.5 g and stirring and mixing for 2 minutes, the mixture was stirred and cooled to room temperature as it was to obtain a dispersion. All stirring in the above manufacturing process was performed at 400 rpm.
- Comparative Example 3 A comparative example in which 0.5% by mass of tricalcium phosphate shown in Table 3 was blended in the same procedure as in Example 5 except that the composition [1] was not blended and the pure water was 49.75 g. A dispersion was prepared.
- FIG. 3 shows the tricalcium phosphate blend dispersion (appearance) of Example 6 and Comparative Example 3.
- Comparative Example 3 in which the composition [1] containing Pal-GH was not blended, tricalcium phosphate and other components were separated, resulting in precipitation of tricalcium phosphate.
- Example 6 containing the composition [1] the dispersibility of tricalcium phosphate was improved.
- Example 7 Production of 0.01% by mass of gold foil mixed dispersion
- a dispersion liquid containing 0.01% by mass of gold foil (approximately 2 mm square to 10 mm square) was prepared.
- Example 8 Preparation of 0.05 mass% dispersion of gold foil
- a dispersion containing 0.05% by mass of the gold foil shown in Table 4 was prepared in the same manner as in Example 7 except that 25 mg of the gold foil, 0.5 g of the composition [1] and 49.475 g of pure water were used. Manufactured.
- Comparative Example 4 A dispersion of a comparative example in which 0.01% by mass of the gold foil shown in Table 4 was blended in the same procedure as in Example 7 except that the composition [1] was not blended and the pure water was 49.95 g. Prepared.
- FIG. 4 shows the gold foil-containing dispersion (appearance) of Examples 7 and 8 and Comparative Example 4.
- Comparative Example 4 in which the composition [1] containing Pal-GH was not blended, the gold foil and other components were separated, and the gold foil floated or precipitated depending on its weight.
- the dispersibility of tricalcium phosphate was improved.
- Example 9 Preparation of 17% by mass of pigment and preparation of O / W liquid foundation
- Table 5 a foundation in which 17% by mass of pigment was uniformly dispersed was prepared.
- a 200 mL beaker made by HARIO
- 34.0 g of pigment fresh color base aqua
- 139.6 g of purified water
- 0.2 g of sodium N-stearoylmethyl taurine NIKKOL SMT, Nikko Chemicals
- LPA lecithin
- 0.2 g of Nikko Chemicals Co., Ltd. 0.2 g of EDTA-2Na (Pure Chemical Co., Ltd.)
- 0.4 g of hydroxypropylcellulose Nippon Soda Co., Ltd.
- xanthan gum KELTROL-CG-ST, 0.4 g of Sanki Co., Ltd.
- phase B was mixed and heated and stirred at 75 ° C. for 10 minutes (phase B).
- NIKKOL Nicomulus 41 Nikko Chemicals Co., Ltd.
- NIKKOL NATURAL OILS Nikko Chemicals Co., Ltd.
- NIKKOL Nicoguard 88 Nikko Chemicals Co., Ltd. 1 0.0 g was added and stirred with heating at 75 ° C. for 10 minutes (phase A).
- Phase A was added to Phase B with slow stirring, and the resulting mixture was added at 75 ° C.
- phase B was mixed and heated and stirred at 75 ° C. for 10 minutes (phase B).
- NIKKOL Nicomulus 41 Nikko Chemicals Co., Ltd.
- NIKKOL NATURAL OILS Nikko Chemicals Co., Ltd.
- NIKKOL Nicoguard 88 Nikko Chemicals Co., Ltd. 1 0.0 g was added and stirred with heating at 75 ° C. for 10 minutes (phase A).
- Phase A was added to Phase B with slow stirring, and the resulting mixture was added at 75 ° C.
- FIG. 5 shows the results of pigment dispersibility evaluation by observation (photograph) of a polarizing microscope (manufactured by Olympus Corporation) of the O / W liquid foundation of Example 9 and Comparative Example 5.
- a polarizing microscope manufactured by Olympus Corporation
- FIG. 6 shows the O / W liquid foundation (appearance) of Example 9 and Comparative Example 5 after the liquid foundation was prepared and stored for one month.
- Comparative Example 5 in which the composition [1] containing Pal-GH was not blended, separation of the pigment and oil was observed (in the figure, the separation state was uneven color). Observed), the dispersibility was non-uniform, but in Example 9 in which the composition [1] was blended, the dispersibility of the pigment was improved.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Abstract
Description
本発明は顔料又は粉体用分散剤を含有する分散液に関し、詳細には、脂質ペプチド型化合物からなる顔料又は粉体用分散剤を含む分散液及び前記顔料又は粉体用分散剤に関する。 The present invention relates to a dispersion containing a pigment or a powder dispersant, and in particular, to a dispersion containing a pigment or powder dispersant made of a lipid peptide type compound and the pigment or powder dispersant.
水性の組成物は皮膚等への適用時に高い清涼感が得られることや、油性の組成物と比べ使用後のべたつきがなく、さらっとした使用感であることなどから、化粧料等向けに様々な商品が上市、提案されている。
例えば固形状の水性組成物としては従来、水と脂肪酸石鹸と油分と粉末を含有する固形状水中油型メーキャップ化粧料(特許文献1)、アルキル及び/またはアルケニルオリゴグリコシド、油性物質、及びノニオン性乳化剤を含有するスティック状の水性化粧品(特許文献2)等が提案されている。
また液状の水性組成物としては、従来より水を主成分とし保湿剤等の各種添加剤等を配合した水性化粧料や、油性成分と水性成分に乳化剤を配合したエマルション型の組成物が数多く提案されている。
The water-based composition has a high refreshing feeling when applied to the skin, etc., and has a sticky feeling after use compared to the oil-based composition. New products have been put on the market and proposed.
For example, as a solid aqueous composition, conventionally, a solid oil-in-water makeup cosmetic (Patent Document 1) containing water, fatty acid soap, oil and powder, alkyl and / or alkenyl oligoglycoside, oily substance, and nonionic property A stick-shaped aqueous cosmetic (Patent Document 2) containing an emulsifier has been proposed.
As liquid aqueous compositions, there have been many proposals of water-based cosmetics containing water as the main ingredient and various additives such as moisturizers, and emulsion-type compositions containing oily ingredients and aqueous ingredients with emulsifiers. Has been.
上述の水性化粧料には、例えば皮膚の彩色用として各種顔料や粉体等が配合された数多くの製品が提案されているが、こうした水性化粧料を長期間静置すると顔料・粉体が分離・沈降し、場合によってはハードケーキ化することがある。
そのため、各種樹脂や増粘剤、分散剤等の添加剤の配合により、分散液の安定化を図る提案が検討されており、顔料や粉体の分離・沈降、そしてそれらの凝集や固化をより抑制できる技術提案が求められる。
In the above-mentioned aqueous cosmetics, for example, many products containing various pigments and powders for coloring the skin have been proposed, but when these aqueous cosmetics are left standing for a long period of time, the pigments and powders are separated.・ Sedimentation and in some cases hard cake.
Therefore, proposals to stabilize dispersions by blending various resins, thickeners, dispersants, and other additives have been studied, and the separation and sedimentation of pigments and powders, as well as the aggregation and solidification of them, are being investigated. Technical proposals that can be controlled are required.
本発明は上記の事情に基いてなされたものであり、その解決しようとする課題は、顔料又は粉体を含有する分散液において、顔料等の経時の分離・沈降を防止できる分散液並びに分散剤を提供することである。 The present invention has been made on the basis of the above circumstances, and the problem to be solved is a dispersion and a dispersing agent capable of preventing separation and settling of pigments and the like over time in a dispersion containing pigment or powder. Is to provide.
本発明者らは上記課題を解決すべく鋭意研究を行った結果、低分子脂質ペプチド又はその薬学的に使用可能な塩からなる脂質ペプチド型化合物を顔料又は粉体用分散剤として用いた分散液において、配合した顔料等における経時の分離・沈降が抑制された分散液が得られることを見出し、本発明を完成させた。 As a result of diligent research to solve the above problems, the present inventors have found that a dispersion using a lipid peptide type compound comprising a low-molecular-weight lipid peptide or a pharmaceutically usable salt thereof as a dispersant for pigments or powders The inventors have found that a dispersion in which separation and sedimentation with time in the blended pigments and the like are suppressed can be obtained, and the present invention has been completed.
すなわち本発明は、第1観点として、
界面活性剤と、
水と、
下記式(1)乃至式(3)で表される化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物からなる顔料又は粉体用分散剤と、
1,2-アルカンジオール又は1,3-アルカンジオールと、
少なくとも一種の脂肪酸と、
顔料及び粉体からなる群から選択される少なくとも一種とを含む、
分散液に関する。
第2観点として、前記顔料及び粉体からなる群から選択される少なくとも一種が、分散液の総質量に基いて25質量%以下の割合にて含まれてなる、第1観点に記載の分散液に関する。
第3観点として、前記顔料又は粉体用分散剤が、分散液の総質量に基いて0.01質量%乃至1質量%の割合にて含まれてなる、第1観点又は第2観点に記載の分散液。
第4観点として、さらに多価アルコールを含む、第1観点乃至第3観点のうち何れか一項に記載の分散液に関する。
第5観点として、前記多価アルコールが、グリセリンである、第4観点に記載の分散液に関する。
第6観点として、前記界面活性剤が、エチレングリコールアルキルエーテル、リン脂質、ポリグリセリン脂肪酸エステル及びポリオキシエチレンポリオキシプロピレンアルキルエーテルからなる群から選択される1種類以上の化合物である、第1観点乃至第5観点のうち何れか一項に記載の分散液に関する。
第7観点として、前記脂肪酸がステアリン酸である、第1観点乃至第6観点のうち何れか一項に記載の分散液に関する。
第8観点として、化粧料用の分散液である、第1観点乃至第7観点のうち何れか一項に記載の分散液に関する。
第9観点として、下記式(1)乃至式(3)で表される化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物からなる顔料又は粉体用分散剤に関する。
A surfactant,
water and,
A pigment or powder dispersant comprising a lipid peptide type compound comprising at least one of the compounds represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof:
1,2-alkanediol or 1,3-alkanediol;
At least one fatty acid,
Including at least one selected from the group consisting of pigments and powders,
Concerning the dispersion.
As a second aspect, the dispersion according to the first aspect, wherein at least one selected from the group consisting of the pigment and the powder is contained in a proportion of 25% by mass or less based on the total mass of the dispersion. About.
As a third aspect, the pigment or the dispersant for powder is included in a ratio of 0.01% by mass to 1% by mass based on the total mass of the dispersion, described in the first aspect or the second aspect. Dispersion.
As a 4th viewpoint, it is related with the dispersion liquid as described in any one of the 1st viewpoint thru | or a 3rd viewpoint containing a polyhydric alcohol further.
As a 5th viewpoint, the said polyhydric alcohol is related with the dispersion liquid as described in a 4th viewpoint which is glycerol.
As a sixth aspect, the surfactant is one or more compounds selected from the group consisting of ethylene glycol alkyl ethers, phospholipids, polyglycerin fatty acid esters, and polyoxyethylene polyoxypropylene alkyl ethers. Thru | or 5th viewpoint It is related with the dispersion liquid as described in any one.
As a seventh aspect, the present invention relates to the dispersion according to any one of the first to sixth aspects, in which the fatty acid is stearic acid.
As an 8th viewpoint, it is related with the dispersion liquid as described in any one among the 1st viewpoint thru | or the 7th viewpoint which is a dispersion liquid for cosmetics.
As a ninth aspect, the present invention relates to a pigment or a powder dispersant composed of a lipid peptide compound composed of at least one of the compounds represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof. .
本発明によれば、脂質ペプチド型化合物を顔料又は粉体の分散剤として使用することにより、経時において顔料や粉体が分散液から分離したり沈降したりすることなく、これらを安定的に分散させた分散液とすることができる。
特に本発明の分散剤を用いることにより、顔料を10質量%以上も配合した場合や、金箔などの比較的大きな粉体を配合した場合においても、安定的に分散した分散液を調製できる。
According to the present invention, by using a lipid peptide type compound as a dispersant for pigments or powders, the pigments and powders can be stably dispersed without being separated or settled from the dispersion over time. It can be set as the made dispersion liquid.
In particular, by using the dispersant of the present invention, a stably dispersed dispersion can be prepared even when 10% by mass or more of the pigment is blended or when a relatively large powder such as a gold foil is blended.
また本発明の分散剤を構成する脂質ペプチド化合物は、脂質とペプチドのみから構成される非常に安全性の高い人工低分子化合物である。
さらに本発明の分散液において添加剤として含まれる各種成分は食品や化粧品、医薬品の添加剤として汎用の添加剤である。
すなわち、本発明の分散液は生体安全性が高く、特に、医薬品や化粧品等において要求される安全性の観点からみて、上記用途において非常に有用である。
その上、本発明の分散液は、ヒトの肌等に適用した場合に清涼感並びに伸びがよい分散液となることが期待され、医薬品向けや化粧品向けの顔料や粉体を配合した液状の基材としての使用が期待でき、非常に有用である。
The lipid peptide compound constituting the dispersant of the present invention is a very safe artificial low molecular weight compound composed only of lipid and peptide.
Furthermore, various components contained as additives in the dispersion of the present invention are general-purpose additives as additives for foods, cosmetics, and pharmaceuticals.
That is, the dispersion of the present invention has high biological safety, and is particularly useful in the above applications from the viewpoint of safety required for pharmaceuticals and cosmetics.
In addition, the dispersion of the present invention is expected to be a dispersion with good refreshing feeling and elongation when applied to human skin or the like, and is a liquid base containing pigments and powders for pharmaceuticals and cosmetics. It can be expected to be used as a material and is very useful.
本発明は、界面活性剤と、水と、下記式(1)乃至式(3)で表される化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物からなる顔料又は粉体用分散剤と、1,2-アルカンジオール又は1,3-アルカンジオールと、脂肪酸と、顔料及び粉体からなる群から選択される少なくとも一種と及び所望によりその他添加剤とを含む分散液に関する。また本発明は、前記脂質ペプチド型化合物からなる顔料又は粉体用分散剤も対象とする。
以下、各構成成分について説明する。
The present invention relates to a pigment comprising a lipid peptide compound comprising a surfactant, water, and a compound represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof: Or a dispersion containing a dispersant for powder, 1,2-alkanediol or 1,3-alkanediol, fatty acid, at least one selected from the group consisting of pigments and powder, and optionally other additives. Regarding liquids. The present invention is also directed to a pigment or powder dispersant comprising the lipid peptide type compound.
Hereinafter, each component will be described.
[顔料又は粉体用分散剤:脂質ペプチド型化合物]
本発明の顔料又は粉体用分散剤として用いる脂質ペプチド型化合物としては、下記式(1)乃至式(3)で表される化合物(脂質ペプチド)又はその薬学的に使用可能な塩(疎水性部位である脂質部と親水性部位であるペプチド部とを有する低分子化合物)を用いることができる。
The lipid peptide type compound used as the pigment or powder dispersant of the present invention is a compound (lipid peptide) represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof (hydrophobic) A low molecular compound having a lipid part as a site and a peptide part as a hydrophilic site can be used.
上記式(1)において、R1は炭素原子数9乃至23の脂肪族基を表し、好ましくは、R1は不飽和結合を0乃至2個有し得る炭素原子数11乃至23の直鎖状脂肪族基であることが望ましい。
R1と隣接するカルボニル基で構成される脂質部(アシル基)の具体例としては、ラウロイル基、ドデシルカルボニル基、ミリストイル基、テトラデシルカルボニル基、パルミトイル基、マルガロイル基、オレオイル基、エライドイル基、リノレオイル基、ステアロイル基、バクセノイル基、オクタデシルカルボニル基、アラキドイル基、エイコシルカルボニル基、ベヘノイル基、エルカノイル基、ドコシルカルボニル基、リグノセイル基、ネルボノイル基等を挙げることができ、特に好ましいものとして、ラウロイル基、ミリストイル基、パルミトイル基、マルガロイル基、ステアロイル基、オレオイル基、エライドイル基及びベヘノイル基が挙げられる。
In the above formula (1), R 1 represents an aliphatic group having 9 to 23 carbon atoms, and preferably R 1 is a straight chain having 11 to 23 carbon atoms which may have 0 to 2 unsaturated bonds. An aliphatic group is desirable.
Specific examples of the lipid moiety (acyl group) composed of a carbonyl group adjacent to R 1 include lauroyl group, dodecylcarbonyl group, myristoyl group, tetradecylcarbonyl group, palmitoyl group, margaroyl group, oleoyl group, and elideoyl group. Linoleoyl group, stearoyl group, baccenoyl group, octadecylcarbonyl group, arachidyl group, eicosylcarbonyl group, behenoyl group, ercanoyl group, docosylcarbonyl group, lignoceyl group, nerbonoyl group, etc. Examples include lauroyl group, myristoyl group, palmitoyl group, margaroyl group, stearoyl group, oleoyl group, elidoyl group, and behenoyl group.
上記式(1)において、ペプチド部に含まれるR2は、水素原子、又は炭素原子数1若しくは2の分枝鎖を有し得る炭素原子数1乃至4のアルキル基を表す。
上記炭素原子数1若しくは2の分岐鎖を有し得る炭素原子数1乃至4のアルキル基とは、主鎖の炭素原子数が1乃至4であり、かつ炭素原子数1若しくは2の分岐鎖を有し得るアルキル基を意味し、その具体例としては、メチル基、エチル基、n-プロピル基、i-プロピル基、n-ブチル基、i-ブチル基、sec-ブチル基又はtert-ブチル基などが挙げられる。
上記R2は好ましくは、水素原子、又は炭素原子数1の分岐鎖を有し得る炭素原子数1乃至3のアルキル基であり、より好ましくは水素原子である。
炭素原子数1の分岐鎖を有し得る炭素原子数1乃至3のアルキル基とは、主鎖の炭素原子数が1乃至3であり、かつ炭素原子数1の分岐鎖を有し得るアルキル基を意味し、その具体例としては、メチル基、エチル基、n-プロピル基、i-プロピル基、i-ブチル基又はsec-ブチル基などが挙げられ、好ましくはメチル基、i-プロピル基、i-ブチル基又はsec-ブチル基である。
In the above formula (1), R 2 contained in the peptide part represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms.
The alkyl group having 1 to 4 carbon atoms that may have a branched chain having 1 or 2 carbon atoms is a branched chain having 1 to 4 carbon atoms in the main chain and 1 or 2 carbon atoms. Means an alkyl group which may have, and specific examples thereof include methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, i-butyl group, sec-butyl group or tert-butyl group Etc.
R 2 is preferably a hydrogen atom or an alkyl group having 1 to 3 carbon atoms which may have a branched chain having 1 carbon atom, and more preferably a hydrogen atom.
The alkyl group having 1 to 3 carbon atoms which can have a branched chain having 1 carbon atom is an alkyl group having 1 to 3 carbon atoms in the main chain and having a branched chain having 1 carbon atom. Specific examples thereof include a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an i-butyl group, or a sec-butyl group, preferably a methyl group, an i-propyl group, An i-butyl group or a sec-butyl group.
上記式(1)において、R3は-(CH2)n-X基を表す。上記-(CH2)n-X基において、nは1乃至4の数を表し、Xはアミノ基、グアニジノ基、-CONH2基、又は窒素原子を1乃至3個有し得る5員環式基若しくは6員環式基、又は5員環と6員環から構成される縮合複素環式基を表す。
上記R3を表す-(CH2)n-X基において、Xは好ましくはアミノ基、グアニジノ基、カルバモイル基(-CONH2基)、ピロール基、イミダゾール基、ピラゾール基又はインドール基であり、より好ましくはイミダゾール基である。また、上記-(CH2)n-X基において、nは好ましくは1又は2であり、より好ましくは1である。
従って、上記-(CH2)n-基は、好ましくはアミノメチル基、2-アミノエチル基、3-アミノプロピル基、4-アミノブチル基、カルバモイルメチル基、2-カルバモイルエチル基、3-カルバモイルブチル基、2-グアニジノエチル基、3-グアニジノブチル基、ピロールメチル基、4-イミダゾールメチル基、ピラゾールメチル基、又は3-インドールメチル基を表し、より好ましくは4-アミノブチル基、カルバモイルメチル基、2-カルバモイルエチル基、3-グアニジノブチル基、4-イミダゾールメチル基又は3-インドールメチル基を表し、さらに好ましくは4-イミダゾールメチル基である。
In the above formula (1), R 3 represents a — (CH 2 ) n—X group. In the — (CH 2 ) n—X group, n represents a number of 1 to 4, and X is an amino group, a guanidino group, a —CONH 2 group, or a 5-membered cyclic group having 1 to 3 nitrogen atoms. Represents a group, a 6-membered cyclic group, or a condensed heterocyclic group composed of a 5-membered ring and a 6-membered ring.
In the — (CH 2 ) n—X group representing R 3 , X is preferably an amino group, guanidino group, carbamoyl group (—CONH 2 group), pyrrole group, imidazole group, pyrazole group or indole group, and more Preferably it is an imidazole group. In the — (CH 2 ) n—X group, n is preferably 1 or 2, and more preferably 1.
Therefore, the — (CH 2 ) n- group is preferably an aminomethyl group, 2-aminoethyl group, 3-aminopropyl group, 4-aminobutyl group, carbamoylmethyl group, 2-carbamoylethyl group, 3-carbamoyl group. Represents a butyl group, a 2-guanidinoethyl group, a 3-guanidinobutyl group, a pyrrolemethyl group, a 4-imidazolemethyl group, a pyrazolemethyl group, or a 3-indolemethyl group, more preferably a 4-aminobutyl group, a carbamoylmethyl group Represents a 2-carbamoylethyl group, a 3-guanidinobutyl group, a 4-imidazolemethyl group or a 3-indolemethyl group, more preferably a 4-imidazolemethyl group.
上記式(1)で表される化合物において、脂質ペプチド型化合物として特に好適な脂質ペプチドとしては、以下の脂質部とペプチド部(アミノ酸集合部)から形成される化合物である。なおアミノ酸の略称としては、アラニン(Ala)、アスパラギン(Asn)、グルタミン(Gln)、グリシン(Gly)、ヒスチジン(His)、イソロシン(Ile)、ロイシン(Leu)、リジン(Lys)、トリプトファン(Trp)、バリン(Val)を表す。:ラウロイル-Gly-His、ラウロイル-Gly-Gln、ラウロイル-Gly-Asn、ラウロイル-Gly-Trp、ラウロイル-Gly-Lys、ラウロイル-Ala-His、ラウロイル-Ala-Gln、ラウロイル-Ala-Asn、ラウロイル-Ala-Trp、ラウロイル-Ala-Lys;ミリストイル-Gly-His、ミリストイル-Gly-Gln、ミリストイル-Gly-Asn、ミリストイル-Gly-Trp、ミリストイル-Gly-Lys、ミリストイル-Ala-His、ミリストイル-Ala-Gln、ミリストイル-Ala-Asn、ミリストイル-Ala-Trp、ミリストイル-Ala-Lys;パルミトイル-Gly-His、パルミトイル-Gly-Gln、パルミトイル-Gly-Asn、パルミトイル-Gly-Trp、パルミトイル-Gly-Lys、パルミトイル-Ala-His、パルミトイル-Ala-Gln、パルミトイル-Ala-Asn、パルミトイル-Ala-Trp、パルミトイル-Ala-Lys;ステアロイル-Gly-His、ステアロイル-Gly-Gln、ステアロイル-Gly-Asn、ステアロイル-Gly-Trp、ステアロイル-Gly-Lys、ステアロイル-Ala-His、ステアロイル-Ala-Gln、ステアロイル-Ala-Asn、ステアロイル-Ala-Trp、ステアロイル-Ala-Lys。 In the compound represented by the above formula (1), a lipid peptide particularly suitable as a lipid peptide type compound is a compound formed from the following lipid part and peptide part (amino acid assembly part). As abbreviations for amino acids, alanine (Ala), asparagine (Asn), glutamine (Gln), glycine (Gly), histidine (His), isorosine (Ile), leucine (Leu), lysine (Lys), tryptophan (Trp) ), Valine (Val). Lauroyl-Gly-His, Lauroyl-Gly-Gln, Lauroyl-Gly-Asn, Lauroyl-Gly-Trp, Lauroyl-Gly-Lys, Lauroyl-Ala-His, Lauroyl-Ala-Gln, Lauroyl-Ala-Asn, Lauroyl -Ala-Trp, Lauroyl-Ala-Lys; Myristoyl-Gly-His, Myristoyl-Gly-Gln, Myristoyl-Gly-Asn, Myristoyl-Gly-Trp, Myristoyl-Gly-Lys, Myristoyl-Ala-His, Myristoyl-Ala -Gln, Myristoyl-Ala-Asn, Myristoyl-Ala-Trp, Myristoyl-Ala-Lys; Palmitoyl-Gly-His, Palmitoyl-Gly-Gln, Palmitoyl-Gly-A n, Palmitoyl-Gly-Trp, Palmitoyl-Gly-Lys, Palmitoyl-Ala-His, Palmitoyl-Ala-Gln, Palmitoyl-Ala-Asn, Palmitoyl-Ala-Trp, Palmitoyl-Ala-Lys; Stearoyl-Gly-His Stearoyl-Gly-Gln, stearoyl-Gly-Asn, stearoyl-Gly-Trp, stearoyl-Gly-Lys, stearoyl-Ala-His, stearoyl-Ala-Gln, stearoyl-Ala-Asn, stearoyl-Ala-Trp, stearoyl- Ala-Lys.
最も好ましいものとして、ラウロイル-Gly-His、ラウロイル-Ala-His-ミリストイル-Gly-His、ミリストイル-Ala-His;パルミトイル-Gly-His、パルミトイル-Ala-His;ステアロイル-Gly-His、ステアロイル-Ala-Hisが挙げられる。 Most preferred are lauroyl-Gly-His, lauroyl-Ala-His-myristoyl-Gly-His, myristoyl-Ala-His; palmitoyl-Gly-His, palmitoyl-Ala-His; stearoyl-Gly-His, stearoyl-Ala -His.
上記式(2)において、R4は炭素原子数9乃至23の脂肪族基を表し、好ましい具体例としては、前出のR1で定義したものと同じ基が挙げられる。
上記式(2)において、R5乃至R7は、それぞれ独立して、水素原子、又は炭素原子数1若しくは2の分枝鎖を有し得る炭素原子数1乃至4のアルキル基、又は-(CH2)n-X基を表し、且つR5乃至R7のうち少なくとも一つ以上が-(CH2)n-X基を表す。nは1乃至4の数を表し、Xはアミノ基、グアニジノ基、-CONH2基、又は窒素原子を1乃至3個有し得る5員環式基若しくは6員環式基、又は5員環と6員環から構成される縮合複素環式基を表す。ここでR5乃至R7の好ましい具体例としては、前出のR2及びR3で定義したものと同じ基が挙げられる。
In the above formula (2), R 4 represents an aliphatic group having 9 to 23 carbon atoms, and preferred specific examples include the same groups as defined for R 1 above.
In the above formula (2), R 5 to R 7 each independently represent a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, or — ( CH 2 ) nX group, and at least one of R 5 to R 7 represents a — (CH 2 ) nX group. n represents a number of 1 to 4, and X represents an amino group, a guanidino group, a —CONH 2 group, or a 5-membered cyclic group or a 6-membered cyclic group which may have 1 to 3 nitrogen atoms, or a 5-membered ring And a condensed heterocyclic group composed of a 6-membered ring. Here, preferred specific examples of R 5 to R 7 include the same groups as defined for R 2 and R 3 above.
上記式(2)で表される化合物において、好適な脂質ペプチドとしては、以下の脂質部とペプチド部(アミノ酸集合部)から形成される化合物である。例えば、ラウロイル-Gly-Gly-His、ラウロイル-Gly-Gly-Gln、ラウロイル-Gly-Gly-Asn、ラウロイル-Gly-Gly-Trp、ラウロイル-Gly-Gly-Lys、ラウロイル-Gly-Ala-His、ラウロイル-Gly-Ala-Gln、ラウロイル-Gly-Ala-Asn、ラウロイル-Gly-Ala-Trp、ラウロイル-Gly-Ala-Lys、ラウロイル-Ala-Gly-His、ラウロイル-Ala-Gly-Gln、ラウロイル-Ala-Gly-Asn、ラウロイル-Ala-Gly-Trp、ラウロイル-Ala-Gly-Lys、ラウロイル-Gly-His-Gly、ラウロイル-His-Gly-Gly、ミリストイル-Gly-Gly-His、ミリストイル-Gly-Gly-Gln、ミリストイル-Gly-Gly-Asn、ミリストイル-Gly-Gly-Trp、ミリストイル-Gly-Gly-Lys、ミリストイル-Gly-Ala-His、ミリストイル-Gly-Ala-Gln、ミリストイル-Gly-Ala-Asn、ミリストイル-Gly-Ala-Trp、ミリストイル-Gly-Ala-Lys、ミリストイル-Ala-Gly-His、ミリストイル-Ala-Gly-Gln、ミリストイル-Ala-Gly-Asn、ミリストイル-Ala-Gly-Trp、ミリストイル-Ala-Gly-Lys、ミリストイル-Gly-His-Gly、ミリストイル-His-Gly-Gly、パルミトイル-Gly-Gly-His、パルミトイル-Gly-Gly-Gln、パルミトイル-Gly-Gly-Asn、パルミトイル-Gly-Gly-Trp、パルミトイル-Gly-Gly-Lys、パルミトイル-Gly-Ala-His、パルミトイル-Gly-Ala-Gln、パルミトイル-Gly-Ala-Asn、パルミトイル-Gly-Ala-Trp、パルミトイル-Gly-Ala-Lys、パルミトイル-Ala-Gly-His、パルミトイル-Ala-Gly-Gln、パルミトイル-Ala-Gly-Asn、パルミトイル-Ala-Gly-Trp、パルミトイル-Ala-Gly-Lys、パルミトイル-Gly-His-Gly、パルミトイル-His-Gly-Gly、ステアロイル-Gly-Gly-His、ステアロイル-Gly-Gly-Gln、ステアロイル-Gly-Gly-Asn、ステアロイル-Gly-Gly-Trp、ステアロイル-Gly-Gly-Lys、ステアロイル-Gly-Ala-His、ステアロイル-Gly-Ala-Gln、ステアロイル-Gly-Ala-Asn、ステアロイル-Gly-Ala-Trp、ステアロイル-Gly-Ala-Lys、ステアロイル-Ala-Gly-His、ステアロイル-Ala-Gly-Gln、ステアロイル-Ala-Gly-Asn、ステアロイル-Ala-Gly-Trp、ステアロイル-Ala-Gly-Lys、ステアロイル-Gly-His-Gly、ステアロイル-His-Gly-Gly。 In the compound represented by the above formula (2), a preferable lipid peptide is a compound formed from the following lipid part and peptide part (amino acid assembly part). For example, lauroyl-Gly-Gly-His, lauroyl-Gly-Gly-Gln, lauroyl-Gly-Gly-Asn, lauroyl-Gly-Gly-Trp, lauroyl-Gly-Gly-Lys, lauroyl-Gly-Ala-His, Lauroyl-Gly-Ala-Gln, Lauroyl-Gly-Ala-Asn, Lauroyl-Gly-Ala-Trp, Lauroyl-Gly-Ala-Lys, Lauroyl-Ala-Gly-His, Lauroyl-Ala-Gly-Gln, Lauroyl- Ala-Gly-Asn, Lauroyl-Ala-Gly-Trp, Lauroyl-Ala-Gly-Lys, Lauroyl-Gly-His-Gly, Lauroyl-His-Gly-Gly, Myristoyl-Gly-Gly-His, Myristo Lu-Gly-Gly-Gln, Myristoyl-Gly-Gly-Asn, Myristoyl-Gly-Gly-Trp, Myristoyl-Gly-Gly-Lys, Myristoyl-Gly-Ala-His, Myristoyl-Gly-Ala-Gln, Myristoyl- Gly-Ala-Asn, Myristoyl-Gly-Ala-Trp, Myristoyl-Gly-Ala-Lys, Myristoyl-Ala-Gly-His, Myristoyl-Ala-Gly-Gln, Myristoyl-Ala-Gly-Asn, Myristoyl-Ala- Gly-Trp, Myristoyl-Ala-Gly-Lys, Myristoyl-Gly-His-Gly, Myristoyl-His-Gly-Gly, Palmitoyl-Gly-Gly-His, Palmitoyl-Gly-Gly Gln, Palmitoyl-Gly-Gly-Asn, Palmitoyl-Gly-Gly-Trp, Palmitoyl-Gly-Gly-Lys, Palmitoyl-Gly-Ala-His, Palmitoyl-Gly-Ala-Gln, Palmitoyl-Gly-Aly-Gly-Aly-Gly-Aly Palmitoyl-Gly-Ala-Trp, Palmitoyl-Gly-Ala-Lys, Palmitoyl-Ala-Gly-His, Palmitoyl-Ala-Gly-Gln, Palmitoyl-Ala-Gly-Asn, Palmitoyl-Ala-Gly-Trp Ala-Gly-Lys, Palmitoyl-Gly-His-Gly, Palmitoyl-His-Gly-Gly, Stearoyl-Gly-Gly-His, Stearoyl-Gly-Gly-Gln, Stearoyl -Gly-Gly-Asn, stearoyl-Gly-Gly-Trp, stearoyl-Gly-Gly-Lys, stearoyl-Gly-Ala-His, stearoyl-Gly-Ala-Gln, stearoyl-Gly-Ala-Asn, stearoyl-Gly -Ala-Trp, stearoyl-Gly-Ala-Lys, stearoyl-Ala-Gly-His, stearoyl-Ala-Gly-Gln, stearoyl-Ala-Gly-Asn, stearoyl-Ala-Gly-Trp, stearoyl-Ala-Gly -Lys, stearoyl-Gly-His-Gly, stearoyl-His-Gly-Gly.
これらのうち、最も好ましいものとして、ラウロイル-Gly-Gly-His、ミリストイル-Gly-Gly-His、パルミトイル-Gly-Gly-His、パルミトイル-Gly-His-Gly、パルミトイル-His-Gly-Gly、ステアロイル-Gly-Gly-Hisが挙げられる。 Of these, lauroyl-Gly-Gly-His, myristoyl-Gly-Gly-His, palmitoyl-Gly-Gly-His, palmitoyl-Gly-His-Gly, palmitoyl-His-Gly-Gly, stearoyl -Gly-Gly-His.
上記式(3)において、R8は炭素原子数9乃至23の脂肪族基を表し、好ましい具体例としては、前出のR1で定義したものと同じ基が挙げられる。
上記式(3)において、R9乃至R12は、それぞれ独立して、水素原子、又は炭素原子数1若しくは2の分枝鎖を有し得る炭素原子数1乃至4のアルキル基、又は-(CH2)n-X基を表し、且つR9乃至R12のうち少なくとも一つ以上が-(CH2)n-X基を表す。nは1乃至4の数を表し、Xはアミノ基、グアニジノ基、-CONH2基、又は窒素原子を1乃至3個有し得る5員環式基若しくは6員環式基、又は5員環と6員環から構成される縮合複素環式基を表す。ここでR9乃至R12の好ましい具体例としては、前出のR2及びR3で定義したものと同じ基が挙げられる。
In the above formula (3), R 8 represents an aliphatic group having 9 to 23 carbon atoms, and preferred specific examples include the same groups as defined for R 1 above.
In the above formula (3), R 9 to R 12 are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms, or — ( CH 2 ) nX group, and at least one of R 9 to R 12 represents a — (CH 2 ) nX group. n represents a number of 1 to 4, and X represents an amino group, a guanidino group, a —CONH 2 group, or a 5-membered cyclic group or a 6-membered cyclic group which may have 1 to 3 nitrogen atoms, or a 5-membered ring And a condensed heterocyclic group composed of a 6-membered ring. Here, preferred specific examples of R 9 to R 12 include the same groups as defined for R 2 and R 3 above.
したがって上記式(3)で表される化合物において、好適な脂質ペプチド型化合物として、特に好適な脂質ペプチドとしては、ラウロイル-Gly-Gly-Gly-His、ミリストイル-Gly-Gly-Gly-His、パルミトイル-Gly-Gly-Gly-His、パルミトイル-Gly-Gly-His-Gly、パルミトイル-Gly-His-Gly-Gly、パルミトイル-His-Gly-Gly-Gly、ステアロイル-Gly-Gly-Gly-His等が挙げられる。 Therefore, in the compound represented by the above formula (3), as preferred lipid peptide type compounds, particularly preferred lipid peptides include lauroyl-Gly-Gly-Gly-His, myristoyl-Gly-Gly-Gly-His, palmitoyl. -Gly-Gly-Gly-His, Palmitoyl-Gly-Gly-His-Gly, Palmitoyl-Gly-His-Gly-Gly, Palmitoyl-His-Gly-Gly-Gly, Stearoyl-Gly-Gly-Gly-His, etc. Can be mentioned.
本発明において、顔料又は粉体用分散剤である脂質ペプチド型化合物の配合量は、得られる分散液の総質量に対して、例えば0.01質量%乃至1質量%、あるいは0.01質量%以上1質量%未満、好ましくは0.05質量%乃至0.5質量%、より好ましくは0.05質量%乃至0.3質量%、例えば0.05質量%乃至0.2質量%である。
なお本発明において用いられる脂質ペプチド型化合物は、上記式(1)乃至式(3)で表される化合物(脂質ペプチド)又はその薬学的な使用可能な塩のうちの少なくとも一種からなり、顔料又は粉体用分散剤としてこれら化合物を単独で、或いは二種以上を組み合わせて用いることができる。
In the present invention, the amount of the lipid peptide type compound that is a pigment or a dispersant for powder is, for example, 0.01% by mass to 1% by mass, or 0.01% by mass with respect to the total mass of the resulting dispersion. These are less than 1% by mass, preferably 0.05% by mass to 0.5% by mass, more preferably 0.05% by mass to 0.3% by mass, for example 0.05% by mass to 0.2% by mass.
The lipid peptide type compound used in the present invention comprises at least one of the compounds represented by the above formulas (1) to (3) (lipid peptide) or a pharmaceutically usable salt thereof, These compounds can be used alone or in combination of two or more as a dispersant for powder.
[界面活性剤]
本発明の分散液において使用する界面活性剤として、分子内に親水部と疎水部を有し、かつ該親水部がベタイン構造を有する化合物(以下、ベタイン系化合物とも称する)、エチレングリコールアルキルエーテル、ポリグリセリン脂肪酸エステル、或いはポリオキシエチレンポリオキシプロピレンアルキルエーテルを好適に用いることができる。
[Surfactant]
As the surfactant used in the dispersion of the present invention, a compound having a hydrophilic part and a hydrophobic part in the molecule, and the hydrophilic part having a betaine structure (hereinafter also referred to as a betaine compound), ethylene glycol alkyl ether, Polyglycerin fatty acid ester or polyoxyethylene polyoxypropylene alkyl ether can be preferably used.
上述のようなベタイン系化合物としては、例えばラウリルジメチルアミノ酢酸ベタイン(ラウリルベタイン)等のN-アルキル-N,N-ジメチルアミノ酸ベタイン;コカミドプロピルベタイン、ラウラミドプロピルベタイン等の脂肪酸アミドアルキル-N,N-ジメチルアミノ酸ベタイン;ココアンホ酢酸ナトリウム、ラウロアンホ酢酸ナトリウム等のイミダゾリン型ベタイン;ラウリルヒドロキシスルホベタイン、アルキルジメチルタウリン等のアルキルスルホベタイン;アルキルジメチルアミノエタノール硫酸エステル等の硫酸型ベタイン;アルキルジメチルアミノエタノールリン酸エステル等のリン酸型ベタイン等、両性界面活性剤として既知のベタイン系化合物を使用出来る。
また、上記ベタイン系化合物として、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトール、ホスファチジルグリセロール、ジホスファチジルグリセロール(カルジオリピン)、ホスファチジン酸などのグリセロリン脂質;リゾホスファチジルコリン(リゾレシチン)、リゾホスファチジルエタノールアミン、リゾホスファチジルセリン、リゾホスファチジルイノシトール、リゾホスファチジルグリセロール、リゾホスファチジン酸などのリゾグリセロリン脂質;スフィンゴミエリンなどのスフィンゴリン脂質;およびこれらの水素添加物などが挙げられる。これらのリン脂質は、大豆、卵黄などの動植物由来のものでもよく、化学的もしくは酵素的方法により合成されたものでもよい。
上記ベタイン系化合物の中でも、好ましくは、ラウリルジメチルアミノ酢酸ベタイン、ラウリン酸アミドプロピルベタイン、ラウリルヒドロキシスルホベタイン、ステアリルベタイン、リゾホスファチジルコリン(リゾレシチン)、リゾホスファチジルエタノールアミン、リゾホスファチジルセリン、リゾホスファチジルイノシトール、リゾホスファチジルグリセロール、リゾホスファチジン酸などが挙げられ、さらに好ましくは、リゾホスファチジルコリン(リゾレシチン)が挙げられる。
Examples of the betaine compounds as described above include N-alkyl-N, N-dimethylamino acid betaines such as lauryldimethylaminoacetic acid betaine (lauryl betaine); fatty acid amide alkyl-N such as cocamidopropyl betaine and lauramidopropyl betaine. N-dimethylamino acid betaine; imidazoline-type betaines such as sodium cocoamphoacetate and sodium lauroamphoacetate; alkylsulfobetaines such as laurylhydroxysulfobetaine and alkyldimethyltaurine; sulfate-type betaines such as alkyldimethylaminoethanol sulfate; alkyldimethylaminoethanol Known betaine compounds such as phosphate-type betaines such as phosphate esters can be used as amphoteric surfactants.
Examples of the betaine compounds include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, diphosphatidylglycerol (cardiolipin), phosphatidic acid and other glycerophospholipids; lysophosphatidylcholine (lysolecithin), lysophosphatidylethanolamine, Examples thereof include lysoglycerophospholipids such as serine, lysophosphatidylinositol, lysophosphatidylglycerol, and lysophosphatidic acid; sphingophospholipids such as sphingomyelin; and hydrogenated products thereof. These phospholipids may be derived from animals and plants such as soybeans and egg yolks, or may be synthesized by a chemical or enzymatic method.
Among the betaine compounds, preferably lauryldimethylaminoacetic acid betaine, lauric acid amidopropyl betaine, lauryl hydroxysulfobetaine, stearyl betaine, lysophosphatidylcholine (lysolecithin), lysophosphatidylethanolamine, lysophosphatidylserine, lysophosphatidylinositol, lyso Examples thereof include phosphatidylglycerol and lysophosphatidic acid, and more preferably lysophosphatidylcholine (lysolecithin).
上記エチレングリコールアルキルエーテルとしては、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンラウリルエーテル、ポリオキシエチレンパルミトイルエーテル、ポリオキシエチレンステアリルエーテル等が挙げられる。またエチレングリコールアルキルエーテルは市販品も使用し得、そのような製品としては、例えば花王(株)のエマルゲン(登録商標)シリーズ及びエマノーン(登録商標)シリーズのうち、エマルゲン102KG、エマルゲン103、エマルゲン104P、エマルゲン105、エマルゲン106、エマルゲン108、エマルゲン109P、エマルゲン120、エマルゲン123P、エマルゲン130K、エマルゲン147、エマルゲン150、エマルゲン210P、エマルゲン220、エマルゲン306P、エマルゲン320P、エマルゲン350、エマルゲン404、エマルゲン408、エマルゲン409PV、エマルゲン420、エマルゲン430、エマルゲン705、エマルゲン707、エマルゲン709、エマルゲン1108、エマルゲン1118S-70、エマルゲン1135S-70、エマルゲン1150S-60、エマルゲン4085、エマルゲン2020G-HA、エマルゲン2025G、エマノーン1112、エマノーン3199V、エマノーン3299V、エマノーン3299RV、エマノーン4110が挙げられる。より好ましくは、花王(株)のエマルゲン103、エマルゲン104P、エマルゲン105、エマルゲン106、エマルゲン108、エマルゲン109P、エマルゲン210P、エマルゲン306P、エマルゲン320P、エマルゲン404、エマルゲン408、エマルゲン409PV、エマルゲン420、エマルゲン705、エマルゲン707、エマルゲン709、エマルゲン1108、エマルゲン2020G-HA、エマノーン1112、エマノーン4110が挙げられる。さらに好ましくは、花王(株)のエマルゲン104P、エマルゲン105、エマルゲン106、エマルゲン108、エマルゲン210P、エマルゲン306P、エマルゲン408、エマルゲン409PV、エマルゲン705、エマルゲン707、エマルゲン709、エマルゲン1108、エマルゲン2020G-HA、エマノーン1112、エマノーン4110が挙げられる。これの他、日光ケミカルズ(株)のNIKKOL(登録商標)シリーズからも適宜選択し得る。例えば、NIKKOL BT-5、NIKKOL BT-7、NIKKOL BT-9、NIKKOL BT-12、NIKKOL BL-2、NIKKOL BL-4.2、NIKKOL BL-9EX等が挙げられ、最も好ましくは、NIKKOL BL-4.2が挙げられる。 Examples of the ethylene glycol alkyl ether include polyoxyethylene alkyl ether, polyoxyethylene lauryl ether, polyoxyethylene palmitoyl ether, polyoxyethylene stearyl ether and the like. Also, commercially available ethylene glycol alkyl ethers can be used. Examples of such products include Emulgen 102KG, Emargen 103, and Emulgen 104P in Kao's Emulgen (registered trademark) series and Emanon (registered trademark) series. Emulgen 105, Emulgen 106, Emulgen 108, Emulgen 109P, Emulgen 120P, Emulgen 123P, Emulgen 130K, Emulgen 147, Emulgen 150, Emulgen 210P, Emulgen 220, Emulgen 306P, Emulgen 320P, Emulgen 350, Emulgen 404, Emulgen 408, Emulgen 409PV, Emulgen 420, Emulgen 430, Emulgen 705, Emulgen 707, Emulgen 709, Emulgen 1108, Emulgen 1118S-70, Emulgen 1135S-70, Emulgen 1150S-60, Emulgen 4085, Emulgen 2020G-HA, Emulgen 2025G, Emanon 1112, Emanor 3199V, Emanon 3299V, Emanon 3299RV, include the Emanon 4110. More preferably, Kao's Emulgen 103, Emulgen 104P, Emulgen 105, Emulgen 106, Emulgen 108, Emulgen 109P, Emulgen 210P, Emulgen 306P, Emulgen 320P, Emulgen 404, Emulgen 408, Emulgen 409PV, Emulgen 420, Emulgen 705 , Emulgen 707, Emulgen 709, Emulgen 1108, Emulgen 2020G-HA, Emanon 1112, Emanon 4110. More preferably, Kao's Emulgen 104P, Emulgen 105, Emulgen 106, Emulgen 108, Emulgen 210P, Emulgen 306P, Emulgen 408, Emulgen 409PV, Emulgen 705, Emulgen 707, Emulgen 709, Emulgen 1108, Emulgen 2020G-HA, Emanon 1112, Emanon 4110. In addition to this, it can be appropriately selected from the NIKKOL (registered trademark) series of Nikko Chemicals. For example, NIKKOL BT-5, NIKKOL BT-7, NIKKOL BT-9, NIKKOL BT-12, NIKKOL BL-2, NIKKOL BL-4.2, NIKKOL BL-9EX, etc., most preferably NIKOL BL-9EX 4.2.
上記ポリグリセリン脂肪酸エステルとしては、ステアリン酸グリセリル、イソステアリン酸グリセリル、パルミチン酸グリセリル、ミリスチン酸グリセリル、オレイン酸グリセリル、ヤシ油脂肪酸グリセリル、モノ綿実油脂肪酸グリセリン、モノエルカ酸グリセリン、セスキオレイン酸グリセリン、α,α’-オレイン酸ピログルタミン酸グリセリン、モノステアリン酸グリセリンリンゴ酸等のグリセリン脂肪酸部分エステル類;ステアリン酸ポリグリセリル-2、同3、同4、同5、同6、同8、同10、ジステアリン酸ポリグリセリル-6、同10、トリステアリン酸ポリグリセリル-2、デカステアリン酸ポリグリセリル-10、イソステアリン酸ポリグリセリル-2、同3、同4、同5、同6、同8、同10、ジイソステアリン酸ポリグリセリル-2(ジイソステアリン酸ジグリセリル)、同3、同10(ジイソステアリン酸デカグリセリル)、トリイソステアリン酸ポリグリセリル-2、テトライソステアリン酸ポリグリセリル-2、デカイソステアリン酸ポリグリセリル-10、オレイン酸ポリグリセリル-2、同3、同4、同5、同6、同8、同10、ジオレイン酸ポリグリセリル-6、トリオレイン酸ポリグリセリル-2、デカオレイン酸ポリグリセリル-10等が挙げられる。
Examples of the polyglycerin fatty acid ester include glyceryl stearate, glyceryl isostearate, glyceryl palmitate, glyceryl myristate, glyceryl oleate, glyceryl coconut oil fatty acid, mono-cotton oil fatty acid glycerin, glyceryl monosulcate, glyceryl sesquioleate, α, α '-Glycerin fatty acid partial esters such as glyceryl oleate, glyceryl monostearate, and malic monostearate; polyglyceryl stearate-2, 3, 4, 5, 6, 6, 8, 10 polyglyceryl distearate 6, same 10, polyglyceryl tristearate-2,
ポリオキシエチレンポリオキシプロピレンアルキルエーテルとしては、花王(株)のエマルゲン(登録商標)LS-106、エマルゲンLS-110、エマルゲンLS-114、エマルゲンMS-110、および日光ケミカルズ(株)のNIKKOL(登録商標) PBC-31、NIKKOL PBC-33、NIKKOL PBC-34、NIKKOL PBC-41、NIKKOL PBC-44、NIKKOL PBN-4612、NIKKOL PBN-4620、NIKKOL PBN-4630が挙げられる。より好ましくは、エマルゲンLS-106、エマルゲンLS-110、エマルゲンLS-114、エマルゲンMS-110が挙げられる。さらに好ましくは、エマルゲンLS-106、エマルゲンLS-110、エマルゲンMS-110が挙げられる。 Polyoxyethylene polyoxypropylene alkyl ethers include Kao's Emulgen (registered trademark) LS-106, Emulgen LS-110, Emulgen LS-114, Emulgen MS-110, and Nikko Chemicals' NIKKOL (registered) Trademarks) PBC-31, NIKKOL PBC-33, NIKKOL PBC-34, NIKKOL PBC-41, NIKKOL PBC-44, NIKKOL PBN-4612, NIKKOL PBN-4620, NIKKOL PBN-4630. More preferred are Emulgen LS-106, Emulgen LS-110, Emulgen LS-114, and Emulgen MS-110. More preferred are Emulgen LS-106, Emulgen LS-110, and Emulgen MS-110.
また本発明において使用する界面活性剤として、そのHLB(Hydrophile-Lipophile Balance)値が8乃至20であるものを好適に使用することができる。より好ましくは、HLB値が8乃至14である。
このような界面活性剤としては、例えばイソステアリン酸ソルビタン、ステアレス-8、ベヘネス-10、ラウレス-4、ラウレス-5、セテス-7、オレス-8、イソステアリン酸PEG-8グリセリル、コレス-10、イソステアリン酸PEG-10BG、トリイソステアリン酸PEG-30グリセリル、トリイソステアリン酸PEG-30グリセリル、トリオレイン酸PEG-30グリセリル、トリイソステアリン酸PEG-30トリメチロールプロパン、ラウリン酸PEG-30水添ヒマシ油、PCAイソステアリン酸PEG-30水添ヒマシ油、オクチルドデセス-10、ジラウリン酸PEG-12、テトラオレイン酸ソルベス-40、ジイソステアリン酸ポリグリセリル-10(ジイソステアリン酸デカグリセリル)、ジイソステアリン酸PEG-20グリセリル、イソステアリン酸PEG-8、イソステアリン酸PEG-10グリセリル、トリイソステアリン酸PEG-60水添ヒマシ油、PPG-2-デセス-7、オレス-10、水添ダイマージリノレス-20、ヤシ脂肪酸ソルビタン、イソステアレス-10、ステアレス-11、トリミリスチン酸PEG-30トリメチロールプロパン、イソステアリン酸PEG-40水添ヒマシ油、イソステアリン酸PEG-40水添ヒマシ油、PCAイソステアリン酸PEG-40水添ヒマシ油、ラウレス-7、イソセテス-10、セテス-10、イソステアリン酸PEG-10、ステアリン酸PEG-10、オレイン酸PEG-10、ステアリン酸PEG-10グリセリル、オレス-12、デシルテトラデセス-15、コレス-15、ジラウリン酸PEG-16、PEG-30水添ヒマシ油、トリイソステアリン酸PEG-40グリセリル、トリオレイン酸PEG-40グリセリル、トリイソステアリン酸PEG-40トリメチロールプロパン、ラウリン酸PEG-40水添ヒマシ油、ラウリン酸PEG-12などが挙げられる。
In addition, as the surfactant used in the present invention, those having an HLB (Hydrophile-Lipophile Balance) value of 8 to 20 can be preferably used. More preferably, the HLB value is 8 to 14.
Examples of such surfactants include sorbitan isostearate, steareth-8, behenez-10, laureth-4, laureth-5, ceteth-7, oleth-8, PEG-8 glyceryl isostearate, choles-10, isostearic acid Acid PEG-10BG, PEG-30 glyceryl triisostearate, PEG-30 glyceryl triisostearate, PEG-30 glyceryl trioleate, PEG-30 triisostearate PEG-30, hydrogenated castor oil lauric acid PEG-30, PCA PEG-30 isostearic acid hydrogenated castor oil, octyldedes-10, PEG-12 dilaurate, sorbes-40 tetraoleate, polyglyceryl-10 diisostearate (decaglyceryl diisostearate), diisos PEG-20 glyceryl acrylate, PEG-8 isostearate, PEG-10 glyceryl isostearate, PEG-60 triisostearate hydrogenated castor oil, PPG-2-Decess-7, Ores-10, hydrogenated dimerino 20, palm fatty acid sorbitan, isosteares-10, steareth-11, trimyristate PEG-30 trimethylolpropane, isostearic acid PEG-40 hydrogenated castor oil, isostearic acid PEG-40 hydrogenated castor oil, PCA isostearic acid PEG-40 Hydrogenated castor oil, laureth-7, isocetes-10, ceteth-10, PEG-10 isostearate, PEG-10 stearate, PEG-10 oleate, PEG-10 glyceryl stearate, oles-12, decyltetradeces -15, co -15, PEG-16 dilaurate, PEG-30 hydrogenated castor oil, PEG-40 glyceryl triisostearate, PEG-40 glyceryl trioleate, PEG-40 trimethylolpropane triisostearate, PEG-40 water laurate Examples thereof include castor oil and PEG-12 laurate.
本発明において、界面活性剤の配合量は、得られる分散液の総質量に対して、例えば0.01質量%乃至2質量%、また例えば0.01質量%乃至1質量%、好ましくは、0.01質量%乃至0.5質量%、より好ましくは0.01質量%乃至0.3質量%、例えば0.02質量%乃至0.2質量%である。
なお本発明において用いられる界面活性剤は、上述の界面活性剤群の少なくとも一種であり、これら界面活性剤を単独で、或いは二種以上を組み合わせて用いることができる。
In the present invention, the compounding amount of the surfactant is, for example, 0.01% by mass to 2% by mass, or, for example, 0.01% by mass to 1% by mass, preferably 0% with respect to the total mass of the resulting dispersion. 0.01 mass% to 0.5 mass%, more preferably 0.01 mass% to 0.3 mass%, for example 0.02 mass% to 0.2 mass%.
The surfactant used in the present invention is at least one of the above-mentioned surfactant group, and these surfactants can be used alone or in combination of two or more.
[1,2-アルカンジオールまたは1,3-アルカンジオール]
本発明の分散液において使用する1,2-アルカンジオールまたは1,3-アルカンジオールは、前記顔料又は粉体用分散剤である脂質ペプチド型化合物の溶解性を促進させる働きをもつ。
前記1,2-アルカンジオールの具体例としては、1,2-ペンタンジオール、1,2-ヘキサンジオール、1,2-オクタンジオール及び1,2-デカンジオールなどが挙げられる。好ましくは、1,2-ペンタンジオール、1,2-ヘキサンジオール、1,2-オクタンジオールが挙げられる。さらに好ましくは、1,2-ペンタンジオール又は1,2-ヘキサンジオールである。
前記1,3-アルカンジオールの具体例としては、1,3-プロパンジオール、2-メチル-1,3-プロパンジオール、1,3-ブタンジオール、3-メチル-1,3-ブタンジオール、1,3-ペンタンジオール、1,3-ヘキサンジオール、2-エチル-1,3-ヘキサンジオール、2-エチル-1,3-オクタンジオール及び1,3-デカンジオールなどが挙げられる。好ましくは、1,3-ブタンジオール、1,3-ペンタンジオール、1,3-ヘキサンジオール、2-エチル-1,3-ヘキサンジオール、2-エチル-1,3-オクタンジオールが挙げられる。さらに好ましくは、1,3-ブタンジオール、2-エチル-1,3-ヘキサンジオール、2-エチル-1,3-オクタンジオールである。
これら1,2-アルカンジオールまたは1,3-アルカンジオールを単独で、或いは二種以上を組み合わせて用いることができる。
[1,2-alkanediol or 1,3-alkanediol]
The 1,2-alkanediol or 1,3-alkanediol used in the dispersion of the present invention has a function of promoting the solubility of the lipid peptide type compound which is the pigment or powder dispersant.
Specific examples of the 1,2-alkanediol include 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, and the like. Preferred are 1,2-pentanediol, 1,2-hexanediol, and 1,2-octanediol. More preferred is 1,2-pentanediol or 1,2-hexanediol.
Specific examples of the 1,3-alkanediol include 1,3-propanediol, 2-methyl-1,3-propanediol, 1,3-butanediol, 3-methyl-1,3-butanediol, , 3-pentanediol, 1,3-hexanediol, 2-ethyl-1,3-hexanediol, 2-ethyl-1,3-octanediol, 1,3-decanediol, and the like. Preferred are 1,3-butanediol, 1,3-pentanediol, 1,3-hexanediol, 2-ethyl-1,3-hexanediol, and 2-ethyl-1,3-octanediol. More preferred are 1,3-butanediol, 2-ethyl-1,3-hexanediol, and 2-ethyl-1,3-octanediol.
These 1,2-alkanediols or 1,3-alkanediols can be used alone or in combination of two or more.
本発明において、1,2-アルカンジオール又はまたは1,3-アルカンジオールの配合量は、得られる分散液の総質量に対して、例えば0.001質量%乃至15質量%、好ましくは、0.005質量%乃至15質量%、より好ましくは0.01質量%乃至15質量%、例えば0.01質量%乃至12質量%である。 In the present invention, the blending amount of 1,2-alkanediol or 1,3-alkanediol is, for example, 0.001% by mass to 15% by mass, preferably 0.001% by mass with respect to the total mass of the resulting dispersion. 005 mass% to 15 mass%, more preferably 0.01 mass% to 15 mass%, for example 0.01 mass% to 12 mass%.
[脂肪酸]
本発明の分散液において使用する脂肪酸は、好ましくは炭素原子数10乃至20の飽和脂肪酸及び不飽和脂肪酸並びにそれら脂肪酸の塩からなる群から選択される少なくとも1種であり、例えば脂肪酸としてはカプリン酸、ウンデカン酸、ラウリン酸、トリデカン酸、ミリスチン酸、ペンタデカン酸、パルミチン酸、マルガリン酸、ステアリン酸が挙げられる。さらに好ましくは、カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸が挙げられ、なかでもステアリン酸が好ましい。
本発明において、使用される脂肪酸の配合量は、得られる分散液の総質量に対して、例えば0.001質量%乃至1質量%、好ましくは0.001質量%乃至0.1質量%、より好ましくは0.005質量%乃至0.05質量%である。
なお本発明において用いられる脂肪酸は、上記脂肪酸群から選択される少なくとも1種であり、これら脂肪酸を単独で、或いは二種以上を組み合わせて用いることができる。
[fatty acid]
The fatty acid used in the dispersion of the present invention is preferably at least one selected from the group consisting of saturated and unsaturated fatty acids having 10 to 20 carbon atoms and salts of these fatty acids. For example, the fatty acid is capric acid. , Undecanoic acid, lauric acid, tridecanoic acid, myristic acid, pentadecanoic acid, palmitic acid, margaric acid, stearic acid. More preferably, capric acid, lauric acid, myristic acid, palmitic acid, and stearic acid are mentioned, and stearic acid is particularly preferable.
In the present invention, the amount of fatty acid used is, for example, 0.001% to 1% by weight, preferably 0.001% to 0.1% by weight, based on the total weight of the resulting dispersion. Preferably it is 0.005 mass% thru | or 0.05 mass%.
In addition, the fatty acid used in this invention is at least 1 sort (s) selected from the said fatty acid group, These fatty acids can be used individually or in combination of 2 or more types.
[顔料又は粉体]
本発明の分散液に配合される顔料又は粉体としては、特に限定されるものではない。
例えば顔料としては、二酸化チタン、酸化亜鉛等の無機白色顔料;赤酸化鉄(ベンガラ)、チタン酸鉄等の無機赤色系顔料;γ-酸化鉄等の無機褐色系顔料;黄酸化鉄、黄土等の無機黄色系顔料;黒酸化鉄、低次酸化チタン等の無機黒色系顔料;マンゴバイオレット、コバルトバイオレット等の無機紫色系顔料;酸化クロム、水酸化クロム、チタン酸コバルト等の無機緑色系顔料;群青、紺青等の無機青色系顔料;酸化チタンコーテッドマイカ、酸化チタンコーテッドオキシ塩化ビスマス、酸化チタンコーテッドタルク、着色酸化チタンコーテッドマイカ、オキシ塩化ビスマス、魚鱗箔等のパール顔料;タルク、セリサイト、マイカ、カオリン、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸、硫酸バリウム、水酸化アルミニウム等の体質顔料;アルミニウムパウダー、カッパーパウダー、金等の金属粉末顔料;表面処理無機及び金属粉末顔料;ジルコニウム、バリウム又はアルミニウムレーキ等の有機顔料;表面処理有機顔料等が挙げられる。これら顔料の中でも、親水性の顔料が、より好ましい。
また粉体としては、マイカ、タルク、カオリン、セリサイト、モンモリロナイト、カオリナイト、雲母、白雲母、金雲母、合成雲母、紅雲母、黒雲母、パーミキュライト、炭酸マグネシウム、炭酸カルシウム、ケイ酸アルミニウム、ケイ酸バリウム、ケイ酸カルシウム、ケイ酸マグネシウム、ケイ酸ストロンチウム、タングステン酸金属塩、マグネシウム、ゼオライト、硫酸バリウム、焼成硫酸カルシウム、リン酸三カルシウム等のリン酸カルシウム、弗素アパタイト、ヒドロキシアパタイト、セラミックパウダー、ベントナイト、スメクタイト、粘土、泥、金属石鹸(例えば、ミリスチン酸亜鉛、パルミチン酸カルシウム、ステアリン酸アルミニウム)、炭酸カルシウム、ベンガラ、黄酸化鉄、黒酸化鉄、群青、紺青、カーボンブラック、酸化チタン、微粒子及び超微粒子酸化チタン、酸化亜鉛、微粒子及び超微粒子酸化亜鉛、アルミナ、シリカ、煙霧状シリカ(超微粒子無水ケイ酸)、雲母チタン、魚鱗箔、窒化ホウ素、ホトクロミック顔料、合成フッ素金雲母、微粒子複合粉体、金、銀、プラチナ、アルミニウム等の各種の大きさ・形状の無機粉体、及び、これらをハイドロジェンシリコーン、環状ハイドロジェンシリコーン等のシリコーン若しくはその他のシラン若しくはチタンカップリング剤等の各種表面処理剤で処理を行って疎水化若しくは親水化した粉体等の無機粉体;デンプン、セルロース、ナイロンパウダー、ポリエチレン末、ポリメタクリル酸メチル末、ポリスチレン末、スチレンとアクリル酸の共重合体樹脂粉末、ポリエステル末、ベンゾグアナミン樹脂粉末、ポリエチレンテレフタレート・ポリメチルメタクリレート積層末、ポリエチレンテレフタレート・アルミニウム・エポキシ積層末等、ウレタン粉末、シリコーン粉末、テフロン(登録商標)粉末等の各種の大きさ・形状の有機系粉体及び表面処理粉体、有機無機複合粉体が好ましいものとして挙げられる。
本発明において、顔料又は粉体は、分散液の総質量に対して、例えば25質量%以下、好ましくは、20質量%以下とすることができる。なお顔料又は粉体の配合量の下限は特に限定されないが、例えば0.001質量%程度である。
なお本発明において用いられる上記顔料又は粉体は、上述の顔料群及び粉体群の少なくとも一種であり、これら顔料又は粉体を単独で、或いは二種以上を組み合わせて用いられ得る。
[Pigment or powder]
The pigment or powder blended in the dispersion of the present invention is not particularly limited.
Examples of pigments include inorganic white pigments such as titanium dioxide and zinc oxide; inorganic red pigments such as red iron oxide (Bengara) and iron titanate; inorganic brown pigments such as γ-iron oxide; yellow iron oxide and loess Inorganic black pigments such as black iron oxide and low-order titanium oxide; inorganic purple pigments such as mango violet and cobalt violet; inorganic green pigments such as chromium oxide, chromium hydroxide and cobalt titanate; Inorganic blue pigments such as ultramarine and bitumen; Titanium oxide coated mica, titanium oxide coated bismuth oxychloride chloride, titanium oxide coated talc, colored titanium oxide coated mica, bismuth oxychloride, fish scale foil, etc .; talc, sericite, mica , Constitutions such as kaolin, calcium carbonate, magnesium carbonate, silicic anhydride, barium sulfate, aluminum hydroxide Fee; aluminum powder, copper powder, metal powder pigments such as gold; surface treated inorganic and metallic powder pigments; zirconium, organic pigments such as barium or aluminum lake; surface treatment organic pigments. Among these pigments, hydrophilic pigments are more preferable.
The powders include mica, talc, kaolin, sericite, montmorillonite, kaolinite, mica, muscovite, phlogopite, synthetic mica, sausage, mica, permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, silica Barium, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, zeolite, barium sulfate, calcined calcium sulfate, tricalcium phosphate, calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder, bentonite, Smectite, clay, mud, metal soap (eg zinc myristate, calcium palmitate, aluminum stearate), calcium carbonate, bengara, yellow iron oxide, black iron oxide, ultramarine, bitumen, carbon black, Titanium fluoride, fine and ultrafine titanium oxide, zinc oxide, fine and ultrafine zinc oxide, alumina, silica, fumed silica (ultrafine silica), mica titanium, fish scale foil, boron nitride, photochromic pigment, synthetic fluorine Various sizes and shapes of inorganic powders such as phlogopite, fine particle composite powder, gold, silver, platinum, aluminum, etc., and silicones such as hydrogen silicone and cyclic hydrogen silicone, or other silane or titanium cups Inorganic powder such as powder hydrophobized or hydrophilized by treatment with various surface treatment agents such as ring agent; starch, cellulose, nylon powder, polyethylene powder, polymethyl methacrylate powder, polystyrene powder, styrene and acrylic acid Copolymer resin powder, polyester powder, benzoguanamine resin powder Organic powders and surface-treated powders of various sizes and shapes, such as polyethylene terephthalate / polymethyl methacrylate laminate powder, polyethylene terephthalate / aluminum / epoxy laminate powder, urethane powder, silicone powder, Teflon (registered trademark) powder, etc. Organic-inorganic composite powders are preferred.
In the present invention, the pigment or powder can be, for example, 25% by mass or less, preferably 20% by mass or less, with respect to the total mass of the dispersion. The lower limit of the amount of pigment or powder is not particularly limited, but is, for example, about 0.001% by mass.
In addition, the said pigment or powder used in this invention is at least 1 type of the above-mentioned pigment group and powder group, These pigments or powder can be used individually or in combination of 2 or more types.
[多価アルコール]
本発明の分散液は、さらに多価アルコールを含んでいてもよい。前記多価アルコールは、先に挙げた1,2-アルカンジオール又は1,3-アルカンジオールとは異なる多価アルコールであり、その具体例としてはグリセリン、プロピレングリコール及びポリエチレングリコール等が挙げられる。なお上記ポリエチレングリコールとしては、例えば平均分子量1,000乃至4,000のものを好適に使用できる。
本発明において、多価アルコールを含む場合、その配合量は、得られる分散液の総質量に対して、例えば1質量%乃至60質量%、好ましくは、10質量%乃至30質量%とすることができる。
[Polyhydric alcohol]
The dispersion of the present invention may further contain a polyhydric alcohol. The polyhydric alcohol is a polyhydric alcohol different from the 1,2-alkanediol or 1,3-alkanediol listed above, and specific examples thereof include glycerin, propylene glycol, and polyethylene glycol. For example, polyethylene glycol having an average molecular weight of 1,000 to 4,000 can be preferably used.
In the present invention, when polyhydric alcohol is included, the blending amount thereof is, for example, 1% by mass to 60% by mass, preferably 10% by mass to 30% by mass with respect to the total mass of the obtained dispersion. it can.
[その他添加剤]
本発明の分散液には、必要に応じて一般的に化粧品用添加剤や、医薬部外品用添加剤及び医薬用添加剤として使用可能な添加剤を配合することができる。化粧品、医薬部外品又は医薬等の皮膚外用剤に配合される生理活性物質及び機能性物質等の添加成分としては、例えば油性基剤、保湿剤、感触向上剤、上記以外の界面活性剤、高分子、増粘・ゲル化剤、溶剤、酸化防止剤、還元剤、酸化剤、防腐剤、抗菌剤、殺菌剤、キレート剤、pH調整剤、酸、アルカリ、無機塩、紫外線吸収剤、美白剤、ビタミン類及びその誘導体類、育毛用薬剤、血行促進剤、刺激剤、ホルモン類、抗しわ剤、抗老化剤、ひきしめ剤、冷感剤、温感剤、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤、植物・動物・微生物エキス、鎮痒剤、角質剥離・溶解剤、制汗剤、清涼剤、収れん剤、酵素、核酸、香料、色素、着色剤、染料、消炎剤、抗炎症剤、抗喘息、抗慢性閉塞性肺疾患、抗アレルギー、免疫調整剤、抗感染症剤及び抗真菌剤等が挙げられる。
これらその他添加剤の配合量は、その種類によって種々変化し得るが、分散液の総質量に対して、例えば0.001質量%乃至20質量%、あるいは0.01質量%乃至10質量%程度とすることができる。
[Other additives]
In the dispersion of the present invention, additives that can be generally used as cosmetic additives, quasi-drug additives, and pharmaceutical additives can be blended as necessary. As an additive component such as a physiologically active substance and a functional substance blended in a skin preparation for cosmetics, quasi-drugs or medicines, for example, an oily base, a moisturizer, a touch improver, a surfactant other than the above, Polymer, thickening / gelling agent, solvent, antioxidant, reducing agent, oxidizing agent, preservative, antibacterial agent, bactericidal agent, chelating agent, pH adjusting agent, acid, alkali, inorganic salt, UV absorber, whitening Agents, vitamins and derivatives thereof, hair growth agents, blood circulation promoters, stimulants, hormones, anti-wrinkle agents, anti-aging agents, squeeze agents, cooling sensation agents, warming sensation agents, wound healing promoters, irritation relaxation agents , Analgesic agent, cell activator, plant / animal / microbe extract, antipruritic agent, exfoliating / dissolving agent, antiperspirant, refreshing agent, astringent, enzyme, nucleic acid, fragrance, pigment, colorant, dye, anti-inflammatory agent, Anti-inflammatory agent, anti-asthma, anti-chronic obstructive pulmonary disease, anti-allergy, immunomodulator, anti Infectious diseases agents and antifungal agents.
The amount of these other additives may vary depending on the type of the additive, but is, for example, about 0.001% to 20% by mass, or about 0.01% to 10% by mass with respect to the total mass of the dispersion. can do.
油性基剤としては、オレイルアルコール、ホホバアルコール、キミルアルコール、セラキルアルコール、バチルアルコール、ヘキシルデカノール、イソステアリルアルコール、2-オクチルドデカノール、ダイマージオール等の高級(多価)アルコール類;ベンジルアルコール等のアラルキルアルコール及びその誘導体;イソステアリン酸、ベヘン酸、ウンデシレン酸、12-ヒドロキシステアリン酸、パルミトオレイン酸、オレイン酸、リノール酸、リノレイン酸、エルカ酸、ドコサヘキサエン酸、エイコサペンタエン酸、イソヘキサデカン酸、アンテイソヘンイコサン酸、長鎖分岐脂肪酸、ダイマー酸、水素添加ダイマー酸等;流動パラフィン(ミネラルオイル)、重質流動イソパラフィン、軽質流動イソパラフィン、α-オレフィンオリゴマー、ポリイソブテン、水添ポリイソブテン、ポリブテン、スクワラン、オリーブ由来スクワラン、スクワレン、ワセリン、固形パラフィン等の炭化水素類;キャンデリラワックス、カルナウバワックス、ライスワックス、木ろう、みつろう、モンタンワックス、オゾケライト、セレシン、パラフィンワックス、マイクロクリスタリンワックス、ペトロラタム、フィッシャートロプシュワックス、ポリエチレンワックス、エチレン・プロピレンコポリマー等のワックス類;ヤシ油、パーム油、パーム核油、サフラワー油、オリーブ油、ヒマシ油、アボカド油、ゴマ油、茶油、月見草油、小麦胚芽油、マカデミアナッツ油、ヘーゼルナッツ油、ククイナッツ油、ローズヒップ油、メドウフォーム油、パーシック油、ティートリー油、ハッカ油、トウモロコシ油、ナタネ油、ヒマワリ油、小麦胚芽油、アマニ油、綿実油、大豆油、落花生油、コメヌカ油、カカオ脂、シア脂、水素添加ヤシ油、水素添加ヒマシ油、ホホバ油、水素添加ホホバ油、グレープシード油、アプリコット油(杏仁油)、ツバキ油等の植物油脂類;牛脂、乳脂、馬脂、卵黄油、ミンク油、タートル油等の動物性油脂類;鯨ロウ、ラノリン、オレンジラッフィー油等の動物性ロウ類;液状ラノリン、還元ラノリン、吸着精製ラノリン、酢酸ラノリン、酢酸液状ラノリン、ヒドロキシラノリン、ポリオキシエチレンラノリン、ラノリン脂肪酸、硬質ラノリン脂肪酸、ラノリンアルコール、酢酸ラノリンアルコール、酢酸(セチル・ラノリル)エステル等のラノリン類;コレステロール、ジヒドロコレステロール、ラノステロール、ジヒドロラノステロール、フィトステロール、コール酸等のステロール類;サポゲニン類;サポニン類;酢酸コレステリル、ノナン酸コレステリル、ステアリン酸コレステリル、イソステアリン酸コレステリル、オレイン酸コレステリル、N-ラウロイル-L-グルタミン酸ジ(コレステリル/ベヘニル/オクチルドデシル)、N-ラウロイル-L-グルタミン酸ジ(コレステリル/オクチルドデシル)、N-ラウロイル-L-グルタミン酸ジ(フィトステリル/ベヘニル/オクチルドデシル)、N-ラウロイル-L-グルタミン酸ジ(フィトステリル/オクチルドデシル)、N-ラウロイルサルコシンイソプロピル等のアシルサルコシンアルキルエステル、12-ヒドロキシステアリン酸コレステリル、マカデミアナッツ油脂肪酸コレステリル、マカデミアナッツ油脂肪酸フィトステリル、イソステアリン酸フィトステリル、軟質ラノリン脂肪酸コレステリル、硬質ラノリン脂肪酸コレステリル、長鎖分岐脂肪酸コレステリル、長鎖α-ヒドロキシ脂肪酸コレステリル等のステロールエステル類;リン脂質・コレステロール複合体、リン脂質・フィトステロール複合体等の脂質複合体;ミリスチン酸オクチルドデシル、ミリスチン酸ヘキシルデシル、イソステアリン酸オクチルドデシル、パルミチン酸セチル、パルミチン酸オクチルドデシル、オクタン酸セチル、オクタン酸ヘキシルデシル、イソノナン酸イソトリデシル、イソノナン酸イソノニル、イソノナン酸オクチル、イソノナン酸イソトリデシル、ネオペンタン酸イソデシル、ネオペンタン酸イソトリデシル、ネオペンタン酸イソステアリル、ネオデカン酸オクチルドデシル、オレイン酸オレイル、オレイン酸オクチルドデシル、リシノレイン酸オクチルドデシル、ラノリン脂肪酸オクチルドデシル、ジメチルオクタン酸ヘキシルデシル、エルカ酸オクチルドデシル、イソステアリン酸硬化ヒマシ油、オレイン酸エチル、アボカド油脂肪酸エチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸オクチル、イソステアリン酸イソプロピル、ラノリン脂肪酸イソプロピル、セバチン酸ジエチル、セバチン酸ジイソプロピル、セバチン酸ジオクチル、アジピン酸ジイソプロピル、セバチン酸ジブチルオクチル、アジピン酸ジイソブチル、コハク酸ジオクチル、クエン酸トリエチル等のモノアルコールカルボン酸エステル類;乳酸セチル、リンゴ酸ジイソステアリル、モノイソステアリン酸水添ヒマシ油等のオキシ酸エステル類;トリオクタン酸グリセリル(トリ2-エチルヘキサン酸グリセリル)、トリオレイン酸グリセリル、トリイソステアリン酸グリセリル、ジイソステアリン酸グリセリル、トリ(カプリル酸/カプリン酸)グリセリル、トリ(カプリル酸/カプリン酸/ミリスチン酸/ステアリン酸)グリセリル、水添ロジントリグリセリド(水素添加エステルガム)、ロジントリグリセリド(エステルガム)、ベヘン酸エイコサン二酸グリセリル、トリオクタン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、ジオクタン酸ネオペンチルグリコール、ジカプリン酸ネオペンチルグリコール、ジオクタン酸2-ブチル-2-エチル-1,3-プロパンジオール、ジオレイン酸プロピレングリコール、テトラオクタン酸ペンタエリスリチル、水素添加ロジンペンタエリスリチル、トリエチルヘキサン酸ジトリメチロールプロパン、(イソステアリン酸/セバシン酸)ジトリメチロールプロパン、トリエチルヘキサン酸ペンタエリスリチル、(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル、ジイソステアリン酸ジグリセリル、テトライソステアリン酸ポリグリセリル、ノナイソステアリン酸ポリグリセリル-10、デカ(エルカ酸/イソステアリン酸/リシノレイン酸)ポリグリセリル-8、(ヘキシルデカン酸/セバシン酸)ジグリセリルオリゴエステル、ジステアリン酸グリコール(ジステアリン酸エチレングリコール)、ジネオペンタン酸3-メチル-1,5-ペンタンジオール、ジネオペンタン酸2,4-ジエチル-1,5-ペンタンジオール等の多価アルコール脂肪酸エステル類;ダイマージリノール酸ジイソプロピル、ダイマージリノール酸ジイソステアリル、ダイマージリノール酸ジ(イソステアリル/フィトステリル)、ダイマージリノール酸(フィトステリル/ベヘニル)、ダイマージリノール酸(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル)、ダイマージリノール酸ダイマージリノレイル、ジイソステアリン酸ダイマージリノレイル、ダイマージリノレイル水添ロジン縮合物、ダイマージリノール酸硬化ヒマシ油、ヒドロキシアルキルダイマージリノレイルエーテル等のダイマー酸若しくはダイマージオールの誘導体;ヤシ油脂肪酸モノエタノールアミド(コカミドMEA)、ヤシ油脂肪酸ジエタノールアミド(コカミドDEA)、ラウリン酸モノエタノールアミド(ラウラミドMEA)、ラウリン酸ジエタノールアミド(ラウラミドDEA)、ラウリン酸モノイソプロパノールアミド(ラウラミドMIPA)、パルミチン酸モノエタノールアミド(パルタミドMEA)、パルミチン酸ジエタノールアミド(パルタミドDEA)、ヤシ油脂肪酸メチルエタノールアミド(コカミドメチルMEA)等の脂肪酸アルカノールアミド類;ジメチコン(ジメチルポリシロキサン)、高重合ジメチコン(高重合ジメチルポリシロキサン)、シクロメチコン(環状ジメチルシロキサン、デカメチルシクロペンタシロキサン(単にシクロペンタシロキサンとも))、フェニルトリメチコン、ジフェニルジメチコン、フェニルジメチコン、ステアロキシプロピルジメチルアミン、(アミノエチルアミノプロピルメチコン/ジメチコン)コポリマー、ジメチコノール、ジメチコノールクロスポリマー、シリコーン樹脂、シリコーンゴム、アミノプロピルジメチコン及びアモジメチコン等のアミノ変性シリコーン、カチオン変性シリコーン、ジメチコンコポリオール等のポリエーテル変性シリコーン、ポリグリセリン変性シリコーン、糖変性シリコーン、カルボン酸変性シリコーン、リン酸変性シリコーン、硫酸変性シリコーン、アルキル変性シリコーン、脂肪酸変性シリコーン、アルキルエーテル変性シリコーン、アミノ酸変性シリコーン、ペプチド変性シリコーン、フッ素変性シリコーン、カチオン変性及びポリエーテル変性シリコーン、アミノ変性及びポリエーテル変性シリコーン、アルキル変性及びポリエーテル変性シリコーン、ポリシロキサン・オキシアルキレン共重合体等のシリコーン類;パーフルオロデカン、パーフルオロオクタン、パーフルオロポリエーテル等のフッ素系油剤類が、好ましいものとして挙げられる。 Examples of oily bases include oleyl alcohol, jojoba alcohol, chimyl alcohol, ceralkyl alcohol, batyl alcohol, hexyl decanol, isostearyl alcohol, 2-octyldodecanol, dimer diol and other higher (polyhydric) alcohols; benzyl alcohol, etc. Aralkyl alcohols and derivatives thereof; isostearic acid, behenic acid, undecylenic acid, 12-hydroxystearic acid, palmitooleic acid, oleic acid, linoleic acid, linolenic acid, erucic acid, docosahexaenoic acid, eicosapentaenoic acid, isohexadecanoic acid, Antiisohenicosanoic acid, long-chain branched fatty acid, dimer acid, hydrogenated dimer acid, etc .; liquid paraffin (mineral oil), heavy liquid isoparaffin, light liquid isoparaffin, α-olefin Ligomers, polyisobutene, hydrogenated polyisobutene, polybutene, squalane, olive-derived squalane, squalene, petrolatum, solid paraffin, and other hydrocarbons; candelilla wax, carnauba wax, rice wax, wood wax, beeswax, montan wax, ozokerite, ceresin Waxes such as paraffin wax, microcrystalline wax, petrolatum, Fischer-Tropsch wax, polyethylene wax, ethylene / propylene copolymer; palm oil, palm oil, palm kernel oil, safflower oil, olive oil, castor oil, avocado oil, sesame oil, Tea oil, evening primrose oil, wheat germ oil, macadamia nut oil, hazelnut oil, kukui nut oil, rosehip oil, meadow foam oil, persic oil, tea tree oil, peppermint Oil, corn oil, rapeseed oil, sunflower oil, wheat germ oil, linseed oil, cottonseed oil, soybean oil, peanut oil, rice bran oil, cacao butter, shea butter, hydrogenated palm oil, hydrogenated castor oil, jojoba oil, hydrogenated Vegetable oils such as jojoba oil, grape seed oil, apricot oil (apricot kernel oil), camellia oil; animal fats such as beef tallow, milk fat, horse fat, egg yolk oil, mink oil, turtle oil; whale wax, lanolin, orange Animal waxes such as luffy oil; liquid lanolin, reduced lanolin, adsorbed purified lanolin, lanolin acetate, liquid lanolin acetate, hydroxy lanolin, polyoxyethylene lanolin, lanolin fatty acid, hard lanolin fatty acid, lanolin alcohol, lanolin alcohol acetate, acetic acid Lanolins such as (cetyl lanolyl) ester; cholesterol, dihydrocholesterol, la Sterols such as sterol, dihydrolanosterol, phytosterol and cholic acid; sapogenins; saponins; cholesteryl acetate, cholesteryl nonate, cholesteryl stearate, cholesteryl isostearate, cholesteryl oleate, N-lauroyl-L-glutamate di (cholesteryl / Behenyl / octyldodecyl), N-lauroyl-L-glutamate di (cholesteryl / octyldodecyl), N-lauroyl-L-glutamate di (phytosteryl / behenyl / octyldodecyl), N-lauroyl-L-glutamate di (phytosteryl / octyl) Dodecyl), acyl sarcosine alkyl esters such as N-lauroyl sarcosine isopropyl, cholesteryl 12-hydroxystearate, macadamia nut oil Sterol esters such as cholesteryl fatty acid, macadamia nut oil fatty acid phytosteryl, phytosteryl isostearate, soft lanolin fatty acid cholesteryl, hard lanolin fatty acid cholesteryl, long chain branched fatty acid cholesteryl, long chain α-hydroxy fatty acid cholesteryl; phospholipid / cholesterol complex, phospholipid Lipid complexes such as lipid / phytosterol complexes; octyldodecyl myristate, hexyldecyl myristate, octyldodecyl isostearate, cetyl palmitate, octyldodecyl palmitate, cetyl octanoate, hexyldecyl octanoate, isotridecyl isononanoate, isononanoic acid Isononyl, octyl isononanoate, isotridecyl isononanoate, isodecyl neopentanoate, isotridecyl neopentanoate Isostearyl neopentanoate, octyldodecyl neodecanoate, oleyl oleate, octyldodecyl oleate, octyldodecyl ricinoleate, lanolin fatty acid octyldodecyl, hexyldecyl dimethyloctanoate, octyldodecyl erucate, isostearic acid hydrogenated castor oil, ethyl oleate, Avocado oil fatty acid ethyl, isopropyl myristate, isopropyl palmitate, octyl palmitate, isopropyl isostearate, isopropyl lanolin fatty acid, diethyl sebacate, diisopropyl sebacate, dioctyl sebacate, diisopropyl adipate, dibutyloctyl sebacate, diisobutyl adipate, Monoalcohol carboxylic acid esters such as dioctyl succinate and triethyl citrate; lactic acid Oxyacid esters such as chill, diisostearyl malate, hydrogenated castor oil monoisostearate; glyceryl trioctanoate (glyceryl tri-2-ethylhexanoate), glyceryl trioleate, glyceryl triisostearate, glyceryl diisostearate, tris (Caprylic acid / capric acid) glyceryl, tri (caprylic acid / capric acid / myristic acid / stearic acid) glyceryl, hydrogenated rosin triglyceride (hydrogenated ester gum), rosin triglyceride (ester gum), eicosane diacid glyceryl behenate, Trimethylolpropane trioctanoate, trimethylolpropane triisostearate, neopentyl glycol dioctanoate, neopentyl glycol dicaprate, 2-butyl-2-ethyl-1 dioctanoate , 3-propanediol, propylene glycol dioleate, pentaerythrityl tetraoctanoate, hydrogenated rosin pentaerythrityl, ditrimethylolpropane triethylhexanoate, (isostearic acid / sebacic acid) ditrimethylolpropane, pentaerythrityl triethylhexanoate, (Hydroxystearic acid / stearic acid / rosinic acid) dipentaerythrityl, diglyceryl diisostearate, polyglyceryl tetraisostearate, polyglyceryl nonaisostearate-10, deca (erucic acid / isostearic acid / ricinoleic acid) polyglyceryl-8, (hexyldecanoic acid / sebacin) Acid) diglyceryl oligoester, glycol distearate (ethylene glycol distearate), dineopentanoic acid 3 Polyhydric alcohol fatty acid esters such as methyl-1,5-pentanediol and dineopentanoic acid 2,4-diethyl-1,5-pentanediol; diisopropyl linoleic acid diisopropyl, dimer linoleic acid diisostearyl, dimer linoleic acid Di (isostearyl / phytosteryl), dimer dilinoleic acid (phytosteryl / behenyl), dimer dilinoleic acid (phytosteryl / isostearyl / cetyl / stearyl / behenyl), dimer dilinoleate dimer dilinoleyl, diiso stearic acid dimer dilinoleyl Dimer linoleyl hydrogenated rosin condensate, dimer linoleic acid hydrogenated castor oil, dimer acid or dimer diol derivative such as hydroxyalkyl dimer linoleyl ether; coconut oil fatty acid monoeta Uramide (cocamide MEA), coconut oil fatty acid diethanolamide (cocamide DEA), lauric acid monoethanolamide (lauramide MEA), lauric acid diethanolamide (lauramide DEA), lauric acid monoisopropanolamide (lauramide MIPA), palmitic acid monoethanolamide Fatty acid alkanolamides such as (partamido MEA), palmitic acid diethanolamide (partamide DEA), coconut oil fatty acid methylethanolamide (cocamidomethyl MEA); dimethicone (dimethylpolysiloxane), highly polymerized dimethicone (highly polymerized dimethylpolysiloxane), cyclo Methicon (cyclic dimethylsiloxane, decamethylcyclopentasiloxane (also called simply cyclopentasiloxane)), phenyltrimethicone, dipheny Amino-modified silicones such as rubimethicone, phenyldimethicone, stearoxypropyldimethylamine, (aminoethylaminopropylmethicone / dimethicone) copolymer, dimethiconol, dimethiconol crosspolymer, silicone resin, silicone rubber, aminopropyldimethicone and amodimethicone, cation-modified silicone , Polyether modified silicone such as dimethicone copolyol, polyglycerin modified silicone, sugar modified silicone, carboxylic acid modified silicone, phosphoric acid modified silicone, sulfuric acid modified silicone, alkyl modified silicone, fatty acid modified silicone, alkyl ether modified silicone, amino acid modified silicone , Peptide-modified silicone, fluorine-modified silicone, cation-modified and polyether-modified silicone, Non-modified and polyether-modified silicones, alkyl-modified and polyether-modified silicones, silicones such as polysiloxane / oxyalkylene copolymers; fluorine-based oils such as perfluorodecane, perfluorooctane, and perfluoropolyether are preferred. It is mentioned as a thing.
保湿剤・感触向上剤としては、グリセリン、トリメチロールプロパン、ペンタエリスリトール、ヘキシレングリコール、ジグリセリン、ポリグリセリン、ジエチレングリコール、ジプロピレングリコール、ポリプロピレングリコール、エチレングリコール・プロピレングリコール共重合体等のポリオール類及びその重合体;ジエチレングリコールモノエチルエーテル(エトキシジグリコール)、エチレングリコールモノエチルエーテル、エチレングリコールモノブチルエーテル、ジエチレングリコールジブチルエーテル等のグリコールアルキルエーテル類;(エイコサン二酸/テトラデカン二酸)ポリグリセリル-10、テトラデカン二酸ポリグリセリル-10等の水溶性エステル類;ソルビトール、キシリトール、エリスリトール、マンニトール、マルチトール等の糖アルコール類;グルコース、フルクトース、ガラクトース、マンノース、トレオース、キシロース、アラビノース、フコース、リボース、デオキシリボース、マルトース、トレハロース、ラクトース、ラフィノース、グルコン酸、グルクロン酸、シクロデキストリン類(α-、β-、γ-シクロデキストリン、及び、マルトシル化、ヒドロキシアルキル化等の修飾シクロデキストリン)、β-グルカン、キチン、キトサン、ヘパリン及び誘導体、ペクチン、アラビノガラクタン、デキストリン、デキストラン、グリコーゲン、エチルグルコシド、メタクリル酸グルコシルエチル重合物若しくは共重合物等の糖類及びその誘導体類;ヒアルロン酸、ヒアルロン酸ナトリウム;コンドロイチン硫酸ナトリウム;ムコイチン硫酸、カロニン硫酸、ケラト硫酸、デルマタン硫酸;シロキクラゲ抽出物、シロキクラゲ多糖体;フコイダン;チューベロース多糖体又は天然由来多糖体;クエン酸、酒石酸、乳酸等の有機酸及びその塩;尿素及びその誘導体;2-ピロリドン-5-カルボン酸及びそのナトリウム等の塩;ベタイン(トリメチルグリシン)、プロリン、ヒドロキシプロリン、アルギニン、リジン、セリン、グリシン、アラニン、フェニルアラニン、チロシン、β-アラニン、スレオニン、グルタミン酸、グルタミン、アスパラギン、アスパラギン酸、システイン、システイン、メチオニン、ロイシン、イソロイシン、バリン、トリプトファン、ヒスチジン、タウリン等のアミノ酸類及びその塩;コラーゲン、魚由来コラーゲン、アテロコラーゲン、ゼラチン、エラスチン、コラーゲン分解ペプチド、加水分解コラーゲン、塩化ヒドロキシプロピルアンモニウム加水分解コラーゲン、エラスチン分解ペプチド、ケラチン分解ペプチド、加水分解ケラチン、コンキオリン分解ペプチド、加水分解コンキオリン、シルク蛋白分解ペプチド、加水分解シルク、ラウロイル加水分解シルクナトリウム、大豆蛋白分解ペプチド、小麦蛋白分解ペプチド、加水分解小麦蛋白、カゼイン分解ペプチド、アシル化ペプチド等の蛋白ペプチド類及びその誘導体;パルミトイルオリゴペプチド、パルミトイルペンタペプチド、パルミトイルテトラペプチド等のアシル化ペプチド類;シリル化ペプチド類;乳酸菌培養液、酵母抽出液、卵殻膜タンパク、牛顎下腺ムチン、ヒポタウリン、ゴマリグナン配糖体、グルタチオン、アルブミン、乳清;塩化コリン、ホスホリルコリン;胎盤抽出液、エアラスチン、コラーゲン、アロエ抽出物、ハマメリス水、ヘチマ水、カモミラエキス、カンゾウエキス、コンフリーエキス、シルクエキス、イザヨイバラエキス、セイヨウノコギリソウエキス、ユーカリエキス、メリロートエキス等の動物・植物抽出成分、天然型セラミド(タイプ1、2、3、4、5、6)、ヒドロキシセラミド、疑似セラミド、スフィンゴ糖脂質、セラミド及び糖セラミド含有エキス等のセラミド類が好ましいものとして挙げられる。
Examples of moisturizers / feel improvers include glycerin, trimethylolpropane, pentaerythritol, hexylene glycol, diglycerin, polyglycerin, diethylene glycol, dipropylene glycol, polypropylene glycol, ethylene glycol / propylene glycol copolymer and the like polyols and Polymers; glycol alkyl ethers such as diethylene glycol monoethyl ether (ethoxydiglycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, diethylene glycol dibutyl ether; (eicosane diacid / tetradecanedioic acid) polyglyceryl-10, tetradecane Water-soluble esters such as polyglyceryl-10; sorbitol, xylitol, erythritol, man Sugar alcohols such as tol and maltitol; glucose, fructose, galactose, mannose, threose, xylose, arabinose, fucose, ribose, deoxyribose, maltose, trehalose, lactose, raffinose, gluconic acid, glucuronic acid, cyclodextrins (α -, Β-, γ-cyclodextrin and modified cyclodextrins such as maltosylation, hydroxyalkylation, etc.), β-glucan, chitin, chitosan, heparin and derivatives, pectin, arabinogalactan, dextrin, dextran, glycogen, ethyl Sugars such as glucoside, glucosylethyl methacrylate polymer or copolymer, and derivatives thereof; hyaluronic acid, sodium hyaluronate; chondroitin sulfate sodium; mucoichi Sulfate, caronine sulfate, keratosulfate, dermatan sulfate; white jellyfish extract, white jellyfish polysaccharide; fucoidan; tuberose polysaccharide or naturally derived polysaccharide; organic acids such as citric acid, tartaric acid, lactic acid and their salts; urea and its derivatives; 2-pyrrolidone-5-carboxylic acid and salts thereof such as sodium; betaine (trimethylglycine), proline, hydroxyproline, arginine, lysine, serine, glycine, alanine, phenylalanine, tyrosine, β-alanine, threonine, glutamic acid, glutamine, Amino acids such as asparagine, aspartic acid, cysteine, cysteine, methionine, leucine, isoleucine, valine, tryptophan, histidine, taurine and their salts; collagen, fish-derived collagen, atelocollagen, gelatin , Elastin, collagenolytic peptide, hydrolyzed collagen, hydroxypropylammonium chloride hydrolyzed collagen, elastinolytic peptide, keratinolytic peptide, hydrolyzed keratin, conchiolinolytic peptide, hydrolyzed conchioline, silk proteolytic peptide, hydrolyzed silk, lauroyl hydrolyzed Degraded silk sodium, soybean proteolytic peptide, wheat proteolytic peptide, hydrolyzed wheat protein, casein degrading peptide, acylated peptide and other protein peptides and derivatives thereof; acylation of palmitoyl oligopeptide, palmitoyl pentapeptide, palmitoyl tetrapeptide, etc. Peptides; Silylated peptides; Lactic acid bacteria culture, yeast extract, eggshell membrane protein, bovine submandibular gland mucin, hypotaurine, sesameignan glycoside, glutathione, Albumin, whey; choline chloride, phosphorylcholine; placenta extract, aerostin, collagen, aloe extract, hamamelis water, loofah water, chamomile extract, licorice extract, comfrey extract, silk extract, Izayoi rose extract, yarrow extract, eucalyptus extract Ceramides, such as animal and plant extract components such as merirot extract, natural ceramide (
界面活性剤としては、陰イオン性界面活性剤、非イオン性界面活性剤、陽イオン性界面活性剤、両性界面活性剤、高分子界面活性剤等が好ましいものとして挙げられる。界面活性剤として好ましいものを例示すると、陰イオン性界面活性剤としては、ラウリン酸カリウム、ミリスチン酸カリウム等の脂肪酸塩;ラウリル硫酸ナトリウム、ラウリル硫酸トリエタノールアミン、ラウリル硫酸アンモニウム等のアルキル硫酸エステル塩;ラウレス硫酸ナトリウム、ラウレス硫酸トリエタノールアミン等のポリオキシエチレンアルキル硫酸塩;ココイルメチルタウリンナトリウム、ココイルメチルタウリンカリウム、ラウロイルメチルタウリンナトリウム、ミリストイルメチルタウリンナトリウム、ラウロイルメチルアラニンナトリウム、ラウロイルサルコシンナトリウム、ラウロイルサルコシントリエタノールアミン、ラウロイルグルタミン酸メチルアラニンナトリウム等のアシルN-メチルアミノ酸塩;ココイルグルタミン酸ナトリウム、ココイルグルタミン酸トリエタノールアミン、ラウロイルグルタミン酸ナトリウム、ミリストイルグルタミン酸ナトリウム、ステアロイルグルタミン酸ナトリウム、パルミトイルアスパラギン酸ジトリエタノールアミン、ココイルアラニントリエタノールアミン等のアシルアミノ酸塩;ラウレス酢酸ナトリウム等のポリオキシエチレンアルキルエーテル酢酸塩;ラウロイルモノエタノールアミドコハク酸ナトリウム等のコハク酸エステル塩;脂肪酸アルカノールアミドエーテルカルボン酸塩;アシル乳酸塩;ポリオキシエチレン脂肪アミン硫酸塩;脂肪酸アルカノールアミド硫酸塩;硬化ヤシ油脂肪酸グリセリン硫酸ナトリウム等の脂肪酸グリセリド硫酸塩;アルキルベンゼンポリオキシエチレン硫酸塩;α-オレフィンスルホン酸ナトリウム等のオレフィンスルホン酸塩;スルホコハク酸ラウリル2ナトリウム、スルホコハク酸ジオクチルナトリウム等のアルキルスルホコハク酸塩;スルホコハク酸ラウレス2ナトリウム、モノラウロイルモノエタノールアミドポリオキシエチレンスルホコハク酸ナトリウム、ラウリルポリプロピレングリコールスルホコハク酸ナトリウム等のアルキルエーテルスルホコハク酸塩;テトラデシルベンゼンスルホン酸ナトリウム、テトラデシルベンゼンスルホン酸トリエタノールアミン等のアルキルベンゼンスルホン酸塩;アルキルナフタレンスルホン酸塩;アルカンスルホン酸塩;α-スルホ脂肪酸メチルエステル塩;アシルイセチオン酸塩;アルキルグリシジルエーテルスルホン酸塩;アルキルスルホ酢酸塩;ラウレスリン酸ナトリウム、ジラウレスリン酸ナトリウム、トリラウレスリン酸ナトリウム、モノオレスリン酸ナトリウム等のアルキルエーテルリン酸エステル塩;ラウリルリン酸カリウム等のアルキルリン酸エステル塩;カゼインナトリウム;アルキルアリールエーテルリン酸塩;脂肪酸アミドエーテルリン酸塩;ホスファチジルグリセロール、ホスファチジルイノシトール、ホスファチジン酸等のリン脂質類;カルボン酸変性シリコーン、リン酸変性シリコーン、硫酸変性シリコーン等のシリコーン系陰イオン性界面活性剤等;非イオン性界面活性剤としては、ラウレス(ポリオキシエチレンラウリルエーテル)類、セテス(ポリオキシエチレンセチルエーテル)類、ステアレス(ポリオキシエチレンステアリルエーテル)類、ベヘネス(ポリオキシエチレンベヘニルエーテル)類、イソステアレス(ポリオキシエチレンイソステアリルエーテル)類、オクチルドデセス(ポリオキシエチレンオクチルドデシルエーテル)類等の種々のポリオキシエチレン付加数のポリオキシエチレンアルキルエーテル類;ポリオキシエチレンアルキルフェニルエーテル;ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油モノイソステアレート、ポリオキシエチレン硬化ヒマシ油トリイソステアレート、ポリオキシエチレン硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、ポリオキシエチレン硬化ヒマシ油マレイン酸等のヒマシ油及び硬化ヒマシ油誘導体;ポリオキシエチレンフィトステロール;ポリオキシエチレンコレステロール;ポリオキシエチレンコレスタノール;ポリオキシエチレンラノリン;ポリオキシエチレン還元ラノリン;ポリオキシエチレン・ポリオキシプロピレンセチルエーテル、ポリオキシエチレン・ポリオキシプロピレン2-デシルテトラデシルエーテル、ポリオキシエチレン・ポリオキシプロピレンモノブチルエーテル、ポリオキシエチレン・ポリオキシプロピレン水添ラノリン、ポリオキシエチレン・ポリオキシプロピレングリセリンエーテル等のポリオキシエチレン・ポリオキシプロピレンアルキルエーテル;ポリオキシエチレン・ポリオキシプロピレングリコール;PPG-9ジグリセリル等の(ポリ)グリセリンポリオキシプロピレングリコール;ステアリン酸グリセリル、イソステアリン酸グリセリル、パルミチン酸グリセリル、ミリスチン酸グリセリル、オレイン酸グリセリル、ヤシ油脂肪酸グリセリル、モノ綿実油脂肪酸グリセリン、モノエルカ酸グリセリン、セスキオレイン酸グリセリン、α,α’-オレイン酸ピログルタミン酸グリセリン、モノステアリン酸グリセリンリンゴ酸等のグリセリン脂肪酸部分エステル類;ステアリン酸ポリグリセリル-2、同3、同4、同5、同6、同8、同10、ジステアリン酸ポリグリセリル-6、同10、トリステアリン酸ポリグリセリル-2、デカステアリン酸ポリグリセリル-10、イソステアリン酸ポリグリセリル-2、同3、同4、同5、同6、同8、同10、ジイソステアリン酸ポリグリセリル-2(ジイソステアリン酸ジグリセリル)、同3、同10、トリイソステアリン酸ポリグリセリル-2、テトライソステアリン酸ポリグリセリル-2、デカイソステアリン酸ポリグリセリル-10、オレイン酸ポリグリセリル-2、同3、同4、同5、同6、同8、同10、ジオレイン酸ポリグリセリル-6、トリオレイン酸ポリグリセリル-2、デカオレイン酸ポリグリセリル-10等のポリグリセリン脂肪酸エステル;モノステアリン酸エチレングリコール等のエチレングリコールモノ脂肪酸エステル;モノステアリン酸プロピレングリコール等のプロピレングリコールモノ脂肪酸エステル;ペンタエリスリトール部分脂肪酸エステル;ソルビトール部分脂肪酸エステル;マルチトール部分脂肪酸エステル;マルチトールエーテル;ソルビタンモノオレエート、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ソルビタンセスキオレエート、ソルビタントリオレエート、ペンタ-2-エチルヘキシル酸ジグリセロールソルビタン、テトラ-2-エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル;ショ糖脂肪酸エステル、メチルグルコシド脂肪酸エステル、ウンデシレン酸トレハロース等の糖誘導体部分エステル;カプリリルグルコシド等のアルキルグルコシド;アルキルポリグリコシド;ラノリンアルコール;還元ラノリン;ポリオキシエチレンジステアレート、ポリチレングリコールジイソステアレート、ポリオキシエチレンモノオレエート、ポリオキシエチレンジオレエート等のポリオキシエチレン脂肪酸モノ及びジエステル;ポリオキシエチレン・プロピレングリコール脂肪酸エステル;ポリオキシエチレングリセリンモノステアレート、ポリオキシエチレングリセリンモノイソステアレート、ポリオキシエチレングリセリントリイソステアレート等のポリオキシエチレンモノオレエート等のポリオキシエチレングリセリン脂肪酸エステル;ポリオキシエチレンソルビタンモノオレエート、ポリオキシエチレンソルビタンモノステアレート、ポリオキシエチレンソルビタンモノオレート、ポリオキシエチレンソルビタンテトラオレエート等のポリオキシエチレンソルビタン脂肪酸エステル;ポリオキシエチレンソルビトールモノラウレート、ポリオキシエチレンソルビトールモノオレエート、ポリオキシエチレンソルビトールペンタオレエート、ポリオキシエチレンソルビトールモノステアレート等のポリオキシエチレンソルビトール脂肪酸エステル;ポリオキシエチレンメチルグルコシド脂肪酸エステル;ポリオキシエチレンアルキルエーテル脂肪酸エステル;ポリオキシエチレンソルビトールミツロウ等のポリオキシエチレン動植物油脂類;イソステアリルグリセリルエーテル、キミルアルコール、セラキルアルコール、バチルアルコール等のアルキルグリセリルエーテル類;多価アルコールアルキルエーテル;ポリオキシエチレンアルキルアミン;テトラポリオキシエチレン・テトラポリオキシプロピレン-エチレンジアミン縮合物類;サポニン、ソホロリピッド等の天然系界面活性剤;ポリオキシエチレン脂肪酸アミド;ヤシ油脂肪酸モノエタノールアミド(コカミドMEA)、ヤシ油脂肪酸ジエタノールアミド(コカミドDEA)、ラウリン酸モノエタノールアミド(ラウラミドMEA)、ラウリン酸ジエタノールアミド(ラウラミドDEA)、ラウリン酸モノイソプロパノールアミド(ラウラミドMIPA)、パルミチン酸モノエタノールアミド(パルタミドMEA)、パルミチン酸ジエタノールアミド(パルタミドDEA)、ヤシ油脂肪酸メチルエタノールアミド(コカミドメチルMEA)等の脂肪酸アルカノールアミド類;ラウラミンオキシド、コカミンオキシド、ステアラミンオキシド、ベヘナミンオキシド等のアルキルジメチルアミンオキシド;アルキルエトキシジメチルアミンオキシド;ポリオキシエチレンアルキルメルカプタン;ジメチコンコポリオール等のポリエーテル変性シリコーン、ポリシロキサン・オキシアルキレン共重合体、ポリグリセリン変性シリコーン、糖変性シリコーン等のシリコーン系非イオン性界面活性剤等;陽イオン性界面活性剤としては、ベヘントリモニウムクロリド、ステアルトリモニウムクロリド、セトリモニウムクロリド、ラウリルトリモニウムクロリド等のアルキルトリメチルアンモニウムクロリド;ステアリルトリモニウムブロミド等のアルキルトリメチルアンモニウムブロミド;ジステアリルジモニウムクロリド、ジココジモニウムクロリド等のジアルキルジメチルアンモニウムクロリド;ステアラミドプロピルジメチルアミン、ステアラミドエチルジエチルアミン等の脂肪酸アミドアミン及びその塩;ステアロキシプロピルジメチルアミン等のアルキルエーテルアミン及びその塩又は四級塩;エチル硫酸長鎖分岐脂肪酸(12~31)アミノプロピルエチルジメチルアンモニウム、エチル硫酸ラノリン脂肪酸アミノプロピルエチルジメチルアンモニウム等の脂肪酸アミド型四級アンモニウム塩;ポリオキシエチレンアルキルアミン及びその塩又は四級塩;アルキルアミン塩;脂肪酸アミドグアニジウム塩;アルキルエーテルアミンモニウム塩;アルキルトリアルキレングリコールアンモニウム塩;ベンザルコニウム塩;ベンゼトニウム塩;塩化セチルピリジニウム等のピリジニウム塩;イミダゾリニウム塩;アルキルイソキノリニウム塩;ジアルキルモリホニウム塩;ポリアミン脂肪酸誘導体;アミノプロピルジメチコン及びアモジメチコン等のアミノ変性シリコーン、カチオン変性シリコーン、カチオン変性及びポリエーテル変性シリコーン、アミノ変性及びポリエーテル変性シリコーン等のシリコーン系陽イオン性界面活性剤等;両性界面活性剤としては、
ラウリルベタイン(ラウリルジメチルアミノ酢酸ベタイン)等のN-アルキル-N,N-ジメチルアミノ酸ベタイン;コカミドプロピルベタイン、ラウラミドプロピルベタイン等の脂肪酸アミドアルキル-N,N-ジメチルアミノ酸ベタイン;ココアンホ酢酸ナトリウム、ラウロアンホ酢酸ナトリウム等のイミダゾリン型ベタイン;アルキルジメチルタウリン等のアルキルスルホベタイン;アルキルジメチルアミノエタノール硫酸エステル等の硫酸型ベタイン;アルキルジメチルアミノエタノールリン酸エステル等のリン酸型ベタイン;ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、スフィンゴミエリン等のスフィンゴリン脂質、リゾレシチン、水素添加大豆リン脂質、部分水素添加大豆リン脂質、水素添加卵黄リン脂質、部分水素添加卵黄リン脂質、水酸化レシチン等のリン脂質類;シリコーン系両性界面活性剤等;高分子界面活性剤としては、ポリビニルアルコール、アルギン酸ナトリウム、デンプン誘導体、トラガントガム、アクリル酸・メタアクリル酸アルキル共重合体;シリコーン系各種界面活性剤が好ましいものとして挙げられる。
Preferred examples of the surfactant include an anionic surfactant, a nonionic surfactant, a cationic surfactant, an amphoteric surfactant, and a polymer surfactant. Examples of preferable surfactants include fatty acid salts such as potassium laurate and potassium myristate; alkyl sulfate esters such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and ammonium lauryl sulfate; Polyoxyethylene alkyl sulfates such as sodium laureth sulfate and triethanolamine laureth sulfate; cocoyl methyl taurine sodium, cocoyl methyl taurine potassium, lauroyl methyl taurine sodium, myristoyl methyl taurine sodium, lauroyl methyl alanine sodium, lauroyl sarcosine sodium, lauroyl sarcosine tri Acyl N-methyl amino acid salts such as ethanolamine and sodium methylalanine lauroylglutamate; cocoyl Acyl amino acid salts such as sodium glutamate, triethanolamine cocoyl glutamate, sodium lauroyl glutamate, sodium myristoyl glutamate, sodium stearoyl glutamate, ditriethanolamine palmitoyl aspartate, cocoylalanine triethanolamine; polyoxyethylene alkyl ethers such as sodium laureth acetate Acetic acid salt; Succinic acid ester salt such as sodium lauroyl monoethanolamide succinate; Fatty acid alkanolamide ether carboxylate; Acyl lactate; Polyoxyethylene fatty amine sulfate; Fatty acid alkanolamide sulfate; Hardened coconut oil fatty acid sodium glyceryl sulfate Fatty acid glyceride sulfate such as alkylbenzene polyoxyethylene sulfate; α-olefin Olefin sulfonates such as sodium sulfonic acid sulfonate; Alkyl sulfosuccinates such as disodium lauryl sulfosuccinate and dioctyl sodium sulfosuccinate; disodium laureth sulfosuccinate, monolauroyl monoethanolamide polyoxyethylene sodium sodium sulfosuccinate, lauryl polypropylene glycol sulfosuccinic acid Alkyl ether sulfosuccinates such as sodium; alkylbenzene sulfonates such as sodium tetradecylbenzenesulfonate and triethanolamine tetradecylbenzenesulfonate; alkylnaphthalenesulfonates; alkanesulfonates; α-sulfo fatty acid methyl ester salts; Acyl isethionate; alkyl glycidyl ether sulfonate; alkyl sulfoacetate; laureth Alkyl ether phosphate salts such as sodium phosphate, sodium dilaureth phosphate, sodium trilaureth phosphate, sodium monooles phosphate; alkyl phosphate ester salts such as potassium lauryl phosphate; sodium caseinate; alkyl aryl ether phosphate; fatty acid amide Ether phosphates; Phospholipids such as phosphatidylglycerol, phosphatidylinositol, and phosphatidic acid; Silicone anionic surfactants such as carboxylic acid-modified silicone, phosphoric acid-modified silicone, and sulfuric acid-modified silicone; Nonionic surfactants These include laureth (polyoxyethylene lauryl ether), ceteth (polyoxyethylene cetyl ether), steareth (polyoxyethylene stearyl ether), behenez (polyoxy). Polyoxyethylene alkyl ethers with various polyoxyethylene addition numbers such as silethylene behenyl ethers), isosteares (polyoxyethylene isostearyl ether) s, octyldecesses (polyoxyethylene octyldodecyl ethers); Ether: Polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil monoisostearate, polyoxyethylene hydrogenated castor oil triisostearate, polyoxyethylene hydrogenated castor oil monopyroglutamic acid monoisostearic acid diester Castor oil and hardened castor oil derivatives such as polyoxyethylene hydrogenated castor oil maleic acid; polyoxyethylene phytosterol; polyoxyethylene cholesterol Polyoxyethylene cholestanol; polyoxyethylene lanolin; polyoxyethylene reduced lanolin; polyoxyethylene / polyoxypropylene cetyl ether, polyoxyethylene / polyoxypropylene 2-decyltetradecyl ether, polyoxyethylene / polyoxypropylene monobutyl ether Polyoxyethylene / polyoxypropylene hydrogenated lanolin, polyoxyethylene / polyoxypropylene glycerin ether and other polyoxyethylene / polyoxypropylene alkyl ethers; polyoxyethylene / polyoxypropylene glycol; PPG-9 diglyceryl and the like ( Poly) glycerin polyoxypropylene glycol; glyceryl stearate, glyceryl isostearate, glyceryl palmitate, milli Glyceryl fatty acid partial esters such as glyceryl tinate, glyceryl oleate, glyceryl coconut oil fatty acid glyceryl, mono-cotton oil fatty acid glycerin, glyceryl monoerucate, glyceryl sesquioleate, glycerin α, α'-oleic acid pyroglutamate, glyceryl monostearate Polyglyceryl stearate-2, 3, 4, 5, 6, 8, 10, 10 polyglyceryl-6 distearate, 10, polyglyceryl tristearate, polyglyceryl decastearate-10, isostearin Polyglyceryl-2, 3, 4, 5, 6, 8, 10, diisostearate polyglyceryl-2 (diglyceryl diisostearate), 3, 10, polyglyceryl-2 triisostearate, tetraisostearate Polyglyceryl-2, polyglyceryl-10 decaisostearate, polyglyceryl-2 oleate, 3, 4, 5, 6, 8, 10, dioleate polyglyceryl-6, trioleate polyglyceryl-2, dekaoleic acid Polyglyceryl fatty acid esters such as polyglyceryl-10; ethylene glycol monofatty acid esters such as ethylene glycol monostearate; propylene glycol monofatty acid esters such as propylene glycol monostearate; pentaerythritol partial fatty acid esters; sorbitol partial fatty acid esters; maltitol moieties Fatty acid ester; maltitol ether; sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbi Monostearate, sorbitan sesquioleate, sorbitan trioleate, penta-2-ethylhexyl diglycerol sorbitan, tetra-2-ethylhexyl diglycerol sorbitan, etc .; sucrose fatty acid ester, methyl glucoside fatty acid ester, undecylene Sugar derivative partial ester such as acid trehalose; alkyl glucoside such as caprylyl glucoside; alkyl polyglycoside; lanolin alcohol; reduced lanolin; polyoxyethylene distearate, polytylene glycol diisostearate, polyoxyethylene monooleate, poly Polyoxyethylene fatty acid mono- and diesters such as oxyethylene dioleate; polyoxyethylene propylene glycol fatty acid ester; Polyoxyethylene glycerol fatty acid esters such as polyoxyethylene monooleate such as xylethylene glycerol monostearate, polyoxyethylene glycerol monoisostearate, polyoxyethylene glycerol triisostearate; polyoxyethylene sorbitan monooleate, poly Polyoxyethylene sorbitan fatty acid esters such as oxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan tetraoleate; polyoxyethylene sorbitol monolaurate, polyoxyethylene sorbitol monooleate, polyoxyethylene sorbitol Polyoxyethylene sorbitol such as pentaoleate and polyoxyethylene sorbitol monostearate Fatty acid ester; Polyoxyethylene methyl glucoside fatty acid ester; Polyoxyethylene alkyl ether fatty acid ester; Polyoxyethylene animal and vegetable fats and oils such as polyoxyethylene sorbitol beeswax; Isostearyl glyceryl ether, Kimyl alcohol, Serakyl alcohol, Batyl alcohol, etc. Polyglyceryl ethers; polyoxyethylene alkylamines; tetrapolyoxyethylene / tetrapolyoxypropylene-ethylenediamine condensates; natural surfactants such as saponins and sophorolipids; polyoxyethylene fatty acid amides; Palm oil fatty acid monoethanolamide (cocamide MEA), palm oil fatty acid diethanolamide (cocamide DEA), lauric acid monoethanolamide (Lauramide MEA), lauric acid diethanolamide (lauramide DEA), lauric acid monoisopropanolamide (lauramide MIPA), palmitic acid monoethanolamide (partamide MEA), palmitic acid diethanolamide (partamide DEA), palm oil fatty acid methylethanolamide ( Fatty acid alkanolamides such as cocamidomethyl MEA); alkyldimethylamine oxides such as lauramine oxide, cocamamine oxide, stearamine oxide, and behenamine oxide; alkylethoxydimethylamine oxide; polyoxyethylene alkyl mercaptan; dimethicone copolyol, etc. Polyether-modified silicone, polysiloxane / oxyalkylene copolymer, polyglycerin-modified silicone, sugar-modified silicone, etc. Nonionic surfactants of silicone, etc .; cationic surfactants include alkyltrimethylammonium chlorides such as behentrimonium chloride, steartrimonium chloride, cetrimonium chloride, lauryltrimonium chloride; stearyltrimonium bromide, etc. Alkyltrimethylammonium bromides; dialkyldimethylammonium chlorides such as distearyldimonium chloride and dicocodimonium chloride; fatty acid amidoamines and salts thereof such as stearamidepropyldimethylamine and stearamideethyldiethylamine; alkyl ethers such as stearoxypropyldimethylamine Amines and salts or quaternary salts thereof; ethyl sulfate long chain branched fatty acid (12-31) aminopropylethyldimethylammonium Fatty acid amide type quaternary ammonium salts such as lanolin fatty acid aminopropylethyldimethylammonium; polyoxyethylene alkylamines and salts or quaternary salts thereof; alkylamine salts; fatty acid amidoguanidinium salts; alkyl etheraminemonium salts; Benzalkonium salts; benzethonium salts; pyridinium salts such as cetylpyridinium chloride; imidazolinium salts; alkylisoquinolinium salts; dialkyl morpholinium salts; polyamine fatty acid derivatives; aminopropyl dimethicone and amodimethicone, etc. Silicone-based cationic surfactants such as amino-modified silicone, cation-modified silicone, cation-modified and polyether-modified silicone, amino-modified and polyether-modified silicone Examples of the amphoteric surfactant; etc
N-alkyl-N, N-dimethylamino acid betaines such as lauryl betaine (lauryldimethylaminoacetic acid betaine); fatty acid amide alkyl-N, N-dimethylamino acid betaines such as cocamidopropyl betaine and lauramidopropyl betaine; sodium cocoamphoacetate; Imidazoline-type betaines such as sodium lauroamphoacetate; alkylsulfobetaines such as alkyldimethyltaurine; sulfate-type betaines such as alkyldimethylaminoethanol sulfate; phosphate-type betaines such as alkyldimethylaminoethanol phosphate; phosphatidylcholine, phosphatidylethanolamine, Sphingophospholipids such as phosphatidylserine and sphingomyelin, lysolecithin, hydrogenated soybean phospholipid, partially hydrogenated soybean phospholipid, hydrogen Egg yolk phospholipids, partially hydrogenated egg yolk phospholipids, phospholipids such as hydroxylated lecithin; silicone-based amphoteric surfactants; polymer surfactants include polyvinyl alcohol, sodium alginate, starch derivatives, tragacanth gum, acrylic acid -Alkyl methacrylate copolymers; various silicone surfactants are preferred.
高分子・増粘剤・ゲル化剤としては、グアーガム、ローカストビーンガム、クィーンスシード、カラギーナン、ガラクタン、アラビアガム、タラガム、タマリンド、ファーセレラン、カラヤガム、トロロアオイ、キャラガム、トラガントガム、ペクチン、ペクチン酸及びナトリウム塩等の塩、アルギン酸及びナトリウム塩等の塩、マンナン;コメ、トウモロコシ、バレイショ、コムギ等のデンプン;キサンタンガム、デキストラン、サクシノグルカン、カードラン、ヒアルロン酸及びその塩、ザンサンガム、プルラン、ジェランガム、キチン、キトサン、寒天、カッソウエキス、コンドロイチン硫酸塩、カゼイン、コラーゲン、ゼラチン、アルブミン;メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース及びそのナトリウム等の塩、メチルヒドロキシプロピルセルロース、セルロース硫酸ナトリウム、ジアルキルジメチルアンモニウム硫酸セルロース、結晶セルロース、セルロース末等のセルロース及びその誘導体;可溶性デンプン、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン、メチルデンプン等のデンプン系高分子、塩化ヒドロキシプロピルトリモニウムデンプン、オクテニルコハク酸トウモロコシデンプンアルミニウム等のデンプン誘導体;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等アルギン酸誘導体;ポリビニルピドリドン(PVP)、ポリビニルアルコール(PVA)、ビニルピドリドン・ビニルアルコール共重合体、ポリビニルメチルエーテル;ポリエチレングリコール、ポリプロピレングリコール、ポリオキシエチレン・ポリオキシプロピレン共重合体;(メタクリロイルオキシエチルカルボキシベタイン/メタクリル酸アルキル)コポリマー、(アクリレーツ/アクリル酸ステアリル/メタクリル酸エチルアミンオキシド)コポリマー等の両性メタクリル酸エステル共重合体;(ジメチコン/ビニルジメチコン)クロスポリマー、(アクリル酸アルキル/ジアセトンアクリルアミド)コポリマー、(アクリル酸アルキル/ジアセトンアクリルアミド)コポリマーAMP;ポリ酢酸ビニル部分けん化物、マレイン酸共重合体;ビニルピロリドン・メタクリル酸ジアルキルアミノアルキル共重合体;アクリル樹脂アルカノールアミン;ポリエステル、水分散性ポリエステル;ポリアクリルアミド;ポリアクリル酸エチル等のポリアクリル酸エステル共重合体、カルボキシビニルポリマー、ポリアクリル酸及びそのナトリウム塩等の塩、アクリル酸・メタアクリル酸エステル共重合体;アクリル酸・メタアクリル酸アルキル共重合体;ポリクオタニウム-10等のカチオン化セルロース、ポリクオタニウム-7等のジアリルジメチルアンモニウムクロリド・アクリルアミド共重合体、ポリクオタニウム-22等のアクリル酸・ジアリルジメチルアンモニウムクロリド共重合体、ポリクオタニウム-39等のアクリル酸・ジアリルジメチルアンモニウムクロリド・アクリルアミド共重合体、アクリル酸・カチオン化メタアクリル酸エステル共重合体、アクリル酸・カチオン化メタアクリル酸アミド共重合体、ポリクオタニウム-47等のアクリル酸・アクリル酸メチル・塩化メタクリルアミドプロピルトリメチルアンモニウム共重合体、塩化メタクリル酸コリンエステル重合体;カチオン化オリゴ糖、カチオン化デキストラン、グアーヒドロキシプロピルトリモニウムクロリド等のカチオン化多糖類;ポリエチレンイミン;カチオンポリマー;ポリクオタニウム-51等の2-メタクリロイルオキシエチルホスホリルコリンの重合体及びメタクリル酸ブチル共重合体等との共重合体;アクリル樹脂エマルジョン、ポリアクリル酸エチルエマルジョン、ポリアクリルアルキルエステルエマルジョン、ポリ酢酸ビニル樹脂エマルジョン、天然ゴムラテックス、合成ラテックス等の高分子エマルジョン;ニトロセルロース;ポリウレタン類及び各種共重合体;各種シリコーン類;アクリル-シリコーングラフト共重合体等のシリコーン系各種共重合体;各種フッ素系高分子;12-ヒドロキシステアリン酸及びその塩;パルミチン酸デキストリン、ミリスチン酸デキストリン等のデキストリン脂肪酸エステル;無水ケイ酸、煙霧状シリカ(超微粒子無水ケイ酸)、ケイ酸アルミニウムマグネシウム、ケイ酸ナトリウムマグネシウム、金属石鹸、ジアルキルリン酸金属塩、ベントナイト、ヘクトライト、有機変性粘土鉱物、ショ糖脂肪酸エステル、フラクトオリゴ糖脂肪酸エステルが好ましいものとして挙げられる。前記例示の中でも、セルロース及びその誘導体、アルギン酸及びその塩、ポリビニルアルコール、ヒアルロン酸及びその塩、又はコラーゲンが好ましい。 Polymers, thickeners and gelling agents include guar gum, locust bean gum, queens seed, carrageenan, galactan, arabic gum, tara gum, tamarind, far selelain, karaya gum, troarooi, cara gum, tragacanth gum, pectin, pectic acid and sodium Salt such as salt, salt such as alginic acid and sodium salt, mannan; starch such as rice, corn, potato, wheat; xanthan gum, dextran, succinoglucan, curdlan, hyaluronic acid and its salt, xanthan gum, pullulan, gellan gum, chitin , Chitosan, agar, gypsophila extract, chondroitin sulfate, casein, collagen, gelatin, albumin; methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypro Cellulose, hydroxypropylmethylcellulose, carboxymethylcellulose and salts thereof such as sodium, methylhydroxypropylcellulose, sodium cellulose sulfate, cellulose dialkyldimethylammonium sulfate, crystalline cellulose, cellulose powder such as cellulose powder; soluble starch, carboxymethyl starch, Starch polymers such as methylhydroxypropyl starch and methyl starch, starch derivatives such as hydroxypropyltrimonium chloride, octenyl succinate corn starch and aluminum; alginic acid derivatives such as sodium alginate and propylene glycol alginate; polyvinylpyridone (PVP) and polyvinyl Alcohol (PVA), vinyl pydridone, vinyl alcohol Coal copolymer, polyvinyl methyl ether; polyethylene glycol, polypropylene glycol, polyoxyethylene / polyoxypropylene copolymer; (methacryloyloxyethylcarboxybetaine / alkyl methacrylate) copolymer, (acrylates / stearyl acrylate / ethylamine methacrylate oxide) ) Amphoteric methacrylate copolymers such as copolymers; (dimethicone / vinyl dimethicone) crosspolymer, (alkyl acrylate / diacetone acrylamide) copolymer, (alkyl acrylate / diacetone acrylamide) copolymer AMP; polyvinyl acetate partial saponified product , Maleic acid copolymer; vinylpyrrolidone / dialkylaminoalkyl methacrylate copolymer; acrylic resin alkanolamine; poly Esters, water dispersible polyesters; polyacrylamides; polyacrylic acid ester copolymers such as polyethyl acrylate, carboxyvinyl polymers, salts of polyacrylic acid and its sodium salts, acrylic acid / methacrylic acid ester copolymers; Acrylic acid / alkyl methacrylate copolymer; cationic cellulose such as polyquaternium-10, diallyldimethylammonium chloride / acrylamide copolymer such as polyquaternium-7, and acrylic acid / diallyldimethylammonium chloride copolymer such as polyquaternium-22 Acrylic acid / diallyldimethylammonium chloride / acrylamide copolymer, acrylic acid / cationized methacrylic acid ester copolymer, acrylic acid / cationized meta-acrylate, etc. Acrylic acid / methyl acrylate / methacrylamidopropyltrimethylammonium chloride copolymer such as polyquaternium-47, methacrylic acid choline ester polymer; cationized oligosaccharide, cationized dextran, guar hydroxypropyltri Cationic polysaccharides such as monium chloride; polyethyleneimine; cationic polymers; copolymers of 2-methacryloyloxyethyl phosphorylcholine such as polyquaternium-51 and copolymers of butyl methacrylate; acrylic resin emulsion, polyacrylic acid Polymer emulsions such as ethyl emulsion, polyacrylic alkyl ester emulsion, polyvinyl acetate resin emulsion, natural rubber latex, synthetic latex; nitrocellulose; Tans and various copolymers; Various silicones; Various silicone-based copolymers such as acrylic-silicone graft copolymers; Various fluoropolymers; 12-hydroxystearic acid and its salts; Dextrin palmitate and dextrin myristate Dextrin fatty acid esters such as silicic anhydride, fumed silica (ultrafine silicic anhydride), magnesium aluminum silicate, sodium magnesium silicate, metal soap, metal dialkyl phosphate, bentonite, hectorite, organically modified clay mineral, Preferred examples include sucrose fatty acid esters and fructooligosaccharide fatty acid esters. Among the examples, cellulose and derivatives thereof, alginic acid and salts thereof, polyvinyl alcohol, hyaluronic acid and salts thereof, or collagen is preferable.
溶剤としては、エタノール、2-プロパノール(イソプロピルアルコール)、ブタノール、イソブチルアルコール等の低級アルコール類;プロピレングリコール、ジエチレングリコール、ジプロピレングリコール、イソペンチルジオール等のグリコール類;ジエチレングリコールモノエチルエーテル(エトキシジグリコール)、エチレングリコールモノエチルエーテル、エチレングリコールモノブチルエーテル、トリエチレングリコールモノエチルエーテル、ジエチレングリコールジエチルエーテル、ジエチレングリコールジブチルエーテル、プロピレングリコールモノエチルエーテル、ジプロピレングリコールモノエチルエーテル等のグリコールエーテル類;エチレングリコールモノエチルエーテルアセテート、ジエチレングリコールモノエチルエーテルアセテート、プロピレングリコールモノエチルエーテルアセテート等のグリコールエーテルエステル類;コハク酸ジエトキシエチル、エチレングリコールジサクシネート等のグリコールエステル類;ベンジルアルコール、ベンジルオキシエタノール、炭酸プロピレン、炭酸ジアルキル、アセトン、酢酸エチル、N-メチルピロリドン;トルエン等が好ましいものとして挙げられる。 Solvents include lower alcohols such as ethanol, 2-propanol (isopropyl alcohol), butanol and isobutyl alcohol; glycols such as propylene glycol, diethylene glycol, dipropylene glycol and isopentyl diol; diethylene glycol monoethyl ether (ethoxydiglycol) , Glycol ethers such as ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, triethylene glycol monoethyl ether, diethylene glycol diethyl ether, diethylene glycol dibutyl ether, propylene glycol monoethyl ether, dipropylene glycol monoethyl ether; ethylene glycol monoethyl ether Acetate, diethylene glycol Glycol ether esters such as ethyl ether acetate and propylene glycol monoethyl ether acetate; glycol esters such as diethoxyethyl succinate and ethylene glycol disuccinate; benzyl alcohol, benzyloxyethanol, propylene carbonate, dialkyl carbonate, acetone, acetic acid Preferred examples include ethyl, N-methylpyrrolidone and toluene.
酸化防止剤としては、トコフェロール(ビタミンE)、酢酸トコフェロール等のトコフェロール誘導体;BHT、BHA;没食子酸プロピル等の没食子酸誘導体;ビタミンC(アスコルビン酸)及び/又はその誘導体;エリソルビン酸及びその誘導体;亜硫酸ナトリウム等の亜硫酸塩;亜硫酸水素ナトリウム等の亜硫酸水素塩;チオ硫酸ナトリウム等のチオ硫酸塩;メタ亜硫酸水素塩;チオタウリン、ヒポタウリン;チオグリセロール、チオ尿素、チオグリコール酸、システイン塩酸塩が好ましいものとして挙げられる。 Antioxidants include tocopherol derivatives such as tocopherol (vitamin E) and tocopherol acetate; BHT, BHA; gallic acid derivatives such as propyl gallate; vitamin C (ascorbic acid) and / or derivatives thereof; erythorbic acid and derivatives thereof; Preferred are sulfites such as sodium sulfite; bisulfites such as sodium bisulfite; thiosulfates such as sodium thiosulfate; metabisulfites; thiotaurine, hypotaurine; thioglycerol, thiourea, thioglycolic acid, cysteine hydrochloride As mentioned.
還元剤としては、チオグリコール酸、システイン、システアミン等が好ましいものとして挙げられる。 Preferred examples of the reducing agent include thioglycolic acid, cysteine, cysteamine and the like.
酸化剤としては、過酸化水素水、過硫酸アンモニウム、臭素酸ナトリウム、過炭酸等が好ましいものとして挙げられる。 Preferred examples of the oxidizing agent include hydrogen peroxide water, ammonium persulfate, sodium bromate, percarbonate, and the like.
防腐剤・抗菌剤・殺菌剤としては、メチルパラベン、エチルパラベン、プロピルパラベン、ブチルパラベン等のヒドロキシ安息香酸及びその塩若しくはそのエステル;サリチル酸;安息香酸ナトリウム;フェノキシエタノール;メチルクロロイソチアゾリノン、メチルイソチアゾリノン等のイソチアゾリンオン誘導体;イミダゾリニウムウレア;デヒドロ酢酸及びその塩;フェノール類;トリクロサン等のハロゲン化ビスフェノール類、酸アミド類、四級アンモニウム塩類;トリクロロカルバニド、ジンクピリチオン、塩化ベンザルコニウム、塩化ベンゼトニウム、ソルビン酸、クロルヘキシジン、グルコン酸クロルヘキシジン、ハロカルバン、ヘキサクロロフェン、ヒノキチオール;フェノール、イソプロピルフェノール、クレゾール、チモール、パラクロロフェノール、フェニルフェノール、フェニルフェノールナトリウム等のその他フェノール類;フェニルエチルアルコール、感光素類、抗菌性ゼオライト、銀イオンが好ましいものとして挙げられる。 Examples of preservatives, antibacterial agents, and bactericides include hydroxybenzoic acid such as methylparaben, ethylparaben, propylparaben, and butylparaben, and salts or esters thereof; salicylic acid; sodium benzoate; phenoxyethanol; methylchloroisothiazolinone, methylisothiazo Isothiazolinone derivatives such as linone; imidazolinium urea; dehydroacetic acid and its salts; phenols; halogenated bisphenols such as triclosan, acid amides, quaternary ammonium salts; trichlorocarbanide, zinc pyrithione, benzalkonium chloride, chloride Benzethonium, sorbic acid, chlorhexidine, chlorhexidine gluconate, halocarban, hexachlorophene, hinokitiol; phenol, isopropylphenol, cresol, Mall, para chlorophenol, phenylphenol, other phenols such as phenylphenol sodium; phenylethyl alcohol, photosensitive Motorui, be mentioned as antibacterial zeolite, silver ion.
キレート剤としては、EDTA、EDTA2Na、EDTA3Na、EDTA4Na等のエデト酸塩(エチレンジアミン四酢酸塩);HEDTA3Na等のヒドロキシエチルエチレンジアミン三酢酸塩;ペンテト酸塩(ジエチレントリアミン五酢酸塩);フィチン酸;エチドロン酸等のホスホン酸及びそのナトリウム塩等の塩類;ポリアスパラギン酸、ポリグルタミン酸等のポリアミノ酸類;ポリリン酸ナトリウム、メタリン酸ナトリウム、リン酸;クエン酸ナトリウム、クエン酸、アラニン、ジヒドロキシエチルグリシン、グルコン酸、アスコルビン酸、コハク酸、酒石酸が好ましいものとして挙げられる。 Examples of chelating agents include edetate (ethylenediaminetetraacetate) such as EDTA, EDTA2Na, EDTA3Na, and EDTA4Na; hydroxyethylethylenediaminetriacetate such as HEDTA3Na; pentetate (diethylenetriaminepentaacetate); phytic acid; Phosphonic acid and its sodium salt; polyamino acids such as polyaspartic acid and polyglutamic acid; sodium polyphosphate, sodium metaphosphate, phosphoric acid; sodium citrate, citric acid, alanine, dihydroxyethylglycine, gluconic acid, Ascorbic acid, succinic acid and tartaric acid are preferred.
pH調整剤・酸・アルカリとしては、アスコルビン酸、クエン酸、クエン酸ナトリウム、乳酸、乳酸ナトリウム、乳酸カリウム、グリコール酸、コハク酸、酢酸、酢酸ナトリウム、リンゴ酸、酒石酸、フマル酸、リン酸、塩酸、硫酸、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、イソプロパノールアミン、トリイソプロパノールアミン、2-アミノ-2-メチル-1,3-プロパンジオール、2-アミノ-2-ヒドロキシメチル-1,3-プロパンジオール、アルギニン、水酸化ナトリウム、水酸化カリウム、アンモニア水、炭酸グアニジン、炭酸アンモニウムが好ましいものとして挙げられる。 pH adjusters / acids / alkalis include ascorbic acid, citric acid, sodium citrate, lactic acid, sodium lactate, potassium lactate, glycolic acid, succinic acid, acetic acid, sodium acetate, malic acid, tartaric acid, fumaric acid, phosphoric acid, Hydrochloric acid, sulfuric acid, monoethanolamine, diethanolamine, triethanolamine, isopropanolamine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propane Preferred examples include diol, arginine, sodium hydroxide, potassium hydroxide, aqueous ammonia, guanidine carbonate, and ammonium carbonate.
無機塩類としては、食塩、並塩、岩塩、海塩、天然塩等の塩化ナトリウム含有塩類;塩化カリウム、塩化アルミニウム、塩化カルシウム、塩化マグネシウム、にがり、塩化亜鉛、塩化アンモニウム;硫酸ナトリウム、硫酸アルミニウム、硫酸アルミニウム・カリウム(ミョウバン)、硫酸アルミニウム・アンモニウム、硫酸バリウム、硫酸カルシウム、硫酸カリウム、硫酸マグネシウム、硫酸亜鉛、硫酸鉄、硫酸銅;リン酸1Na・2Na・3Na等のリン酸ナトリウム類、リン酸カリウム類、リン酸カルシウム類、リン酸マグネシウム類が好ましいものとして挙げられる。 Inorganic salts include sodium chloride-containing salts such as salt, common salt, rock salt, sea salt, natural salt; potassium chloride, aluminum chloride, calcium chloride, magnesium chloride, bittern, zinc chloride, ammonium chloride; sodium sulfate, aluminum sulfate, Aluminum sulfate / potassium sulfate (alum), aluminum sulfate / ammonium sulfate, barium sulfate, calcium sulfate, potassium sulfate, magnesium sulfate, zinc sulfate, iron sulfate, copper sulfate; sodium phosphates such as 1Na, 2Na and 3Na phosphates, phosphoric acid Potassium, calcium phosphates and magnesium phosphates are preferred.
紫外線吸収剤としては、パラアミノ安息香酸、パラアミノ安息香酸モノグリセリンエステル、N,N-ジプロポキシパラアミノ安息香酸エチルエステル、N,N-ジエトキシパラアミノ安息香酸エチルエステル、N,N-ジメチルパラアミノ安息香酸エチルエステル、N,N-ジメチルパラアミノ安息香酸ブチルエステル、N,N-ジメチルパラアミノ安息香酸メチルエステル等の安息香酸系紫外線吸収剤;ホモメンチル-N-アセチルアントラニレート等のアントラニル酸系紫外線吸収剤;サリチル酸及びそのナトリウム塩、アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p-イソプロパノールフェニルサリシレート等のサリチル酸系紫外線吸収剤;オクチルシンナメート、エチル-4-イソプロピルシンナメート、メチル-2,5-ジイソプロピルシンナメート、エチル-2,4-ジイソプロピルシンナメート、メチル-2,4-ジイソプロピルシンナメート、プロピル-p-メトキシシンナメート、イソプロピル-p-メトキシシンナメート、イソアミル-p-メトキシシンナメート、2-エチルヘキシル-p-メトキシシンナメート(パラメトキシケイヒ酸オクチル)、2-エトキシエチル-p-メトキシシンナメート(シノキサート)、シクロヘキシル-p-メトキシシンナメート、エチル-α-シアノ-β-フェニルシンナメート、2-エチルヘキシル-α-シアノ-β-フェニルシンナメート(オクトクリン)、グリセリルモノ-2-エチルヘキサノイル-ジパラメトキシシンナメート、フェルラ酸及びその誘導体等の桂皮酸系紫外線吸収剤;2,4-ジヒドロキシベンゾフェノン、2,2’-ジヒドロキシ-4-メトキシベンゾフェノン、2,2’-ジヒドロキシ-4,4’-ジメトキシベンゾフェノン、2,2’,4,4’-テトラヒドロキシベンゾフェノン、2-ヒドロキシ-4-メトキシベンゾフェノン(オキシベンゾン-3)、2-ヒドロキシ-4-メトキシ-4’-メチルベンゾフェノン、2-ヒドロキシ-4-メトキシベンゾフェノン-5-スルホン酸塩、4-フェニルベンゾフェノン、2-エチルヘキシル-4’-フェニル-ベンゾフェノン-2-カルボキシレート、2-ヒドロキシ-4-n-オクトキシベンゾフェノン、4-ヒドロキシ-3-カルボキシベンゾフェノン等のベンゾフェノン系紫外線吸収剤;3-(4’-メチルベンジリデン)-d,l-カンフル、3-ベンジリデン-d,l-カンフル;2-フェニル-5-メチルベンゾキサゾール;2,2’-ヒドロキシ-5-メチルフェニルベンゾトリアゾール;2-(2’-ヒドロキシ-5’-t-オクチルフェニル)ベンゾトリアゾール;2-(2’-ヒドロキシ-5’-メチルフェニルベンゾトリアゾール;ジベンザラジン;ジアニソイルメタン;5-(3,3-ジメチル-2-ノルボルニリデン)-3-ペンタン-2-オン;4-t-ブチルメトキシジベンゾイルメタン等のジベンゾイルメタン誘導体;オクチルトリアゾン;ウロカニン酸及びウロカニン酸エチル等のウロカニン酸誘導体;2-(2’-ヒドロキシ-5’-メチルフェニル)ベンゾトリアゾール、1-(3,4-ジメトキシフェニル)-4,4-ジメチル-1,3-ペンタンジオン、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2-エチルヘキシル等のヒダントイン誘導体、フェニルベンズイミダソゾールスルホン酸、テレフタリリデンジカンフルスルホン酸、ドロメトリゾールトリシロキサン、アントラニル酸メチル、ルチン及びその誘導体、オリザノール及びその誘導体が好ましいものとして挙げられる。 Examples of ultraviolet absorbers include paraaminobenzoic acid, paraaminobenzoic acid monoglycerin ester, N, N-dipropoxyparaaminobenzoic acid ethyl ester, N, N-diethoxyparaaminobenzoic acid ethyl ester, and N, N-dimethylparaaminobenzoic acid ethyl ester. Benzoic acid ultraviolet absorbers such as esters, N, N-dimethylparaaminobenzoic acid butyl ester, N, N-dimethylparaaminobenzoic acid methyl ester; Anthranilic acid ultraviolet absorbers such as homomenthyl-N-acetylanthranilate; Salicylic acid And salicylic acid systems such as sodium salt, amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate External line absorbent: octyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p- Methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, 2-ethylhexyl-p-methoxycinnamate (octyl paramethoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate (sinoxate) Cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate (octocrine), glyceryl mono-2-ethylhexanoyl-diparame Cinnamic acid UV absorbers such as toxicinnamate, ferulic acid and derivatives thereof; 2,4-dihydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone, 2,2′-dihydroxy-4,4′-dimethoxy Benzophenone, 2,2 ′, 4,4′-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone (oxybenzone-3), 2-hydroxy-4-methoxy-4′-methylbenzophenone, 2-hydroxy-4- Methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl-4′-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone Benzofe etc. UV absorbers; 3- (4′-methylbenzylidene) -d, l-camphor, 3-benzylidene-d, l-camphor; 2-phenyl-5-methylbenzoxazole; 2,2′-hydroxy- 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole; 2- (2′-hydroxy-5′-methylphenylbenzotriazole; dibenzalazine; dianisoylmethane; 5- (3,3-dimethyl-2-norbornylidene) -3-pentan-2-one; dibenzoylmethane derivatives such as 4-t-butylmethoxydibenzoylmethane; octyl triazone; urocanic acid such as urocanic acid and ethyl urocanate Derivatives; 2- (2′-hydroxy-5′-methylphenyl) benzotriazole Hydantoin derivatives such as 1- (3,4-dimethoxyphenyl) -4,4-dimethyl-1,3-pentanedione, dimethoxybenzylidenedioxoimidazolidinepropionate 2-ethylhexyl, phenylbenzimidazolazolesulfonic acid, terephthalate Preference is given to liridene dicamphorsulfonic acid, drometrizol trisiloxane, methyl anthranilate, rutin and its derivatives, oryzanol and its derivatives.
美白剤としては、アルブチン、α-アルブチン等のヒドロキノン配糖体及びそのエステル類;アスコルビン酸、アスコルビン酸リン酸エステルナトリウム塩及びアスコルビン酸リン酸エステルマグネシウム塩等のアスコルビン酸リン酸エステル塩、アスコルビン酸テトライソパルミチン酸エステル等のアスコルビン酸脂肪酸エステル、アスコルビン酸エチルエーテル等のアスコルビン酸アルキルエーテル、アスコルビン酸-2-グルコシド等のアスコルビン酸グルコシド及びその脂肪酸エステル類、アスコルビン酸硫酸エステル、リン酸トコフェリルアスコルビル等のアスコルビン酸誘導体;コウジ酸、エラグ酸、トラネキサム酸及びその誘導体、フェルラ酸及びその誘導体、プラセンタエキス、グルタチオン、オリザノール、ブチルレゾルシノール、油溶性カモミラエキス、油溶性カンゾウエキス、西河柳エキス、ユキノシタエキス等植物エキスが好ましいものとして挙げられる。 Examples of whitening agents include hydroquinone glycosides such as arbutin and α-arbutin and their esters; ascorbic acid phosphates such as ascorbic acid, sodium ascorbic acid phosphate and magnesium ascorbic acid phosphate, ascorbic acid Ascorbic acid fatty acid esters such as tetraisopalmitic acid ester, ascorbic acid alkyl ethers such as ascorbic acid ethyl ether, ascorbic acid glucosides such as ascorbic acid-2-glucoside and fatty acid esters thereof, ascorbic acid sulfate ester, tocopheryl ascorbyl phosphate Ascorbic acid derivatives such as kojic acid, ellagic acid, tranexamic acid and its derivatives, ferulic acid and its derivatives, placenta extract, glutathione, oryzanol, butylreso Shinoru, oil-soluble Kamomiraekisu, oil-soluble licorice extract, Nishikawa willow extract, be mentioned as saxifrage extract, and the like plant extracts are preferred.
ビタミン類及びその誘導体類としては、レチノール、酢酸レチノール、パルミチン酸レチノール等のビタミンA類;チアミン塩酸塩、チアミン硫酸塩、リボフラビン、酢酸リボフラビン、塩酸ピリドキシン、ピリドキシンジオクタノエート、ピリドキシンジパルミテート、フラビンアデニンジヌクレオチド、シアノコバラミン、葉酸類、ニコチン酸アミド・ニコチン酸ベンジル等のニコチン酸類、コリン類等のビタミンB群類;アスコルビン酸及びそのナトリウム等の塩等のビタミンC類;ビタミンD;α、β、γ、δ-トコフェロール等のビタミンE類;パントテン酸、ビオチン等のその他ビタミン類;アスコルビン酸リン酸エステルナトリウム塩及びアスコルビン酸リン酸エステルマグネシウム塩等のアスコルビン酸リン酸エステル塩、アスコルビン酸テトライソパルミチン酸エステル・ステアリン酸アスコルビル・パルミチン酸アスコルビル・ジパルミチン酸アスコルビル等のアスコルビン酸脂肪酸エステル、アスコルビン酸エチルエーテル等のアスコルビン酸アルキルエーテル、アスコルビン酸-2-グルコシド等のアスコルビン酸グルコシド及びその脂肪酸エステル、リン酸トコフェリルアスコルビル等のアスコルビン酸誘導体;ニコチン酸トコフェロール、酢酸トコフェロール、リノール酸トコフェロール、フェルラ酸トコフェロール、トコフェロールリン酸エステル等のトコフェロール誘導体等のビタミン誘導体、トコトリエノール、その他各種ビタミン誘導体類が好ましいものとして挙げられる。 Vitamins and their derivatives include vitamin A such as retinol, retinol acetate, retinol palmitate; thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, pyridoxine dipalmitate, Flavin adenine dinucleotide, cyanocobalamin, folic acid, nicotinic acid such as nicotinic acid amide / benzyl nicotinate, vitamin B group such as choline; vitamin C such as ascorbic acid and its sodium salt; vitamin D; α, Vitamin E such as β, γ, and δ-tocopherol; other vitamins such as pantothenic acid and biotin; ascorbic acid phosphates such as ascorbic acid phosphate sodium salt and ascorbic acid phosphate magnesium salt, Ascorbic acid fatty acid esters such as ascorbyl tetraisopalmitate, ascorbyl stearate, ascorbyl palmitate and ascorbyl dipalmitate, ascorbic acid alkyl ethers such as ascorbic acid ethyl ether, ascorbic acid glucosides such as ascorbic acid-2-glucoside and Ascorbic acid derivatives such as fatty acid esters and tocopheryl phosphate ascorbyl; vitamin derivatives such as tocopherol nicotinate, tocopherol acetate, tocopherol acetate, tocopherol linoleate, tocopherol phosphate, tocopherol phosphate etc., tocotrienol, and other various vitamin derivatives Is preferable.
育毛用薬剤・血行促進剤・刺激剤としては、センブリエキス、トウガラシチンキ、ショウキョウチンキ、ショウキョウエキス、カンタリスチンキ等の植物エキス・チンキ類;カプサイシン、ノニル酸ワニリルアミド、ジンゲロン、イクタモール、タンニン酸、ボルネオール、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ-オリザノール、ビタミンE及びニコチン酸トコフェロール・酢酸トコフェロール等の誘導体、γ-オリザノール、ニコチン酸及びニコチン酸アミド・ニコチン酸ベンジルエステル・イノシトールヘキサニコチネート、ニコチンアルコール等の誘導体、アラントイン、感光素301、感光素401、塩化カプロニウム、ペンタデカン酸モノグリセリド、フラバノノール誘導体、スチグマステロール又はスチグマスタノール及びその配糖体、ミノキシジルが好ましいものとして挙げられる。 Plant extracts and tinctures such as assembly extract, red pepper tincture, ginger tincture, ginger extract, cantalis tincture; capsaicin, nonylic acid vanillylamide, gingeron, ictamol, tannic acid Borneol, cyclandrate, cinnarizine, trazoline, acetylcholine, verapamil, cephalanthin, γ-oryzanol, vitamin E and derivatives such as tocopherol / nicotinic acid tocopherol, γ-oryzanol, nicotinic acid, nicotinic acid amide, nicotinic acid benzyl ester, Inositol hexanicotinate, derivatives such as nicotine alcohol, allantoin, photosensitive element 301, photosensitive element 401, capronium chloride, pentadecanoic acid monoglyceride, flavonol Derivatives, stigmasterol or stigmasterol and its glycosides, and minoxidil are preferred.
ホルモン類としては、エストラジオール、エストロン、エチニルエストラジオール、コルチゾン、ヒドロコルチゾン、プレドニゾン等が好ましいものとして挙げられる。抗しわ剤、抗老化剤、ひきしめ剤、冷感剤、温感剤、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤等のその他の薬効剤としては、レチノール類、レチノイン酸類、レチノイン酸トコフェリル;乳酸、グリコール酸、グルコン酸、フルーツ酸、サリチル酸及びその配糖体・エステル化物等の誘導体、ヒドロキシカプリン酸、長鎖α-ヒドロキシ脂肪酸、長鎖α-ヒドロキシ脂肪酸コレステリル等のα-又はβ-ヒドロキシ酸類及びその誘導体類;γ-アミノ酪酸、γ-アミノ-β-ヒドロキシ酪酸;カルニチン;カルノシン;クレアチン;セラミド類、スフィンゴシン類;カフェイン、キサンチン等及びその誘導体;コエンザイムQ10、カロチン、リコピン、アスタキサンチン、ルテイン、α-リポ酸、白金ナノコロイド、フラーレン類等の抗酸化・活性酸素消去剤;カテキン類;ケルセチン等のフラボン類;イソフラボン類;没食子酸及びエステル糖誘導体;タンニン、セサミン、プロトアントシアニジン、クロロゲン酸、リンゴポリフェノール等のポリフェノール類;ルチン及び配糖体等の誘導体;ヘスペリジン及び配糖体等の誘導体;リグナン配糖体;グラブリジン、グラブレン、リクイリチン、イソリクイリチン等のカンゾウエキス関連物質;ラクトフェリン;ショウガオール、ジンゲロール;メントール、セドロール等の香料物質及びその誘導体;カプサイシン、バニリン等及び誘導体;ジエチルトルアミド等の昆虫忌避剤;生理活性物質とシクロデキストリン類との複合体が好ましいものとして挙げられる。 Preferred examples of hormones include estradiol, estrone, ethinyl estradiol, cortisone, hydrocortisone, prednisone and the like. Other remedies such as anti-wrinkle agents, anti-aging agents, squeeze agents, cooling sensations, warming sensation agents, wound healing promoters, irritation relievers, analgesics, cell activators include retinols, retinoic acids, retinoin Acid tocopheryl; derivatives such as lactic acid, glycolic acid, gluconic acid, fruit acid, salicylic acid and glycosides / esterified products thereof, α- or such as hydroxycapric acid, long chain α-hydroxy fatty acid, long chain α-hydroxy fatty acid cholesteryl β-hydroxy acids and derivatives thereof; γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid; carnitine; carnosine; creatine; ceramides, sphingosines; caffeine, xanthine and the like; coenzyme Q10, carotene, lycopene , Astaxanthin, lutein, α-lipoic acid, platinum nanocolloid, fullerenes, etc. Antioxidant / active oxygen scavengers; catechins; flavones such as quercetin; isoflavones; gallic acid and ester sugar derivatives; polyphenols such as tannin, sesamin, protoanthocyanidin, chlorogenic acid, apple polyphenol; rutin and glycosides, etc. Derivatives of hesperidin and glycosides; lignan glycosides; licorice extract-related substances such as grabrizine, glabrene, liquiritin and isoliquiritin; lactoferrin; shogaol, gingerol; fragrance substances such as menthol and cedrol and their derivatives; capsaicin And insecticides such as diethyl toluamide; complexes of physiologically active substances and cyclodextrins are preferred.
植物・動物・微生物エキス類としては、アイリスエキス、アシタバエキス、アスナロエキス、アスパラガスエキス、アボカドエキス、アマチャエキス、アーモンドエキス、アルテアエキス、アルニカエキス、アロエエキス、アンズエキス、アンズ核エキス、イチョウエキス、インチコウエキス、ウイキョウエキス、インチンコウエキス、ウコンエキス、ウーロン茶エキス、ウワウルシエキス、エイジツエキス、エチナシ葉エキス、エンメイソウエキス、オウゴンエキス、オウバクエキス、オウレンエキス、オオムギエキス、オタネニンジンエキス、オトギリソウエキス、オドリコソウエキス、オノニスエキス、オランダカラシエキス、オレンジエキス、海水乾燥物、海藻エキス、カキ葉エキス、カキョクエキス、加水分解エラスチン、加水分解コムギ末、加水分解シルク、カッコンエキス、カモミラエキス、油溶性カモミラエキス、カロットエキス、カワラヨモギエキス、カラスムギエキス、カルカデエキス、カンゾウエキス、油溶性カンゾウエキス、キウイエキス、キオウエキス、キクラゲエキス、キナエキス、キューカンバーエキス、キリ葉エキス、グアノシン、グアバエキス、クジンエキス、クチナシエキス、クマザサエキス、クララエキス、クルミエキス、クリエキス、グレープフルーツエキス、クレマティスエキス、黒米エキス、黒砂糖抽出物、黒酢、クロレラエキス、クワエキス、ゲンチアナエキス、ゲンノショウコエキス、紅茶エキス、酵母エキス、コウボクエキス、コーヒーエキス、ゴボウエキス、コメエキス、コメ発酵エキス、コメヌカ発酵エキス、コメ胚芽油、コンフリーエキス、コラーゲン、コケモモエキス、サイシンエキス、サイコエキス、サイタイ抽出液、サフランエキス、サルビアエキス、サボンソウエキス、ササエキス、サンザシエキス、サンシャエキス、サンショウエキス、シイタケエキス、ジオウエキス、シコンエキス、シソエキス、シナノキエキス、シモツケソウエキス、ジャトバエキス、シャクヤクエキス、ショウキュウエキス、ショウブ根エキス、シラカバエキス、白キクラゲエキス、スギナエキス、ステビアエキス、ステビア発酵物、西河柳エキス、セイヨウキズタエキス、セイヨウサンザシエキス、セイヨウニワトコエキス、セイヨウノコギリソウエキス、セイヨウハッカエキス、セージエキス、ゼニアオイエキス、センキュウエキス、センブリエキス、ソウハクヒエキス、ダイオウエキス、ダイズエキス、タイソウエキス、タイムエキス、タンポポエキス、地衣類エキス、茶エキス、チョウジエキス、チガヤエキス、チンピエキス、ティートリー油、甜茶エキス、トウガラシエキス、トウキエキス、トウキンセンカエキス、トウニンエキス、トウヒエキス、ドクダミエキス、トマトエキス、納豆エキス、ニンジンエキス、ニンニクエキス、ノバラエキス、ハイビスカスエキス、バクモンドウエキス、ハスエキス、パセリエキス、バーチエキス、蜂蜜、ハマメリスエキス、パリエタリアエキス、ヒキオコシエキス、ビサボロール、ヒノキエキス、ビフィズス菌エキス、ビワエキス、フキタンポポエキス、フキノトウエキス、ブクリョウエキス、ブッチャーブルームエキス、ブドウエキス、ブドウ種子エキス、プロポリス、ヘチマエキス、ベニバナエキス、ペパーミントエキス、ボダイジュエキス、ボタンエキス、ホップエキス、マイカイカエキス、マツエキス、マロニエエキス、ミズバショウエキス、ムクロジエキス、メリッサエキス、モズクエキス、モモエキス、ヤグルマギクエキス、ユーカリエキス、ユキノシタエキス、ユズエキス、ユリエキス、ヨクイニンエキス、ヨモギエキス、ラベンダーエキス、緑茶エキス、卵殻膜エキス、リンゴエキス、ルイボス茶エキス、レイシエキス、レタスエキス、レモンエキス、レンギョウエキス、レンゲソウエキス、ローズエキス、ローズマリーエキス、ローマカミツレエキス、ローヤルゼリーエキス、ワレモコウエキス等のエキスが好ましいものとして挙げられる。 Plant / animal / microbe extracts include iris extract, ashitaba extract, asunalo extract, asparagus extract, avocado extract, achacha extract, almond extract, altea extract, arnica extract, aloe extract, apricot extract, apricot kernel extract, ginkgo biloba extract , Chinchilla extract, fennel extract, ginseng extract, turmeric extract, oolong tea extract, walnut extract, ages extract, echinacea leaf extract, enme extract, gonon extract, duckweed extract, pollen extract, barley extract, ginseng extract, hypericum extract , Nettle extract, onionis extract, Dutch mustard extract, orange extract, dried sea water, seaweed extract, oyster leaf extract, oyster extract, hydrolyzed elastin, water Dehydrated wheat powder, hydrolyzed silk, cocoon extract, chamomile extract, oil-soluble chamomile extract, carrot extract, cormorant mugwort extract, oat extract, calcade extract, licorice extract, oil-soluble licorice extract, kiwi extract, kiou extract, jellyfish extract, quina extract, cucumber Extract, Giri Leaf Extract, Guanosine, Guava Extract, Kujin Extract, Gardenia Extract, Kumazasa Extract, Clara Extract, Walnut Extract, Chestnut Extract, Grapefruit Extract, Clematis Extract, Black Rice Extract, Brown Sugar Extract, Black Vinegar, Chlorella Extract, Mulberry Extract, Gentian Extract, Gennoshoco extract, Black tea extract, Yeast extract, Koboku extract, Coffee extract, Burdock extract, Rice extract, Rice fermented extract, Rice bran extract, Rice germ , Comfrey extract, Collagen, Cowberry extract, Saishin extract, Psycho extract, Saitai extract, Saffron extract, Salvia extract, Salmon extract, Sasa extract, Hawthorn extract, Sansha extract, Salamander extract, Shiitake extract, Giant extract, Shikon extract, Perilla extract , Linden extract, citrus extract, jatoba extract, peony extract, ginger cucumber extract, ginger root extract, birch extract, white jellyfish extract, horse chestnut extract, stevia extract, stevia fermented product, Nishikawa willow extract, horseshoe extract, hawthorn extract, elderberry Extract, yarrow extract, mint extract, sage extract, mallow extract, nematode extract, essence extract, sedge extract , Diou extract, Soybean extract, Tisoiso extract, Thyme extract, Dandelion extract, Lichen extract, Tea extract, Clove extract, Chigaya extract, Chimpi extract, Tea tree oil, Chacha tea extract, Capsicum extract, Toki extract, Tokinen extract, Tonin extract, Spruce extract, Dokudami Extract, Tomato Extract, Natto Extract, Carrot Extract, Garlic Extract, Novara Extract, Hibiscus Extract, Bacmond Extract, Lotus Extract, Parsley Extract, Birch Extract, Honey, Hamamelis Extract, Parietalia Extract, Hikikoshi Extract, Bisabolol, Cypress Extract, Bifidobacteria extract, loquat extract, Japanese dandelion extract, Japanese cypress extract, Bukkuri extract, Butcher bloom extract, grape extract, grape seed extract, pro Squirrel, loofah extract, safflower extract, peppermint extract, body sage extract, button extract, hop extract, squirrel squid extract, pine extract, maroonnier extract, citrus extract, sorghum extract, melissa extract, mozuku extract, peach extract, cornflower extract, eucalyptus extract, yukinoshita Extract, Yuzu Extract, Lily Extract, Yakuinin Extract, Artemisia Extract, Lavender Extract, Green Tea Extract, Eggshell Membrane Extract, Apple Extract, Rooibos Tea Extract, Ganoderma Extract, Lettuce Extract, Lemon Extract, Forsythia Extract, Forsythia Extract, Rose Extract, Rosemary Extract , Extracts such as Roman chamomile extract, royal jelly extract, and bitumen extract are preferable.
鎮痒剤としては、塩酸ジフェンヒドラミン、マレイン酸クロルフェニラミン、カンフル、サブスタンス-P阻害剤等が挙げられる。 Examples of antipruritic agents include diphenhydramine hydrochloride, chlorpheniramine maleate, camphor, substance-P inhibitor, and the like.
角質剥離・溶解剤としては、サリチル酸、イオウ、レゾルシン、硫化セレン、ピリドキシン等が挙げられる。 Examples of the exfoliating / dissolving agent include salicylic acid, sulfur, resorcin, selenium sulfide, pyridoxine and the like.
制汗剤としては、クロルヒドロキシアルミニウム、塩化アルミニウム、酸化亜鉛、パラフェノールスルホン酸亜鉛等が挙げられる。 Examples of antiperspirants include chlorohydroxyaluminum, aluminum chloride, zinc oxide, zinc paraphenol sulfonate, and the like.
清涼剤としては、メントール、サリチル酸メチル等が挙げられる。 Examples of the refreshing agent include menthol and methyl salicylate.
収れん剤としては、クエン酸、酒石酸、乳酸、硫酸アルミニウム・カリウム、タンニン酸等が挙げられる。 Examples of astringents include citric acid, tartaric acid, lactic acid, aluminum sulfate / potassium, and tannic acid.
酵素類としては、スーパーオキサイドディスムターゼ、カタラーゼ、塩化リゾチーム、リパーゼ、パパイン、パンクレアチン、プロテアーゼ等が挙げられる。 Enzymes include superoxide dismutase, catalase, lysozyme chloride, lipase, papain, pancreatin, protease, and the like.
核酸類としては、リボ核酸及びその塩、デオキシリボ核酸及びその塩、アデノシン三リン酸二ナトリウムが好ましいものとして挙げられる。 Preferred nucleic acids include ribonucleic acid and its salts, deoxyribonucleic acid and its salts, and adenosine triphosphate disodium.
香料としては、アセチルセドレン、アミルシンナムアルデヒド、アリルアミルグリコレート、β-イオノン、イソイースーパー、イソブチルキノリン、イリス油、イロン、インドール、イランイラン油、ウンデカナール、ウンデセナール、γ-ウンデカラクトン、エストラゴール、オイゲノール、オークモス、オポポナックスレジノイド、オレンジ油、オイゲノール、オーランチオール、ガラクソリッド、カルバクロール、L-カルボン、カンフル、キャノン、キャロットシード油、クローブ油、ケイヒ酸メチル、ゲラニオール、ゲラニルニトリル、酢酸イソボルニル、酢酸ゲラニル、酢酸ジメチルベンジルカルビニル、酢酸スチラリル、酢酸セドリル、酢酸テレピネル、酢酸p-t-ブチルシクロヘキシル、酢酸ベチベリル、酢酸ベンジル、酢酸リナリル、サリチル酸イソペンチル、サリチル酸ベンジル、サンダルウッド油、サンタロール、シクラメンアルデヒド、シクロペンタデカノリド、ジヒドロジャスモン酸メチル、ジヒドロミルセノール、ジャスミンアブソリュート、ジャスミンラクトン、cis-ジャスモン、シトラール、シトロネノール、シトロネラール、シナモンバーク油、1,8-シネオール、シンナムアルデヒド、スチラックスレジノイド、セダーウッド油、セドレン、セドロール、セロリシード油、タイム油、ダマスコン、ダマセノン、チモール、チュベローズアブソリュート、デカナール、デカラクトン、テルピネオール、γ-テルピネン、トリプラール、ネロール、ノナナール、2,6-ノナジエノール、ノナラクトン、パチョリアルコール、バニラアブソリュート、バニリン、バジル油、パチョリ油、ヒドロキシシトロネラール、α-ピネン、ピペリトン、フェネチルアルコール、フェニルアセトアルデヒド、プチグレン油、ヘキシルシンナムアルデヒド、cis-3-ヘキセノール、ペルーバルサム、ベチバー油、ベチベロール、ペパーミント油、ペパー油、ヘリオトロピン、ベルガモット油、ベンジルベンゾエート、ボルネオール、ミルレジノイド、ムスクケトン、メチルノニルアセトアルデヒド、γ-メチルヨノン、メントール、L-メントール、L-メントン、ユーカリ油、β-ヨノン、ライム油、ラベンダー油、D-リモネン、リナロール、リラール、リリアール、レモン油、ローズアブソリュート、ローズオキシド、ローズ油、ローズマリー油、各種精油等の合成香料及び天然香料並びに各種調合香料が好ましいものとして挙げられる。 As perfumes, acetyl cedrene, amylcinnamaldehyde, allyl amyl glycolate, β-ionone, iso-Esuper, isobutyl quinoline, Iris oil, Iron, indole, ylang ylang oil, undecanal, undecenal, γ-undecalactone, Estragole, eugenol, oak moss, opoponax resinoid, orange oil, eugenol, auranthiol, galac solid, carvacrol, L-carvone, camphor, cannon, carrot seed oil, clove oil, methyl cinnamate, geraniol, geranyl nitrile , Isobornyl acetate, geranyl acetate, dimethylbenzyl carvinyl acetate, styraryl acetate, cedolyl acetate, terpinel acetate, pt-butylcyclohexyl acetate, vetiberyl acetate, benzyl acetate Linalyl acetate, isopentyl salicylate, benzyl salicylate, sandalwood oil, santalol, cyclamenaldehyde, cyclopentadecanolide, methyl dihydrojasmonate, dihydromyrsenol, jasmine absolute, jasmine lactone, cis-jasmon, citral, citronenol, Citronellal, cinnamon bark oil, 1,8-cineole, cinnamaldehyde, stylus resinoid, cedarwood oil, cedrene, cedrol, celery seed oil, thyme oil, damascon, damasenone, thymol, tuberose absolute, decanal, decalactone, terpineol, γ- Terpinene, triplar, nerol, nonanal, 2,6-nonadienol, nonalactone, patchouli alcohol, vanilla Solute, vanillin, basil oil, patchouli oil, hydroxycitronellal, α-pinene, piperitone, phenethyl alcohol, phenylacetaldehyde, petitglen oil, hexylcinnamaldehyde, cis-3-hexenol, perubalsum, vetiver oil, vetiverol, peppermint oil , Pepper oil, heliotropin, bergamot oil, benzylbenzoate, borneol, milresinoid, musk ketone, methylnonylacetaldehyde, γ-methylyonone, menthol, L-menthol, L-menton, eucalyptus oil, β-yonone, lime oil, lavender oil Synthetic and natural flavors such as D-limonene, linalool, linal, rillial, lemon oil, rose absolute, rose oxide, rose oil, rosemary oil, and various essential oils In addition, various kinds of blended fragrances are preferable.
色素・着色剤・染料としては、褐色201号、黒色401号、紫色201号、紫色401号、青色1号、青色2号、青色201号、青色202号、青色203号、青色204号、青色205号、青色403号、青色404号、緑色201号、緑色202号、緑色204号、緑色205号、緑色3号、緑色401号、緑色402号、赤色102号、赤色104-1号、赤色105-1号、赤色106号、赤色2号、赤色201号、赤色202号、赤色203号、赤色204号、赤色205号、赤色206号、赤色207号、赤色208号、赤色213号、赤色214号、赤色215号、赤色218号、赤色219号、赤色220号、赤色221号、赤色223号、赤色225号、赤色226号、赤色227号、赤色228号、赤色230-1号、赤色230-2号、赤色231号、赤色232号、赤色3号、赤色401号、赤色404号、赤色405号、赤色501号、赤色502号、赤色503号、赤色504号、赤色505号、赤色506号、橙色201号、橙色203号、橙色204号、橙色205号、橙色206号、橙色207号、橙色401号、橙色402号、橙色403号、黄色201号、黄色202-1号、黄色202-2号、黄色203号、黄色204号、黄色205号、黄色4号、黄色401号、黄色402号、黄色403-1号、黄色404号、黄色405号、黄色406号、黄色407号、黄色5号等の法定色素;Acid Red 14等のその他酸性染料;Arianor Sienna Brown、Arianor Madder Red、Arianor Steel Blue、Arianor Straw Yellow等の塩基染料;HC Yellow 2、HC Yellow 5、HC Red 3、4-hydoxypropylamino-3-nitrophenol、N,N’-bis(2-hydroxyethyl)-2-nitro-p-phenylenediamine、HC Blue 2、Basic Blue 26等のニトロ染料;分散染料;アスタキサンチン、アリザリン等のアントラキノン類、アントシアニジン、β-カロチン、カテナール、カプサンチン、カルコン、カルサミン、クエルセチン、クロシン、クロロフィル、クルクミン、コチニール、シコニン等のナフトキノン類、ビキシン、フラボン類、ベタシアニジン、ヘナ、ヘモグロビン、リコピン、リボフラビン、ルチン等の天然色素・染料;p-フェニレンジアミン、トルエン-2,5-ジアミン、o-,m-,若しくはp-アミノフェノール、m-フェニレンジアミン、5-アミノ-2-メチルフェノール、レゾルシン、1-ナフトール、2,6-ジアミノピリジン等及びその塩等の酸化染料中間体及びカップラー;インドリン等の自動酸化型染料;ジヒドロキシアセトンが好ましいものとして挙げられる。 As pigments / colorants / dyes, brown 201, black 401, purple 201, purple 401, blue 1, blue 2, blue 201, blue 202, blue 203, blue 204, blue 205, Blue 403, Blue 404, Green 201, Green 202, Green 204, Green 205, Green 3, Green 401, Green 402, Red 102, Red 104-1, Red 105-1, Red 106, Red 2, Red 201, Red 202, Red 203, Red 204, Red 205, Red 206, Red 207, Red 208, Red 213, Red 214, Red 215, Red 218, Red 219, Red 220, Red 221, Red 223, Red 225, Red 226, Red 227, Red 228, Red 230-1 Red 230-2, Red 231, Red 232, Red 3, Red 401, Red 404, Red 404, Red 405, Red 501, Red 502, Red 503, Red 504, Red 505 Red No. 506, Orange No. 201, Orange No. 203, Orange No. 204, Orange No. 205, Orange No. 206, Orange No. 207, Orange No. 401, Orange No. 402, Orange No. 403, Yellow No. 201, Yellow No. 202-1 Yellow 202-2, Yellow 203, Yellow 204, Yellow 205, Yellow 4, Yellow 401, Yellow 402, Yellow 403-1, Yellow 404, Yellow 405, Yellow 406, Yellow Legal pigments such as No. 407 and Yellow No. 5; Other acidic dyes such as Acid Red 14; Aryanor Sienna Brown, Aryanor Madder Red, Ari Basic dyes such as nor Steel Blue, Aryanor Straw Yellow, etc .; HC Yellow 2, HC Yellow 5, HC Red 3, 4-hydroxypropylamino-3-Ntrobisphenol, N, N'-bis (2-hydroxyethyl-2) Nitro dyes such as phenylenediamine, HC Blue 2, Basic Blue 26; disperse dyes; anthraquinones such as astaxanthin and alizarin, anthocyanidins, β-carotene, catenal, capsanthin, chalcone, calsamine, quercetin, crocin, chlorophyll, curcumin, cochineal, cochineal Naphthoquinones such as bixin, flavones, betacyanidine, henna, hemoglobin Natural pigments and dyes such as glycine, lycopene, riboflavin and rutin; p-phenylenediamine, toluene-2,5-diamine, o-, m-, or p-aminophenol, m-phenylenediamine, 5-amino-2- Preferable examples include oxidative dye intermediates and couplers such as methylphenol, resorcin, 1-naphthol, 2,6-diaminopyridine, and salts thereof; auto-oxidative dyes such as indoline; and dihydroxyacetone.
消炎剤・抗炎症剤としては、グリチルリチン酸及びその誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキチオール、グアイアズレン、アラントイン、インドメタシン、ケトプロフェン、イブプロフェン、ジクロフェナク、ロキソプロフェン、セレコシキブ、インフリキシマブ、エタネルセプト、酸化亜鉛、酢酸ヒドロコルチゾン、プレドニゾン、塩酸ジフェドラミン、マレイン酸クロルフェニラミン;桃葉エキス、蓬葉エキス等の植物エキスが好ましいものとして挙げられる。 Anti-inflammatory / anti-inflammatory agents include glycyrrhizic acid and its derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, guaiazulene, allantoin, indomethacin, ketoprofen, ibuprofen, diclofenac, loxoprofen, celecoxib, infliximab, etanercept, zinc oxide, hydroacetic acid, zinc acetate, Preferred examples include prednisone, diphedramine hydrochloride, chlorpheniramine maleate; and plant extracts such as peach leaf extract and persimmon leaf extract.
抗喘息、抗慢性閉塞性肺疾患、抗アレルギー、免疫調整剤としては、アミノフィリン、テオフィリン類、ステロイド類(フルチカゾン、ベクロメタゾンなど)、ロイコトリエン拮抗薬類、トロンボキサン阻害薬類、インタール、β2刺激薬類(フォルモテロール、サルメテロール、アルブテロール、ツロブテロール、クレンブテロール、エピネフリンなど)、チオトロピウム、イプラトロピウム、デキストロメトルファン、ジメモルファン、ブロムヘキシン、トラニラスト、ケトチフェン、アゼラスチン、セチリジン、クロルフェニラミン、メキタジン、タクロリムス、シクロスポリン、シロリムス、メトトレキサート、サイトカイン調整剤類、インターフェロン、オマリズマブ、タンパク/抗体製剤が好ましいものとして挙げられる。 Anti-asthma, anti-chronic obstructive pulmonary disease, anti-allergy, immunomodulators include aminophylline, theophylline, steroids (fluticasone, beclomethasone, etc.), leukotriene antagonists, thromboxane inhibitors, intal, β2-stimulant (Formoterol, salmeterol, albuterol, tulobuterol, clenbuterol, epinephrine, etc.), tiotropium, ipratropium, dextromethorphan, dimemorphan, bromhexine, tranilast, ketotifen, azelastine, cetirizine, chlorpheniramine, polyquitolsine, Preferred examples include cytokine regulators, interferons, omalizumab, and protein / antibody preparations.
抗感染症剤、抗真菌剤としては、オセルタミビルとザナミビル、イトラコナゾールが好ましいものとして挙げられる。これらの他、化粧品原料基準、化粧品種別配合成分規格、日本化粧品工業連合会成分表示名称リスト、INCI辞書(The International Cosmetic Ingredient Dictionaryand Handbook)、医薬部外品原料規格、日本薬局方、医薬品添加物規格、食品添加物公定書等に記載されている成分、及び、国際特許分類IPCがA61K7及びA61K8の分類に属する日本国及び諸外国特許公報及び特許公開公報(公表公報・再公表を含む)に記載されている成分等、公知の化粧料成分、医薬品成分、食品成分などを、公知の組み合わせ及び配合比・配合量で含有させることが可能である。 Preferred examples of the anti-infective and antifungal agents include oseltamivir, zanamivir, and itraconazole. In addition to these, cosmetic raw material standards, cosmetic ingredient-specific combination ingredient standards, Japan Cosmetic Industry Association ingredient display name list, INCI dictionary (The International Cosmetic Ingredients and Handbooks), quasi-drug ingredients standards, Japanese pharmacopoeia, pharmaceutical additive standards Ingredients listed in the Food Addendum, etc., and the international patent classification IPC described in Japan and other foreign patent gazettes and patent publications (including publications and republications) belonging to the A61K7 and A61K8 classifications It is possible to contain known cosmetic ingredients, pharmaceutical ingredients, food ingredients, etc., in known combinations, blending ratios and blending amounts.
[分散液の製造方法]
本発明の分散液は、前記式(1)乃至式(3)で表される化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド化合物からなる顔料又は粉体用分散剤と、界面活性剤、水、1,2-アルカンジオール又は1,3-アルカンジオール、脂肪酸、並びに顔料及び粉体からなる群から選択される少なくとも一種、そして所望により多価アルコール等のその他添加剤とを用い、加熱しながらこれらを混合・撹拌し、その後、室温程度になるまで撹拌冷却することによって製造され得る。
[Method for producing dispersion]
The dispersion of the present invention is a pigment or powder dispersant comprising a lipid peptide compound comprising at least one of the compounds represented by the formulas (1) to (3) or a pharmaceutically usable salt thereof. And at least one selected from the group consisting of surfactants, water, 1,2-alkanediols or 1,3-alkanediols, fatty acids, pigments and powders, and optionally other additives such as polyhydric alcohols These are mixed and stirred with heating, and then stirred and cooled to about room temperature.
例えば本発明の分散液は、一例として、下記工程により製造される。
a)上記顔料又は粉体用分散剤(脂質ペプチド化合物)と、界面活性剤と、水を配合し、加熱して溶解液(又は分散液)を調製する工程、
b)上記溶解液(又は分散液)を水に添加し、室温以上100℃未満の温度で加熱する工程、
c)前記加熱工程における温度よりも低い温度になるまで撹拌しながら冷却し、本発明の分散液を得る工程。
ここで、1,2-アルカンジオール又は1,3-アルカンジオール、脂肪酸、並びに顔料及び粉体からなる群から選択される少なくとも一種、そしてその他成分は、a)工程において溶解液(又は分散液)の調製工程において添加してもよいし、b)工程において溶解液(又は分散液)を添加する水に予め添加していてもよい。
またこうして得られた本発明の(顔料及び粉体からなる群から選択される少なくとも一種を含む)分散液の総質量に対して、水は60質量%以上99.9質量%以下であることが好ましい。
For example, the dispersion of the present invention is produced by the following process as an example.
a) a step of blending the above-mentioned pigment or powder dispersant (lipid peptide compound), a surfactant, and water, and heating to prepare a solution (or dispersion);
b) adding the solution (or dispersion) to water and heating at a temperature of room temperature to less than 100 ° C .;
c) A step of cooling with stirring until the temperature is lower than the temperature in the heating step to obtain the dispersion of the present invention.
Here, at least one selected from the group consisting of 1,2-alkanediol or 1,3-alkanediol, fatty acid, and pigment and powder, and the other components are the solution (or dispersion) in step a). It may be added in the preparation step, or may be added in advance to the water to which the solution (or dispersion) is added in step b).
Further, water is 60% by mass or more and 99.9% by mass or less based on the total mass of the dispersion liquid (including at least one selected from the group consisting of pigment and powder) of the present invention thus obtained. preferable.
前記a)工程及びb)工程における加熱温度は好ましくは50℃乃至90℃、より好ましくは60℃乃至90℃、例えば80℃であり、加熱しながら撹拌を行うことが好ましい。この時の夫々の工程における加熱撹拌の時間は、用いる顔料又は粉体用分散剤(脂質ペプチド化合物)や、界面活性剤ほかその他成分の種類、そしてそれらの配合量によって異なるが、通常1分から50分程度で溶解・分散可能である。
a)、b)工程につづいて、液温がb)工程における温度よりも低い温度になるまで撹拌しながら冷却を行う(c)工程)。ここで冷却温度は例えば室温乃至80℃、室温乃至60℃、或いは室温乃至40℃程度である。
The heating temperature in the step a) and the step b) is preferably 50 ° C. to 90 ° C., more preferably 60 ° C. to 90 ° C., for example 80 ° C., and stirring is preferably performed while heating. The heating and stirring time in each step at this time varies depending on the pigment or powder dispersant (lipid peptide compound) used, the type of the surfactant and other components, and the blending amount thereof, but usually from 1 minute to 50 minutes. It can be dissolved and dispersed in about minutes.
Following steps a) and b), cooling is performed with stirring until the liquid temperature is lower than the temperature in step b) (step c). Here, the cooling temperature is, for example, room temperature to 80 ° C., room temperature to 60 ° C., or room temperature to 40 ° C.
また本発明の分散液はプレミックスである水性組成物を製造した後、該プレミックスに他の配合成分を適宜添加して製造することもできる。
例えば、プレミックスを経た分散液の製造方法としては、以下が挙げられる。
1)プレミックスを調製する工程
1-1)界面活性剤及び水と、顔料又は粉体用分散剤(前記式(1)乃至式(3)で表される化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物)とを含む混合系を室温以上100℃未満の温度に加熱する加熱工程、
1-2)続いて、加熱した前記混合系に、1,2-アルカンジオール又は1,3-アルカンジオール、脂肪酸及びその他添加剤を適宜添加する工程、
1-3)前記溶解液又は分散液を冷却し、水性組成物(プレミックス)を得る調製工程、
2)プレミックスを用いて分散液を製造する工程
2-1)室温以上100℃未満の温度に加熱された水相に、室温以上100℃未満の温度に加熱した上記水性組成物(プレミックス)を添加し、混合する、或いは、室温以上100℃未満の温度に加熱した上記水性組成物(プレミックス)に、室温以上100℃未満の温度に加熱された水相を添加し、混合する、混合工程、
2-2)前記混合工程で得られた混合物を撹拌冷却し、分散液を得る冷却工程。
上記2-1)工程における水相は水を含み、さらに高級アルコール、顔料を含み得、また1,2-アルカンジオール又は1,3-アルカンジオール、脂肪酸、及びその他添加剤を含んでいてもよい。また、2-1)において水性組成物(プレミックス)に顔料やその他添加剤を混合した後、水相とあわせてもよい。
さらに、前記混合工程において、更に薬剤の溶解液を添加することにより、薬剤を添加した分散液(製剤)を製造することもできる。
Moreover, after manufacturing the aqueous composition which is a premix, the dispersion liquid of this invention can also be manufactured by adding another compounding component to this premix suitably.
For example, the following is mentioned as a manufacturing method of the dispersion liquid which passed through the premix.
1) Step for preparing premix 1-1) Surfactant and water, pigment or powder dispersant (compound represented by the above formulas (1) to (3) or pharmaceutically usable thereof) A heating step of heating a mixed system comprising a lipid peptide-type compound comprising at least one of salts) to a temperature of room temperature to less than 100 ° C.,
1-2) Subsequently, a step of appropriately adding 1,2-alkanediol or 1,3-alkanediol, fatty acid and other additives to the heated mixed system,
1-3) A preparation step of cooling the solution or dispersion to obtain an aqueous composition (premix),
2) Step of producing dispersion using premix 2-1) The aqueous composition (premix) heated to a temperature of room temperature to less than 100 ° C. in an aqueous phase heated to a temperature of room temperature to less than 100 ° C. Add the water phase heated to a temperature of room temperature to less than 100 ° C. and mix with the aqueous composition (premix) heated to a temperature of room temperature to less than 100 ° C. Process,
2-2) A cooling step in which the mixture obtained in the mixing step is stirred and cooled to obtain a dispersion.
The aqueous phase in the above step 2-1) contains water, may further contain higher alcohols and pigments, and may contain 1,2-alkanediol or 1,3-alkanediol, fatty acids, and other additives. . Further, in 2-1), a pigment and other additives may be mixed with the aqueous composition (premix) and then combined with the aqueous phase.
Furthermore, in the mixing step, a dispersion (preparation) to which a drug is added can also be produced by adding a drug solution.
前記1-1)工程及び1-2)工程における、混合系(及び水性組成物)の加熱温度は好ましくは50℃乃至90℃、より好ましくは60℃乃至90℃、例えば70℃、或いは80℃である。本工程は好ましくは撹拌しながら実施することが好ましい。この時の各工程における加熱(撹拌)の時間は、水性組成物に含まれる顔料又は粉体用分散剤(脂質ペプチド化合物)や界面活性剤ほかその他成分の種類、そしてそれらの配合量によって異なるが、通常5分から50分程度である。本工程により水性組成物を均一に溶解させた状態とする。
また、前記1-3)工程における冷却温度は、例えば室温乃至80℃、室温乃至60℃、或いは室温乃至40℃程度である。この工程において、好ましくは撹拌しながら冷却し、その後撹拌を停止して、静置することがより好ましい。
なお1)工程により得られた水性組成物(プレミックス)の総質量に対して、水は30質量%以上80質量%未満であることが好ましい。
The heating temperature of the mixed system (and aqueous composition) in the steps 1-1) and 1-2) is preferably 50 ° C. to 90 ° C., more preferably 60 ° C. to 90 ° C., for example 70 ° C., or 80 ° C. It is. This step is preferably carried out with stirring. The heating (stirring) time in each step at this time varies depending on the types of pigments, powder dispersants (lipid peptide compounds), surfactants and other components contained in the aqueous composition, and the blending amount thereof. Usually, about 5 to 50 minutes. By this step, the aqueous composition is uniformly dissolved.
The cooling temperature in the step 1-3) is, for example, room temperature to 80 ° C., room temperature to 60 ° C., or room temperature to 40 ° C. In this step, it is more preferable to cool with stirring, and then stop stirring and leave still.
In addition, it is preferable that water is 30 mass% or more and less than 80 mass% with respect to the total mass of the aqueous composition (premix) obtained by the 1) process.
前記2-1)工程における、水相及び水性組成物(プレミックス)の加熱温度は好ましくは50℃乃至90℃、より好ましくは60℃乃至90℃、例えば70℃、或いは80℃、あるいは90℃である。水相の加熱はその他成分を含むことから撹拌しながら行うことが好ましく、含有する成分が均一に溶解・分散するまで、通常1分から50分程度、加熱(撹拌)を実施することが好ましい。なお、水相の加熱温度は、上記水性組成物(プレミックス)の加熱温度と同じ温度としてもよい。 In the step 2-1), the heating temperature of the aqueous phase and the aqueous composition (premix) is preferably 50 ° C. to 90 ° C., more preferably 60 ° C. to 90 ° C., such as 70 ° C., or 80 ° C., or 90 ° C. It is. The aqueous phase is preferably heated with stirring because it contains other components, and it is usually preferred to carry out heating (stirring) for about 1 to 50 minutes until the contained components are uniformly dissolved and dispersed. The heating temperature of the aqueous phase may be the same as the heating temperature of the aqueous composition (premix).
続いて、前記2-2)工程において、前工程で得られた混合物を撹拌冷却し、分散液を得る。撹拌しながら冷却する際、例えば冷却温度が室温ないし80℃、室温ないし60℃、例えば60℃程度となるまで撹拌を実施した後、その後撹拌を停止して静置し冷却してもよい。 Subsequently, in the step 2-2), the mixture obtained in the previous step is stirred and cooled to obtain a dispersion. When cooling with stirring, for example, stirring may be performed until the cooling temperature reaches room temperature to 80 ° C., room temperature to 60 ° C., for example, about 60 ° C., and then stirring may be stopped and allowed to stand and cool.
こうして水性組成物(プレミックス)を用いた得られた分散液においても、水の配合量は、分散液の総質量に対して、60質量%以上99.9質量%以下であることが好ましい。 Thus, also in the obtained dispersion using the aqueous composition (premix), the blending amount of water is preferably 60% by mass or more and 99.9% by mass or less with respect to the total mass of the dispersion.
以下、本発明を実施例及び試験例を例に挙げて詳しく説明するが、本発明がこれらの例に限定されるものではない。 Hereinafter, the present invention will be described in detail by way of examples and test examples, but the present invention is not limited to these examples.
[合成例1:脂質ペプチド(N-パルミトイル-Gly-His)の合成]
本実施例において用いた脂質ペプチド型化合物を以下に示す方法で合成した。
500mLの4つ口フラスコに、ヒスチジン14.2g(91.6mmol)、N-パルミトイル-Gly-メチル30.0g(91.6mmol)、トルエン300gを投入し、塩基であるナトリウムメトキサイド 28%メタノール溶液35.3g(183.2mmol)を加え、油浴で60℃に加熱し1時間撹拌を続けた。その後、油浴を外し、25℃まで放冷し、この溶液をアセトン600gで再沈殿させ、ろ取した。ここで得られた固体を、水600gとメタノール750gの混合溶液に溶解し、ここに6規定塩酸30.5ml(183.2mmol)を加えて中和し固体を析出させ、ろ過した。次に、得られた固体をテトラヒドロフラン120gと水30gの混合溶液に60℃で溶解させ、酢酸エチル150gを加え、60℃から30℃まで冷却した。その後、析出した固体をろ過した。さらに得られた固体を、テトラヒドロフラン120gとアセトニトリル60g溶剤中に溶解し、60℃に加熱し、1時間撹拌した後に冷却し、ろ過した。ここで得られた固体を水120gで洗浄し、ろ過後に減圧乾燥を行いN-パルミトイル-Gly-Hisフリー体(以下、単にPal-GHとも称する)の白色の結晶、26.9g(収率65%)を得た。
[Synthesis Example 1: Synthesis of lipid peptide (N-palmitoyl-Gly-His)]
The lipid peptide type compound used in this example was synthesized by the following method.
A 500 mL four-necked flask was charged with 14.2 g (91.6 mmol) of histidine, 30.0 g (91.6 mmol) of N-palmitoyl-Gly-methyl and 300 g of toluene, and a sodium methoxide 28% methanol solution as a base. 35.3 g (183.2 mmol) was added, and the mixture was heated to 60 ° C. in an oil bath and stirred for 1 hour. Thereafter, the oil bath was removed and the mixture was allowed to cool to 25 ° C. This solution was reprecipitated with 600 g of acetone and collected by filtration. The solid obtained here was dissolved in a mixed solution of 600 g of water and 750 g of methanol, and 30.5 ml (183.2 mmol) of 6N hydrochloric acid was added thereto for neutralization to precipitate a solid, followed by filtration. Next, the obtained solid was dissolved in a mixed solution of 120 g of tetrahydrofuran and 30 g of water at 60 ° C., 150 g of ethyl acetate was added, and the mixture was cooled from 60 ° C. to 30 ° C. Thereafter, the precipitated solid was filtered. Further, the obtained solid was dissolved in 120 g of tetrahydrofuran and 60 g of acetonitrile, heated to 60 ° C., stirred for 1 hour, cooled, and filtered. The solid obtained here was washed with 120 g of water, dried under reduced pressure after filtration, and 26.9 g (yield 65) of white crystals of N-palmitoyl-Gly-His free form (hereinafter also simply referred to as “Pal-GH”). %).
[実施例1:顔料10質量%配合リキッドファンデーションの作製]
下記表1に従い、顔料を10質量%配合したリキッドファンデーションを調製した。
ラボランスクリュー管瓶(No.7、アズワン(株))中で、顔料5.0gと純水33.0gを80℃にて2分間撹拌し、ここに80℃に加熱した1,2-ヘキサンジオール1.0gを添加して、2分間撹拌混合した。
ここに、80℃に加熱した組成物[1]1.0gを添加して2分間撹拌混合した後、80℃に加熱したグリセリン10.0gを添加して3分間撹拌混合し、そのまま室温になるまで撹拌冷却し、リキッドファンデーションを得た。
なお組成物[1]は表1に示す組成にて、Pal-GH、ポリオキシエチレンラウリルエーテル及び精製水を混合し70℃に加熱撹拌し、ここに1,2-ヘキサンジオール及びステアリン酸を加えてさらに70℃で加熱撹拌した後、室温まで放冷することにより得た。また以下の実施例においても、同様の手順にて得た組成物[1]を用いた。
以上の製造工程における撹拌はすべて400rpmで行った。
[Example 1: Preparation of liquid foundation containing 10% by mass of pigment]
According to the following Table 1, a liquid foundation containing 10% by mass of pigment was prepared.
In a Laboran screw tube (No. 7, As One Co., Ltd.), 5.0 g of pigment and 33.0 g of pure water were stirred at 80 ° C. for 2 minutes and heated to 80 ° C. with 1,2-hexane. 1.0 g of diol was added and stirred for 2 minutes.
To this, 1.0 g of the composition [1] heated to 80 ° C. was added and stirred for 2 minutes, then 10.0 g of glycerin heated to 80 ° C. was added and stirred for 3 minutes, and the temperature reached room temperature. The solution was stirred and cooled to obtain a liquid foundation.
Composition [1] has the composition shown in Table 1 and is mixed with Pal-GH, polyoxyethylene lauryl ether, and purified water, heated and stirred at 70 ° C., and 1,2-hexanediol and stearic acid were added thereto. The mixture was further stirred at 70 ° C. and then allowed to cool to room temperature. Also in the following examples, the composition [1] obtained by the same procedure was used.
All stirring in the above manufacturing process was performed at 400 rpm.
[実施例2:顔料10質量%配合水白粉ファンデーションの作製]
組成物[1]を0.5g、純水を33.5gとした以外は実施例1と同様の手順にて、表1に示す顔料を10質量%配合した水白粉ファンデーションを製造した。
[Example 2: Preparation of 10% by mass pigment white water powder foundation]
A white powder foundation containing 10% by mass of the pigment shown in Table 1 was produced in the same procedure as in Example 1 except that 0.5 g of the composition [1] and 33.5 g of pure water were used.
[実施例3:顔料15質量%配合水白粉ファンデーションの作製]
顔料を7.5g、純水を31gとした以外は実施例2と同様の手順にて、表1に示す顔料を15質量%配合した水白粉ファンデーションを製造した。
[Example 3: Preparation of a white powder foundation containing 15% by mass of pigment]
A white powder foundation containing 15% by mass of the pigment shown in Table 1 was produced in the same procedure as in Example 2 except that 7.5 g of the pigment and 31 g of pure water were used.
[比較例1]
組成物[1]を配合せず、純水を34.0gとした以外は、実施例1と同様の手順にて、表1に示す顔料を10質量%配合した比較例のファンデーションを調製した。
[Comparative Example 1]
A foundation of a comparative example in which 10% by mass of the pigment shown in Table 1 was blended was prepared in the same procedure as in Example 1 except that the composition [1] was not blended and the pure water was changed to 34.0 g.
図1に実施例1乃至実施例3並びに比較例1のファンデーション(外観)を示す。
図1に示すように、Pal-GHを含有する組成物[1]を配合した、実施例1乃至実施例3においては、顔料が散し、顔料の分散安定性が確認された。また、Pal-GHを含有する組成物[1]の配合量を調整することにより、粘性の高いリキッドファンデーションタイプ(実施例1)と、それに比べ粘性の低い水白粉ファンデーションタイプ(実施例2及び実施例3)とを調製可能であった。
一方、Pal-GHを含有する組成物[1]を配合しない比較例1では、図1に示すように、顔料とその他の成分が分離し、顔料が沈殿する結果となった。
FIG. 1 shows the foundations (appearance) of Examples 1 to 3 and Comparative Example 1.
As shown in FIG. 1, in Examples 1 to 3 in which the composition [1] containing Pal-GH was blended, the pigment was scattered and the dispersion stability of the pigment was confirmed. Further, by adjusting the blending amount of the composition [1] containing Pal-GH, a liquid foundation type with high viscosity (Example 1) and a white powder foundation type with low viscosity (Example 2 and Example) Example 3) could be prepared.
On the other hand, in Comparative Example 1 in which the composition [1] containing Pal-GH was not blended, as shown in FIG. 1, the pigment and other components were separated, resulting in precipitation of the pigment.
[実施例4:パール顔料2質量%配合分散液の作製]
下記表2に従い、パール顔料を2質量%配合した分散液を調製した。
ラボランスクリュー管瓶(No.7、アズワン(株))中で、パール顔料1.0gと純水33.5gを80℃にて2分間撹拌し、ここに80℃に加熱した1,3-ブチレングリコール(1,3-ブタンジオール)5.0gを添加して、2分間撹拌混合した。
ここに、80℃に加熱した組成物[1]0.5gを添加して2分間撹拌混合した後、80℃に加熱したグリセリン10.0gを添加して3分間撹拌混合し、そのまま室温になるまで撹拌冷却し、分散液を得た。
以上の製造工程における撹拌はすべて400rpmで行った。
[Example 4: Preparation of dispersion liquid containing 2% by mass of pearl pigment]
According to Table 2 below, a dispersion containing 2% by mass of pearl pigment was prepared.
In a Labor screw screw bottle (No. 7, As One Co., Ltd.), 1.0 g of pearl pigment and 33.5 g of pure water were stirred at 80 ° C. for 2 minutes, and then heated to 80 ° C. 5.0 g of butylene glycol (1,3-butanediol) was added and mixed with stirring for 2 minutes.
To this, 0.5 g of composition [1] heated to 80 ° C. was added and mixed with stirring for 2 minutes, then 10.0 g of glycerin heated to 80 ° C. was added and mixed for 3 minutes, and the temperature reached room temperature. The solution was stirred and cooled to obtain a dispersion.
All stirring in the above manufacturing process was performed at 400 rpm.
[実施例5:パール顔料0.5質量%配合分散液の作製]
下記表2に従い、パール顔料を0.5質量%配合した分散液を調製した。
ラボランスクリュー管瓶(No.7、アズワン(株))中で、パール顔料0.25gと純水49.25gを80℃にて2分間撹拌し、ここに80℃に加熱した組成物[1]0.5gを添加して2分間撹拌混合した後、そのまま室温になるまで撹拌冷却し、分散液を得た。
以上の製造工程における撹拌はすべて400rpmで行った。
[Example 5: Preparation of 0.5% by mass of pearl pigment dispersion]
According to the following Table 2, a dispersion liquid containing 0.5% by mass of a pearl pigment was prepared.
In a Labor screw screw bottle (No. 7, AS ONE Co., Ltd.), 0.25 g of pearl pigment and 49.25 g of pure water were stirred at 80 ° C. for 2 minutes and heated to 80 ° C. [1] After adding 0.5 g and stirring and mixing for 2 minutes, the mixture was stirred and cooled to room temperature as it was to obtain a dispersion.
All stirring in the above manufacturing process was performed at 400 rpm.
[比較例2]
組成物[1]を配合せず、純水を34.0gとした以外は、実施例4と同様の手順にて、表2に示すパール顔料を2質量%配合した比較例の分散液を調製した。
[Comparative Example 2]
A dispersion of a comparative example containing 2% by mass of the pearl pigment shown in Table 2 was prepared in the same procedure as in Example 4 except that the composition [1] was not blended and 34.0 g of pure water was used. did.
図2に実施例4及び実施例5並びに比較例2のパール顔料配合分散液(外観)を示す。
図2に示すように、Pal-GHを含有する組成物[1]を配合しなかった比較例2においては、パール顔料とその他成分が分離し、パール顔料が沈殿する結果となったが、該組成物[1]を配合した実施例4及び実施例5においては、パール顔料の分散性が改善される結果となった。
FIG. 2 shows pearl pigment-containing dispersions (appearance) of Examples 4 and 5 and Comparative Example 2.
As shown in FIG. 2, in Comparative Example 2 in which the composition [1] containing Pal-GH was not blended, the pearl pigment and other components were separated, resulting in precipitation of the pearl pigment. In Example 4 and Example 5 in which the composition [1] was blended, the dispersibility of the pearl pigment was improved.
[実施例6:リン酸三カルシウム分散液の作製]
下記表3に従い、リン酸三カルシウムを0.5質量%配合した分散液を調製した。
ラボランスクリュー管瓶(No.7、アズワン(株))中で、リン酸三カルシウム0.25gと純水49.25gを80℃にて2分間撹拌し、ここに80℃に加熱した組成物[1]0.5gを添加して2分間撹拌混合した後、そのまま室温になるまで撹拌冷却し、分散液を得た。
以上の製造工程における撹拌はすべて400rpmで行った。
[Example 6: Preparation of tricalcium phosphate dispersion]
According to Table 3 below, a dispersion containing 0.5% by mass of tricalcium phosphate was prepared.
A composition obtained by stirring 0.25 g of tricalcium phosphate and 49.25 g of pure water at 80 ° C. for 2 minutes in a Laborun screw tube bottle (No. 7, As One Co., Ltd.) and heating it to 80 ° C. [1] After adding 0.5 g and stirring and mixing for 2 minutes, the mixture was stirred and cooled to room temperature as it was to obtain a dispersion.
All stirring in the above manufacturing process was performed at 400 rpm.
[比較例3]
組成物[1]を配合せず、純水を49.75gとした以外は、実施例5と同様の手順にて、表3に示すリン酸三カルシウムを0.5質量%配合した比較例の分散液を調製した。
[Comparative Example 3]
A comparative example in which 0.5% by mass of tricalcium phosphate shown in Table 3 was blended in the same procedure as in Example 5 except that the composition [1] was not blended and the pure water was 49.75 g. A dispersion was prepared.
図3に実施例6及び比較例3のリン酸三カルシウム配合分散液(外観)を示す。
図3に示すように、Pal-GHを含有する組成物[1]を配合しなかった比較例3においては、リン酸三カルシウムとその他成分が分離し、リン酸三カルシウムが沈殿する結果となったが、該組成物[1]を配合した実施例6においては、リン酸三カルシウムの分散性が改善される結果となった。
FIG. 3 shows the tricalcium phosphate blend dispersion (appearance) of Example 6 and Comparative Example 3.
As shown in FIG. 3, in Comparative Example 3 in which the composition [1] containing Pal-GH was not blended, tricalcium phosphate and other components were separated, resulting in precipitation of tricalcium phosphate. However, in Example 6 containing the composition [1], the dispersibility of tricalcium phosphate was improved.
[実施例7:金箔0.01質量%配合分散液の作製]
下記表4に従い、金箔(およそ2mm角~10mm角)を0.01質量%配合した分散液を調製した。
ラボランスクリュー管瓶(No.7、アズワン(株))中で、金箔5mgと、純水49.745gを80℃にて2分間撹拌し、ここに80℃に加熱した組成物[1]0.25gを添加して2分間撹拌混合した後、そのまま室温になるまで撹拌冷却し、分散液を得た。
以上の製造工程における撹拌はすべて400rpmで行った。
[Example 7: Production of 0.01% by mass of gold foil mixed dispersion]
According to Table 4 below, a dispersion liquid containing 0.01% by mass of gold foil (approximately 2 mm square to 10 mm square) was prepared.
A composition [1] 0 in which 5 mg of gold foil and 49.745 g of pure water were stirred at 80 ° C. for 2 minutes and heated to 80 ° C. in a Laboran screw tube (No. 7, As One Co., Ltd.) .25 g was added and stirred and mixed for 2 minutes, and then stirred and cooled to room temperature as it was to obtain a dispersion.
All stirring in the above manufacturing process was performed at 400 rpm.
[実施例8:金箔0.05質量%配合分散液の作製]
金箔を25mg、組成物[1]を0.5g、純水を49.475gとした以外は実施例7と同様の手順にて、表4に示す金箔を0.05質量%配合した分散液を製造した。
[Example 8: Preparation of 0.05 mass% dispersion of gold foil]
A dispersion containing 0.05% by mass of the gold foil shown in Table 4 was prepared in the same manner as in Example 7 except that 25 mg of the gold foil, 0.5 g of the composition [1] and 49.475 g of pure water were used. Manufactured.
[比較例4]
組成物[1]を配合せず、純水を49.95gとした以外は、実施例7と同様の手順にて、表4に示す金箔を0.01質量%配合した比較例の分散液を調製した。
[Comparative Example 4]
A dispersion of a comparative example in which 0.01% by mass of the gold foil shown in Table 4 was blended in the same procedure as in Example 7 except that the composition [1] was not blended and the pure water was 49.95 g. Prepared.
図4に実施例7及び実施例8並びに比較例4の金箔配合分散液(外観)を示す。
図4に示すように、Pal-GHを含有する組成物[1]を配合しなかった比較例4においては、金箔とその他成分が分離し、金箔が浮遊またはその重量によっては沈殿する結果となったが、該組成物[1]を配合した実施例7及び実施例8においては、リン酸三カルシウムの分散性が改善される結果となった。
またこのとき、Pal-GHを含有する組成物[1]の配合量を調整することにより、金箔の配合量や分散液の透明性を調整可能である結果となった。
FIG. 4 shows the gold foil-containing dispersion (appearance) of Examples 7 and 8 and Comparative Example 4.
As shown in FIG. 4, in Comparative Example 4 in which the composition [1] containing Pal-GH was not blended, the gold foil and other components were separated, and the gold foil floated or precipitated depending on its weight. However, in Examples 7 and 8 in which the composition [1] was blended, the dispersibility of tricalcium phosphate was improved.
At this time, it was possible to adjust the blending amount of the gold foil and the transparency of the dispersion by adjusting the blending amount of the composition [1] containing Pal-GH.
[実施例9:顔料17質量%配合 O/Wリキッドファンデーションの作製]
下記表5に従い、顔料17質量%を均一に分散したファンデーションを調製した。
200mLビーカー(HARIO株式会社製)中で、顔料(フレッシュカラーベースアクア)34.0g、精製水139.6g、N-ステアロイルメチルタウリンナトリウム(NIKKOL SMT、日光ケミカルズ(株))0.2g、レシチン(LPA、日光ケミカルズ(株))0.2g、EDTA-2Na(純正化学(株))0.2g、ヒドロキシプロピルセルロース(NISSO SSL、日本曹達(株))0.4g、キサンタンガム(KELTROL-CG-ST、三晶(株))0.4gを混合し、75℃で10分間加熱撹拌した(B相)。
200mLビーカー(HARIO株式会社製)中で、NIKKOLニコムルス41(日光ケミカルズ(株))4.0g、NIKKOL NATURAL OILS(日光ケミカルズ(株))14.0g、NIKKOLニコガード88(日光ケミカルズ(株))1.0gを加えて75℃で10分間加熱撹拌した(A相)。
B相に対してA相をゆっくりと撹拌しながら添加し、得られた混合物を75℃中でホモミキサー(QUICK HOMO MIXER LR-1A、みづほ工業株式会社製)を用いて5,000rpmで3分間乳化処理を行った。さらに、75℃に加熱した組成物[1]2.0gを添加して、75℃中で2分間加熱撹拌した後に、40℃になるまで室温で撹拌冷却を行った。40℃になったことを確認し、NIKKOL NET-813-1(日光ケミカルズ(株))4.0g(C相)を添加して、35℃になるまで撹拌冷却を行った。
以上の工程において、撹拌は全て200rpmで行った。
[Example 9: Preparation of 17% by mass of pigment and preparation of O / W liquid foundation]
According to Table 5 below, a foundation in which 17% by mass of pigment was uniformly dispersed was prepared.
In a 200 mL beaker (made by HARIO), 34.0 g of pigment (fresh color base aqua), 139.6 g of purified water, 0.2 g of sodium N-stearoylmethyl taurine (NIKKOL SMT, Nikko Chemicals), lecithin (LPA) , 0.2 g of Nikko Chemicals Co., Ltd., 0.2 g of EDTA-2Na (Pure Chemical Co., Ltd.), 0.4 g of hydroxypropylcellulose (NISSO SSL, Nippon Soda Co., Ltd.), xanthan gum (KELTROL-CG-ST, 0.4 g of Sanki Co., Ltd. was mixed and heated and stirred at 75 ° C. for 10 minutes (phase B).
In a 200 mL beaker (manufactured by HARIO Co., Ltd.), NIKKOL Nicomulus 41 (Nikko Chemicals Co., Ltd.) 4.0 g, NIKKOL NATURAL OILS (Nikko Chemicals Co., Ltd.) 14.0 g, NIKKOL Nicoguard 88 (Nikko Chemicals Co., Ltd.) 1 0.0 g was added and stirred with heating at 75 ° C. for 10 minutes (phase A).
Phase A was added to Phase B with slow stirring, and the resulting mixture was added at 75 ° C. for 3 minutes at 5,000 rpm using a homomixer (QUICK HOMO MIXER LR-1A, manufactured by Mizuho Industry Co., Ltd.). An emulsification treatment was performed. Further, 2.0 g of the composition [1] heated to 75 ° C. was added, and the mixture was heated and stirred at 75 ° C. for 2 minutes, and then stirred and cooled at room temperature until reaching 40 ° C. After confirming that the temperature reached 40 ° C., 4.0 g (phase C) of NIKKOL NET-813-1 (Nikko Chemicals Co., Ltd.) was added, and stirring and cooling were performed until the temperature reached 35 ° C.
In the above steps, all stirring was performed at 200 rpm.
[比較例5]
下記表5に従い、顔料17質量%を配合したファンデーションを調製した。
200mLビーカー(HARIO株式会社製)中で、顔料(フレッシュカラーベースアクア)34.0g、精製水141.6g、N-ステアロイルメチルタウリンナトリウム(NIKKOL SMT、日光ケミカルズ(株))0.2g、レシチン(LPA、日光ケミカルズ(株))0.2g、EDTA-2Na(純正化学(株))0.2g、ヒドロキシプロピルセルロース(NISSO SSL、日本曹達(株))0.4g、キサンタンガム(KELTROL-CG-ST、三晶(株))0.4gを混合し、75℃で10分間加熱撹拌した(B相)。
200mLビーカー(HARIO株式会社製)中で、NIKKOLニコムルス41(日光ケミカルズ(株))4.0g、NIKKOL NATURAL OILS(日光ケミカルズ(株))14.0g、NIKKOLニコガード88(日光ケミカルズ(株))1.0gを加えて75℃で10分間加熱撹拌した(A相)。
B相に対してA相をゆっくりと撹拌しながら添加し、得られた混合物を75℃中でホモミキサー(QUICK HOMO MIXER LR-1A、みづほ工業株式会社製)を用いて5,000rpmで3分間乳化処理を行った。その後、40℃になるまで室温で撹拌冷却を行い、NIKKOL NET-813-1(日光ケミカルズ(株))4.0g(C相)を添加し、35℃になるまで撹拌冷却を行った。
以上の工程において、撹拌は全て200rpmで行った。
[Comparative Example 5]
According to Table 5 below, a foundation containing 17% by mass of pigment was prepared.
In a 200 mL beaker (manufactured by HARIO), 34.0 g of pigment (fresh color base aqua), 141.6 g of purified water, 0.2 g of sodium N-stearoylmethyltaurine (NIKKOL SMT, Nikko Chemicals), lecithin (LPA) , 0.2 g of Nikko Chemicals Co., Ltd., 0.2 g of EDTA-2Na (Pure Chemical Co., Ltd.), 0.4 g of hydroxypropylcellulose (NISSO SSL, Nippon Soda Co., Ltd.), xanthan gum (KELTROL-CG-ST, 0.4 g of Sanki Co., Ltd. was mixed and heated and stirred at 75 ° C. for 10 minutes (phase B).
In a 200 mL beaker (manufactured by HARIO Co., Ltd.), NIKKOL Nicomulus 41 (Nikko Chemicals Co., Ltd.) 4.0 g, NIKKOL NATURAL OILS (Nikko Chemicals Co., Ltd.) 14.0 g, NIKKOL Nicoguard 88 (Nikko Chemicals Co., Ltd.) 1 0.0 g was added and stirred with heating at 75 ° C. for 10 minutes (phase A).
Phase A was added to Phase B with slow stirring, and the resulting mixture was added at 75 ° C. for 3 minutes at 5,000 rpm using a homomixer (QUICK HOMO MIXER LR-1A, manufactured by Mizuho Industry Co., Ltd.). An emulsification treatment was performed. Thereafter, stirring and cooling were performed at room temperature until reaching 40 ° C., 4.0 g (C phase) of NIKKOL NET-813-1 (Nikko Chemicals Co., Ltd.) was added, and stirring and cooling were performed until reaching 35 ° C.
In the above steps, all stirring was performed at 200 rpm.
図5に実施例9および比較例5のO/Wリキッドファンデーションの偏光顕微鏡(オリンパス(株)製)観察(写真)による顔料分散性評価の結果を示す。図5に示すように、Pal-GHを含有する組成物[1]を配合しなかった比較例5においては、顔料の凝集が多く観察され、分散性が不均一となる結果であったが、該組成物[1]を配合した実施例9においては、顔料の分散性が改善される結果となった。 FIG. 5 shows the results of pigment dispersibility evaluation by observation (photograph) of a polarizing microscope (manufactured by Olympus Corporation) of the O / W liquid foundation of Example 9 and Comparative Example 5. As shown in FIG. 5, in Comparative Example 5 in which the composition [1] containing Pal-GH was not blended, a lot of pigment aggregation was observed, resulting in non-uniform dispersibility. In Example 9 containing the composition [1], the dispersibility of the pigment was improved.
図6に、リキッドファンデーション調製後、1ヶ月静置保存した後の、実施例9および比較例5のO/Wリキッドファンデーション(外観)を示す。図6に示すように、Pal-GHを含有する組成物[1]を配合しなかった比較例5においては、顔料や油分の分離が観察され(図中、分離の状態が色ムラとなって観察される)、分散性が不均一となる結果であったが、該組成物[1]を配合した実施例9においては、顔料の分散性が改善される結果となった。
FIG. 6 shows the O / W liquid foundation (appearance) of Example 9 and Comparative Example 5 after the liquid foundation was prepared and stored for one month. As shown in FIG. 6, in Comparative Example 5 in which the composition [1] containing Pal-GH was not blended, separation of the pigment and oil was observed (in the figure, the separation state was uneven color). Observed), the dispersibility was non-uniform, but in Example 9 in which the composition [1] was blended, the dispersibility of the pigment was improved.
Claims (9)
水と、
下記式(1)乃至式(3)で表される化合物又はその薬学的に使用可能な塩のうちの少なくとも一種からなる脂質ペプチド型化合物からなる顔料又は粉体用分散剤と、
1,2-アルカンジオール又は1,3-アルカンジオールと、
少なくとも一種の脂肪酸と、
顔料及び粉体からなる群から選択される少なくとも一種とを含む、
分散液。
water and,
A pigment or powder dispersant comprising a lipid peptide type compound comprising at least one of the compounds represented by the following formulas (1) to (3) or a pharmaceutically usable salt thereof:
1,2-alkanediol or 1,3-alkanediol;
At least one fatty acid,
Including at least one selected from the group consisting of pigments and powders,
Dispersion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019512559A JPWO2018190383A1 (en) | 2017-04-12 | 2018-04-11 | Dispersion containing pigment or powder dispersant |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017079128 | 2017-04-12 | ||
| JP2017-079128 | 2017-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2018190383A1 true WO2018190383A1 (en) | 2018-10-18 |
Family
ID=63793228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2018/015275 Ceased WO2018190383A1 (en) | 2017-04-12 | 2018-04-11 | Dispersion liquid containing dispersant for pigments or powders |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2018190383A1 (en) |
| TW (1) | TW201902451A (en) |
| WO (1) | WO2018190383A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113957730A (en) * | 2021-12-13 | 2022-01-21 | 高阳县信誉印染有限公司 | Printing and dyeing agent for fabric and printing and dyeing process thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014003015A1 (en) * | 2012-06-25 | 2014-01-03 | 日産化学工業株式会社 | Dispersion liquid and hydrogel formation method |
| WO2015099074A1 (en) * | 2013-12-25 | 2015-07-02 | 日産化学工業株式会社 | Stick-shaped base material containing lipid-peptide compound |
| WO2016121867A1 (en) * | 2015-01-28 | 2016-08-04 | 国立大学法人九州大学 | Transdermally absorbable base material comprising lipid peptide-type compound |
| WO2016121822A1 (en) * | 2015-01-28 | 2016-08-04 | 国立大学法人九州大学 | Moisturizing base material including lipid-peptide compound |
| JP2016193840A (en) * | 2015-03-31 | 2016-11-17 | 株式会社ナリス化粧品 | Aqueous gel-like cosmetic |
| JP2016193836A (en) * | 2015-03-31 | 2016-11-17 | 株式会社ナリス化粧品 | Solid cosmetic |
| WO2016208460A1 (en) * | 2015-06-24 | 2016-12-29 | 日産化学工業株式会社 | Method for adjusting hardness of stick-shaped substrate containing lipid-peptide-type compound |
| WO2016208442A1 (en) * | 2015-06-24 | 2016-12-29 | 日産化学工業株式会社 | Stick-shaped substrate containing lipid-peptide-type compound |
-
2018
- 2018-04-11 JP JP2019512559A patent/JPWO2018190383A1/en active Pending
- 2018-04-11 WO PCT/JP2018/015275 patent/WO2018190383A1/en not_active Ceased
- 2018-04-12 TW TW107112512A patent/TW201902451A/en unknown
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014003015A1 (en) * | 2012-06-25 | 2014-01-03 | 日産化学工業株式会社 | Dispersion liquid and hydrogel formation method |
| WO2015099074A1 (en) * | 2013-12-25 | 2015-07-02 | 日産化学工業株式会社 | Stick-shaped base material containing lipid-peptide compound |
| WO2016121867A1 (en) * | 2015-01-28 | 2016-08-04 | 国立大学法人九州大学 | Transdermally absorbable base material comprising lipid peptide-type compound |
| WO2016121822A1 (en) * | 2015-01-28 | 2016-08-04 | 国立大学法人九州大学 | Moisturizing base material including lipid-peptide compound |
| JP2016193840A (en) * | 2015-03-31 | 2016-11-17 | 株式会社ナリス化粧品 | Aqueous gel-like cosmetic |
| JP2016193836A (en) * | 2015-03-31 | 2016-11-17 | 株式会社ナリス化粧品 | Solid cosmetic |
| WO2016208460A1 (en) * | 2015-06-24 | 2016-12-29 | 日産化学工業株式会社 | Method for adjusting hardness of stick-shaped substrate containing lipid-peptide-type compound |
| WO2016208442A1 (en) * | 2015-06-24 | 2016-12-29 | 日産化学工業株式会社 | Stick-shaped substrate containing lipid-peptide-type compound |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201902451A (en) | 2019-01-16 |
| JPWO2018190383A1 (en) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6274440B2 (en) | Dispersion and hydrogel formation method | |
| JP6132108B2 (en) | Hydrogel-forming material, premix and hydrogel-forming method | |
| KR102292009B1 (en) | Dispersion liquid and method for forming hydrogel | |
| US11771645B2 (en) | Transdermally absorbable base material containing lipid peptide compound | |
| JP6624380B2 (en) | Stick-shaped substrate containing lipid peptide type compound | |
| JP6734568B2 (en) | Stick-shaped substrate containing lipid peptide type compound | |
| JP6802711B2 (en) | Moisturizing base material containing a lipid peptide type compound | |
| JP2015051961A (en) | Percutaneous absorption substrate | |
| JP6613486B2 (en) | Thickening composition containing lipid peptide type compound | |
| JP6694166B2 (en) | Method for adjusting hardness of stick-shaped substrate containing lipid peptide type compound | |
| JP6660034B2 (en) | Stick-shaped substrate containing lipid peptide type compound | |
| WO2018117156A1 (en) | Stick-type solid preparation base for external application to skin | |
| KR20200108447A (en) | Composition containing powder | |
| WO2018190383A1 (en) | Dispersion liquid containing dispersant for pigments or powders | |
| WO2018207947A1 (en) | Polysaccharide-containing stick-shaped base material | |
| WO2018207948A1 (en) | Stick-shaped base material having high water content |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18784536 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2019512559 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 18784536 Country of ref document: EP Kind code of ref document: A1 |